Ina tsammani tsawon wane lokaci ne wannan bayyanar ta ci gaba?
kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman a shekarunka
Kuma da zazzabi.
kuma abin da ya kamata a duba shi ne yawan hawan jini na cholesterol
kuma kuna da zazzabi a yanzu?
kuma kana fama da ciwon kirji a yanzu?
kuma a gefe guda, kuna da wahalar numfashi?
kuma za ku iya gaya mini wasu cututtukan da kuke fuskanta tare da waɗannan cututtukan?
kuma yadda high zafin jiki da zazzabi
kuma ina da tari
kuma na samu mura da kuma tari
kuma kirji na na ciwo sosai a yau
kuma shin wannan lokaci ne mai kyau don kamuwa da cutar rashin lafiyanku?
kuma yana da ciwon kirji
kuma ina ganin ina da zazzabi kadan
kuma ina so ku kwatanta wannan ciwon kirji
kuma suna da zazzabi kadan
kuma tare da tarihin ciwon sukari
kuma ka san na ji kamar na breast zai karya
kuma ka san mutane suna tari a kaina a duk tsawon lokacin
kuma kuna da ciwon kirji
kuma ka ce akwai wani matsa lamba a kirji
kowa a cikin iyali da ke fama da cututtukan zuciya cututtukan zuciya cututtukan zuciya cututtukan zuciya high cholesterol high jini
ko kuma wata cuta ko wata cuta da ka lura da ita ta shafi ciwon tsoka?
Shin akwai wani mutum a gida da yake da irin wannan rashin lafiya?
Shin kana da wasu alamun cututtuka?
Shin kana fama da matsalar numfashi?
Shin har yanzu kuna fama da ciwon kirji?
Domin wannan lokacin na mura ne.
amma kuma bai kamata a ware mu ba saboda ciwon kirji wanda ya fito ne daga zuciya.
Amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji.
amma ina da matsalar numfashi
amma na san mutane da yawa suna tari ni
Amma dole ne mu kula da duk wani ciwon kirji da gaske.
amma kuna numfashi sosai yanzu, ba haka ba?
Na manta da shi a lokacin da na ji zafi a kirjina.
Kuna jin kamar wani yana matsawa a kirjinku?
Shin har yanzu ina jin kamar ina numfashi?
Shin sun yi gunaguni cewa suna da irin wannan rashin lafiya?
Shin kana da wasu cututtuka na kullum kamar hawan jini ko wani abu?
Shin kana da wasu cututtuka masu tsanani kamar ciwon sukari?
Shin kana fama da matsalar numfashi da ke damunka?
Kana da hawan jini?
Shin kana fama da numfashi tare da shi?
Shin kun san alamun da yake fuskanta?
Ka ga wannan hoton?
sha ruwa mai yawa a yau
Amma na yi gwajin ciwon sukari.
Amma ta samu irin wannan bayyanar cututtuka.
Yaya zafin zafin jikinka yake?
Yaya karfin jini kake?
idan kana da zazzabi mai zafi
idan kuna da zazzabi mai zafi da zafin jiki ya kai ɗari biyu ko sama da haka
Idan ka ji wata alama ko wata matsala, kana bukatar a duba ka.
Na yi zazzabi a jiya
Ina da zazzabi kuma
Na yi zazzabi a jiya
Ina da ciwo mai tsanani a kirji.
Ina da matsala kadan na numfashi kuma
Zan aika muku da hoton
Na ji zafi a kirji a yau
Na ji zafi da zazzabi a yau
Ina ganin wannan shi ne mura
Ina ganin wannan shi ne m mura
Shin yana jin kamar wani mutum mai nauyi yana zaune a kan kirjinka?
Dukkanin su na farawa ne da ciwon kai da kuma zazzabi a lokaci guda.
ciwo a tsakiyar ƙirjina
Na ji kamar na ji ciwon kirji
Yana cikin kirji na
Yana cikin ƙirjina.
Yana cikin tsakiyar kirji
Ina jin zafi a kirji
Ina matukar damuwa game da wannan ciwon kirji
Ina so ka gaya mini da kwatanta wannan ciwon kirji
kamar hawan jini ko ciwon sukari
kamar a tsakiyar ƙirjin
Yanzu za ku iya shan candy Tachipirina
Yanzu Mary, tsawon kwanaki nawa ka sha irin wannan bayyanar?
Yanzu ka ce kana da ciwon kirji
Wani lokaci ina jin zafi a kirji.
ok ka samu wasu bayyanar cututtuka tare da wannan banda kawai ciwo
ko kuma wani ya zauna a kan kirjinka?
kusan daidai yake da zazzabi da tari da ciwon kai da ciwon tsoka
a tsakiyar ƙirjina
Ka nuna min a wannan hoton inda kake jin zafi
Tun da yake kana da zazzabi
Shin kana ganin wasu daga cikin cututtukan sun shafi yanayin da kake ciki?
Shin yaranku suna da irin wannan alamun?
Ka gaya mani game da ciwon kirjinka.
zazzabi ya tashi a daren
wannan zazzabin da na sha kwana biyu da suka gabata
Farfadowar ta fara tashi a daren jiya
Wannan shi ne Dr. Porter a cikin wani cibiyar triage dakin gaggawa
Za ka iya gaya mini game da ciwon kirjinka?
Ina jin zafi a gaba na jiki a kirji na.
Ina da ciwo mai tsanani a kirji
Lokacin da na ji zafi a kirji
Shin, kuna jin ciwon kirji a kirjinku?
A wane lokaci ne wannan ciwon kirji ya fara?
A ina kake jin zafi a kirji?
NS
Kana jin kamar numfashi yana cikin kirjinka
Ka san ina da ciwon sukari da sauran cututtuka.
Ka ce kana da wannan ciwon kirji.
Kashi na kamuwa da cutar coronavirus (COVID-19) da ke ƙaruwa cikin sauri a cikin Tarayyar Turai/Tsarki na Tattalin Arziki na Turai da United Kingdom, 1 ga Janairu zuwa 15 ga Maris, 2020
Kasuwancin kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin ƙasashen Tarayyar Turai/Ƙungiyar Tattalin Arzikin Turai da United Kingdom sun tabbatar da cewa, duk da cewa suna cikin matakan daban-daban dangane da ƙasa, annobar COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, ya kamata kasashen, asibitoci da cibiyoyin kula da lafiya su kara shirye-shiryen su na karuwar yawan marasa lafiya da COVID-19 da za su bukaci kulawar lafiya, musamman kulawar lafiya.
A ranar 31 ga Disamba, 2019, an samu rahoton wani kwayar cutar pneumonia daga wani wuri da ba a san asalinsa ba a Wuhan, Hubei Province, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar China ta ruwaito cewa sabon coronavirus ne ke haifar da cutar, wanda yanzu ake kira cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Tun daga wannan lokacin, cutar da ta haifar da kamuwa da cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Ya zuwa yanzu an tabbatar da cewa kusan kashi 80% na mutanen da ke da COVID-19 suna da wani abu mai sauki, wato kamuwa da cutar numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin waɗannan marasa lafiya sun warke.
A cikin kimanin kashi 14 cikin dari na shari'o'in, COVID-19 ya zama mummunan cuta wanda ke buƙatar magani a asibiti yayin da sauran kashi 6 cikin dari na shari'o'in ke da mummunan cuta wanda ke buƙatar kulawa mai kyau.
Mutuwar marasa lafiya da ke asibiti sakamakon COVID-19 ya kai kusan kashi 4%.
A cikin wannan binciken, mun kimanta yanayin yanayin abubuwan da ke faruwa a cikin COVID-19 a kowace ƙasa ta Tarayyar Turai/Ƙungiyar Tattalin Arzikin Turai (EU/EEA) da Burtaniya (UK) kuma mun kwatanta waɗannan ƙasashe da Hubei, China.
Mun kuma kwatanta yawan adadin COVID-19 a cikin EU/EEA da Birtaniya da na Italiya a ranar 31 ga Janairu zuwa 15 ga Maris 2020.
Cutar COVID-19 a cikin EU/EEA da Burtaniya
Bayan China, COVID-19 ya ci gaba da yaduwar yanayin ƙasa kuma halin da cutar COVID-19 ke ciki a duniya a halin yanzu ya yi daidai da halin da kasar ke ciki.
A ranar 11 ga Maris, 2020, Babban Daraktan Hukumar Lafiya ta Duniya (WHO) ya sanar da COVID-19 a matsayin annoba.
A cikin batun 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon tabbatar da COVID-19 a Turai bisa ga ƙayyadaddun yanayin WHO.
A cikin EU/EEA, Faransa ta ruwaito mutum uku na farko da aka tabbatar da cutar a ranar 24 ga Janairu 2020 a tsakanin wadanda suka dawo daga Wuhan, Hubei Province, China.
Har zuwa 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashen EU/EEA 30 da United Kingdom (UK), wanda tsakanin 31 ga Disamba, 2019 da wannan kwanan wata, an ruwaito shari'o'i 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun jimlar adadin da kuma jimlar adadin shari'o'in COVID-19
A Cibiyar Tsare-tsare da Kula da Cututtuka ta Turai (ECDC), an sabunta adadin COVID-19 da aka sanar a kowace ƙasa a duniya, daga tushen hukuma kawai kamar Ma'aikatar Lafiya ta ƙasar, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana a 8:00 am.
Ana amfani da wannan bayanan ne don tantance yanayin COVID-19 a cikin EU/EEA da Burtaniya, da kuma kwatanta bayanan da Italiya.
A matsayin wakili na yaduwar cutar COVID-19, mun ƙidaya mafi yawan adadin adadin COVID-19 na kwanaki 14 na ƙarshe, saboda haka ta hanyar la'akari da yanayin COVID-19, a cikin kowace ƙasa ta EU/EEA da Burtaniya, a lokacin Janairu 1 zuwa 15 Maris 2020.
Mun kuma gabatar da jimlar adadin shari'o'in da aka sanar ga kowace ƙasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe idan aka kwatanta da adadin shari'o'in Italiya na tsawon 31 ga Janairu, 2020 zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da Burtaniya
Yanayin a cikin kwanaki 14 na ƙarshe na adadi na shari'o'in COVID-19 a cikin EU/EEA da UK gabaɗaya suna bin yanayin a Hubei Region (China) (Figure 1).
Ga EU/EEA da UK gabaɗaya, adadin abubuwan da suka faru na COVID-19 ya fara ƙaruwa a kusa da 21 ga Fabrairu sannan ya ƙaru sosai a kusa da 28 ga Fabrairu 2020 (Buga).
Wannan yafi yawa ne saboda saurin karuwa a cikin adadin shari'o'in da aka ruwaito daga Italiya, amma duk sauran kasashen EU/EEA da Burtaniya sun nuna irin wannan karuwar yanayin ga abubuwan da suka faru na COVID-19 (Buga-gaba).
Hoton na 2 ya nuna adadin adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da UK a cikin Italiya na 31 ga Janairu zuwa 15 ga Maris 2020.
Ya jaddada cewa, har zuwa 8 na safe na 15 ga Maris, sauran kasashe 15 na EU/EEA da Burtaniya sun ba da rahoton adadin adadin shari'o'i kamar na Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin shari'o'in COVID-19 da aka ruwaito suna ƙaruwa cikin sauri a cikin EU/EEA da Burtaniya.
Yanayin da ake lura da tarin abubuwan da ke faruwa na COVID-19 ya nuna cewa annobar tana yaduwa a daidai wannan saurin a duk ƙasashe.
Duk da cewa ƙasashe suna kan daban-daban matakan, bambancin cikin martani na lafiyar jama'a na ƙasa da kuma bambancin ma'anar shari'ar da za a iya yi a ƙasashe da kuma yarjejeniyoyi daban-daban don zaɓar marasa lafiya da za a gwada don tabbatar da COVID-19, gami da gwajin bi.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da ke fama da cutar a Italiya sun bayyana halin da ake ciki inda kashi 10% na marasa lafiya da ke fama da cutar COVID-19 ke bukatar kulawa mai kyau kuma kafofin watsa labarai sun ruwaito cewa asibitoci da cibiyoyin kula da lafiya a yankin sun riga sun kai ga iyakar ƙarfin.
Bayanai game da shigar da COVID-19 a asibitoci da/ko cibiyoyin kula da lafiya a halin yanzu suna samuwa a matakin EU/EEA don kashi 6% da 1% na shari'o'in, bi da bi (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara bayanan a cikin tsari don tallafawa bayanan kulawa na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka ruwaito da yawan mutuwar.
Wani bincike da aka gudanar a 2010-11 ya nuna bambancin da ke tsakanin samun gado mai kyau da kulawa ta tsakiya a Turai, daga 29.2 a Jamus zuwa 4.2 a kowace 100,000 mazauna Portugal.
Wannan yana nufin cewa ƙasar tana da albarkatu fiye da Italiya (12.5 gadaje na kulawa da kulawa a kowace 100,000 mazauna a 201011).
An samar da wani tsarin tsarawa dangane da karancin karfin kula da lafiya, tare da kimantawa ga kowace kasa ta EU/EEA da Birtaniya na yaduwar cutar COVID-19 da aka kwantar a asibiti da ke da alaƙa da > 90% na hadarin wucewa da karfin gado na kulawa mai kyau, a cikin sabuntawa na shida na saurin kimanta hadarin COVID-19 ta ECDC.
Tun da har yanzu akwai lokuta da suka kasance a cikin wasu yankuna a cikin EU/EEA da UK, da kuma asibitoci da cibiyoyin kulawa da kyau waɗanda yawanci ke kula da yawan mutanen da ke cikin yanki mai mahimmanci, ya kamata a samar da bayanai game da lokuta da gadajen kulawa da kyau a Tatanama don cibiyoyin kulawa na matakin 2 (NUTS-2).
Kwarewa daga Italiya da kuma abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana yaduwa cikin sauri a cikin EU/EEA da Burtaniya.
Saboda haka, dole ne kasashen da asibitoci da kuma cibiyoyin kula da lafiya su kasance a shirye don yanayin yaduwar SARS-CoV-2 da kuma karuwar yawan marasa lafiya da ke fama da COVID-19 da ke bukatar kula da lafiya, musamman kula da lafiya, kamar yadda yake faruwa a yankunan da cutar ta shafa a Italiya.
Kamar yadda aka jaddada a cikin ECDC's recent Rapid Risk Assessment, hanzari, mai aiki mai kyau da kuma cikakkiyar hanyar da za a bi yana da mahimmanci don rage yaduwar SARS-CoV-2, ta hanyar motsawa daga hanyar dakatarwa zuwa ragewa, saboda tsammanin hanzari a cikin yawan lokuta na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita amsar su yadda ya kamata idan ba a aiwatar da su ba da wuri.
Har ila yau, saurin kimanta haɗarin ya lissafa matakan kiwon lafiya na kowa don rage tasirin cutar.
Akwai gajeren damar da za a iya ganin ƙasashe suna da damar ci gaba da haɓaka ƙoƙarin sarrafa su don rage yaduwar SARS-CoV-2 da rage matsin lamba akan kiwon lafiya.
Idan hakan bai yi nasara ba, to, a cikin kwanaki ko makonni masu zuwa, za a iya fuskantar karuwar marasa lafiya a wasu ƙasashen EU/EEA.
Cutar Coronavirus ta 2019 (COVID-19), wanda ta haifar da cutar ta hanyar cutar ta hanyar numfashi mai tsanani (SARS) coronavirus 2 (SARS-CoV-2), ya riga ya kashe mutane fiye da 3,000 kuma ya kamu da mutane fiye da 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'i ga mutane.
Kamar yadda yake da cutar SARS-CoV, wadda ta haifar da SARS a dubban mutane a shekara ta 2003, SARS-CoV-2 na iya yadawa daga warts kuma yana haifar da irin wannan alamun ta hanyar irin wannan tsari.
Duk da haka, COVID-19 yana da ƙarancin tsanani da yawan mutuwar fiye da SARS amma yana da sauƙi don kamuwa da cutar kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
A sakamakon yawan littattafai da ake wallafawa game da cututtuka masu tasowa, wannan labarin ya yi ƙoƙari ya ba da cikakken bayani game da wannan bincike mai sauri.
Za mu tattauna game da ilimin cututtuka, ilimin halayyar mutum, ilimin cututtuka, ganewar asali, magani, tsinkaye da rigakafin cutar.
Ko da yake tambayoyi da yawa suna bukatar amsoshi, muna fata wannan bita zai taimaka mana mu fahimci kuma mu kawar da wannan cuta mai haɗari.
Bikin bazara na 25 ga watan Janairu 2020 ya zama abin tunawa da ba za a iya mantawa da shi ba ga jama'ar kasar Sin da aka tilasta su zauna a gida a lokacin hutu da kuma makonni bayan barkewar cutar kwayar cutar.
Wannan kwayar cutar ta kasance daidai da coronavirus (CoV) wanda ya haifar da bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Wannan annoba ta fara ne a birnin Wuhan na kasar Sin kuma nan da nan ta bazu zuwa kasar da kusan kasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, cutar ta haifar da fiye da 80,000 da aka tabbatar da COVID-19 shari'o'i, tare da fiye da 40,000 marasa lafiya da aka bari su koma gida kuma fiye da 3,000 marasa lafiya sun mutu.
WHO ta yi gargadin cewa COVID-19 "abokin gaba ne na jama'a na 1" kuma yana da damar zama mafi ƙarfi fiye da tashin hankali.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu, an buga takardu sama da 2000 game da COVID-19 gami da virology, epidemiology, etiology, diagnosis da kuma magani tun daga rahoton farko a ranar 7 ga Janairu 2020 wanda ya tantance yanayin cutar da aka ware daga wasu marasa lafiya.
Wannan bita yana ƙoƙarin taƙaita ci gaban bincike a wannan sabon kuma ci gaba da bunkasa fannin.
A lokacin da ya dace, za mu gwada COVID-19 da SARS da kuma wani cuta na CoV, ciwon huhu na Gabas ta Tsakiya (MERS, wanda aka samo a shekara ta 2012).
Za mu kuma tattauna abin da aka sani game da rigakafi da kuma ganewar asali da kuma wasu muhimman tambayoyi.
An yi la'akari da CoV a matsayin wani abu marar cutarwa ga mutane, wanda ya saba da kusan kashi 15% na mura na kowa 4.
Duk da haka, a cikin wannan karni, mun gano sau biyu cewa akwai cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta CoV a tarihin ɗan adam da aka rubuta.
Kamar yadda aka nuna a cikin Figure 1.1, an fara bayar da rahoton clusters na cutar huhu daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta kasar Sin.
Bayan kwana bakwai, an fitar da takardar shaidar CoV.
A ranar 15 ga Janairu, 2020, an samu rahoton mutuwar farko daga Wuhan.
A halin yanzu, annobar ta yi ta yaduwa cikin sauri zuwa birane, yankuna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an samu rahoton kamuwa da cutar a tsakanin ma'aikatan kiwon lafiya, wanda ya nuna cewa kamuwa da cutar daga mutum zuwa mutum na iya faruwa.
A ranar 23 ga watan Janairu, an dakatar da birnin Wuhan tare da dakatar da duk ayyukan sufuri na jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan wanda ake ɗauka a matsayin farkon farkon kamuwa da cutar daga asalin dabbobi da ba a sani ba.
A ranar 30 ga watan Janairu, WHO ta ayyana cutar a matsayin gaggawa ga lafiyar duniya.
A lokacin da aka ba da rahoton, cutar ta riga ta bazu ko'ina cikin Sin da kusan sauran ƙasashe 50 a duniya (Figure 2).
Tun da yanayin ya ci gaba da sauri, ba a san yadda cutar ta ƙare ba.
A ranar 11 ga Fabrairu, 2020, binciken da aka gudanar a cibiyoyin da dama na marasa lafiya 8,866 ciki har da masu cutar COVID-19 4,021 da aka tabbatar sun ba da ƙarin bayani game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana kamuwa da marasa lafiya na kowane zamani, amma mafi yawan mutane suna da shekaru 30-65.
Kusan rabin (47.7%) na marasa lafiya masu kamuwa da cutar sun wuce shekaru 50, da ƙarancin mutane a ƙarƙashin shekaru 20 kuma mutane 14 ne kawai suka kamu da cutar a ƙarƙashin shekaru 10.
SARS-CoV-2 ya fi kamuwa da maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 yana tasowa a cikin tarin yawa a cikin da kewaye da Hubei.
COVID-19 yana ɗaukar matsakaita kwanaki 5 (2-9) daga farawa zuwa ganewar asali.
Matsakaicin lokacin sanyaya shine kwanaki 4.8.
Matsakaicin lokacin daga farkon zuwa mutuwa shine 9.5 (4.8-13) kwanaki.
Matsayin haihuwa (R0) na asali shine 3.77 (95% CI: 3.51-4.05), kuma daidaitaccen RO shine 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin da aka yi gagarumin motsi kafin bikin bazara a China.
Yawan mutuwar marasa lafiya da aka tabbatar da cutar ya kai 1.44% (95% CI: 1.10-1.86%), kuma daidaitaccen mutuwar marasa lafiya ya kai 3.06% (95% CI: 2.02-4.59%).
Babban dalilai guda uku na COVID-19 sune jinsi (maza), shekaru (≥60) da kuma mummunan cutar huhu.
CoV wani nau'i ne na manyan kwayoyin cuta masu kariya wanda ya ƙunshi RNA mai kwakwalwa guda ɗaya.
Ana iya rarraba kwayar cutar zuwa jinsuna hudu, cth., alpha, beta, gamma, da delta, daga cikin dukkanin alpha- da beta-CoVs da aka sani suna kamuwa da mutane.
Spike (S) glycoprotein surface yana ɗaurewa zuwa ga masu karɓar ƙwayoyin halitta na angiotensin-switching enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, kuma sa'an nan kuma haɗin membrane ya faru.
An saki kwayoyin RNA na kwayar cutar zuwa cikin cytoplasm; bayan an sake kwayar kwayoyin cutar, RNA na kwayar halitta tare da glycoproteins na farfajiya da kuma nucleocapsid proteins suna samar da vesicles da ke dauke da virions, wanda daga baya ya haɗu da membrane na plasma don sakin kwayar cutar.
An bayar da rahoton kwayar cutar SARS-CoV-2 ta farko a ranar 10 ga Janairu, 2020.
SARS-CoV-2 ya zama sabon nau'in beta-CoV tare da fiye da 99.98% na asalin kwayoyin halitta a cikin samfurori 10 da aka samo daga asalin cutar, Kasuwar Ruwanin Ruwa ta Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar daukar hoto na lantarki, an gano SARS-CoV-2 a cikin mafi bakin ciki na epithelium na hanyar numfashi.
An gano cewa ACE2 na mutum shine mai karɓar SARS-CoV-2 da SARS-CoV.
Duk da haka, furotin S na SARS-CoV-2 ya danganta da ACE2 fiye da SARS-CoV, wanda ya yi daidai da gaskiyar cewa SARS-CoV-2 yana haifar da rashin kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya kuma samar da sabon kwayar halitta mai ƙarancin tsari wanda aka yi wa kofin orf3b da kuma kwayar cutar da aka yi wa kofin orf8.
Orf3b don SARS-CoV-2 na iya taka rawa a cikin kamuwa da cutar kuma yana da bayyanar IFNβ; duk da haka, orf8 ba ya ƙunshi wani yanki ko motsi mai aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun ba da rahoton cewa tsarin cyro-EM na ACE2 na mutum yana da cikakken 2.9 Å a cikin ƙuduri a cikin tsari tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa wannan fili, wanda ke da tabbaci na budewa da rufewa, an hada shi a matsayin dimer kuma ACE-BOAT2 complex na iya hada sunadarai biyu na S, wanda ke ba da shaida ga rarraba da kamuwa da CoV.
B0AT1 na iya zama maganin maganin maganin maganin maganin cutar SARS-CoV-2.
Hoto na farko da na tsakiya
An san cewa SARS-CoV da MERS Cov sun fito ne daga kwayoyin halittar da aka watsa zuwa mutane ta hanyar foxes da raƙuma.
Ta hanyar kwatanta filogenetik na SARS-CoV-2 da sauran CoVs, ana ɗaukar warts a matsayin asalin cutar SARS-CoV-2 saboda sabon cutar ya kasance 96% kama da CoVs biyu kamar SARS daga warts da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san ko wane tsakiya ne ke taimaka wa kwayar cutar ta ƙetare shinge na ƙwayoyin cuta don kamuwa da mutane ba, kuma ba a bayyana hanyar watsawa ba.
Ji, et al., sun ba da shawarar cewa maciji ya zama mai ɗaukar kwayar cutar daga warts zuwa mutum wanda ya ƙunshi sake haɗuwa da homologous a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun ba da shawarar cewa gargowa - mai cin abinci mai cin abinci mai cin nama mai tsawon hanci da rassan da aka yi amfani da su a cikin maganin gargajiya na kasar Sin - shine mai yuwuwar matsakaici na SARS-CoV-2 bisa ga 99% na homologous genetic a cikin CoVs da aka samu a gargowa da SARS-CoV-2.
Duk da haka, bambancin 1% da ke cikin jinsunan biyu ya kasance bambanci mai girma; saboda haka, sakamakon ƙarshe na sanya shaida mai mahimmanci yana jiran (Fig.33).
Har yanzu ba a san yawancin halayen sinadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin in vitro na tsawon awanni 48 a cikin yanayin bushe kuma har zuwa kwanaki 45 a ƙarƙashin 20 °C da danshi 40%-50%.
SARS-CoV-2 na iya samun irin wannan hali.
An ruwaito cewa SARS-CoV-2 yana da matukar damuwa da hasken ultraviolet da zafi a 56 °C na tsawon minti 30; ether, 75% ethanol, disinfectant wanda ya ƙunshi chlorine, perasetic acid, chlorofom, da sauran fatty solvents, amma ba chlorhexidine ba, na iya lalata cutar yadda ya kamata.
Dukan mutanen da ke cikin duniya ba su da kariya ga SARS-CoV-2 kuma saboda haka ana ɗaukar su masu saukin kamuwa da cutar coronavirus.
A halin yanzu, babu wani cikakken bincike da aka bayar game da amsawar rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ga wasu binciken da aka yi a baya game da sauran CoVs, musamman SARS-CoV da MERS-CoV (Figure 4).
A gaba ɗaya, bayan kwayar cutar ta mamaye hos, kwayar cutar ta fara ganewa ta hanyar tsarin rigakafin hos ta hanyar masu karɓar ƙayyadewa na tsari (PRRs) ciki har da masu karɓa kamar lectin irin C, masu karɓa kamar Tol (TLR), masu karɓa kamar NOD (NLR), da masu karɓa kamar RIG-I (RLR).
Duk da cewa sun bambanta, cutar ta haifar da bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Duk da haka, furotin N na SARS-CoV zai iya taimaka wa ƙwayoyin cuta su kauce wa amsawar rigakafi.
Ba da daɗewa ba, an daidaita tsarin rigakafin mutum don yaƙi da cutar.
T lymphocytes ciki har da CD4+ da CD8+ T cells suna taka muhimmiyar rawa a cikin tsaro.
CD4+ T-cell yana motsa B-cell don samar da ƙwayoyin antibodies na musamman na kwayar cutar kuma CD8+ T-cell yana ci gaba da kashe ƙwayoyin da suka kamu da cutar.
Kwayoyin T masu taimako suna samar da cytokines na proxyron don taimakawa ƙwayoyin tsaron jiki.
Koyaya, CoV na iya hana T cell aiki ta hanyar haifar da apoptosis na T cell.
Histocin rigakafi na jiki ciki har da abubuwan da ke taimakawa kamar C3a da C5a da kuma rigakafi suna da mahimmanci wajen yaki da kamuwa da cutar.
Alal misali, rigakafin da aka ware daga marasa lafiya da suka warke ya hana MERS-CoV.
A gefe guda kuma, yawan ayyukan da tsarin garkuwar mutum yake yi yana haifar da yawan kwayoyin da ba su da ƙarfi a jikin mutum wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma, a mafi munin yanayin, rashin aiki na wasu gabobin jiki, har ma da mutuwa.
Cutar SARS-CoV-2, bisa ga farkon clusters, ya fi dacewa da shafar 'yan asalin da ke da cutar tare da mata masu ciki.
Yana da kyau a ce mutanen da suka kamu da cutar ko kuma waɗanda ke fama da cutar sun fi kamuwa da ita fiye da sauran mutane.
Matsakaicin lokacin jinkiri na SARS-CoV-2 shine kwanaki 1-14, yawanci kwanaki 3-7 dangane da nazarin farkon shari'o'i 425 a Wuhan.
Duk da haka, binciken da aka yi a kan mutane 1,099 ya nuna cewa tsawon lokacin yin wanka na kwana 3 ne a matsakaici kuma ya kasance daga kwana 0 zuwa 24.
Wani binciken da aka yi kwanan nan, kamar yadda aka ambata a sama, ya nuna cewa lokacin yin sanyaya yana da kwanaki 4.8 (3.0-7.2) bisa ga alƙaluma 8,866 na shari'o'i.
Yana da mahimmanci ga hukumomin kiwon lafiya su daidaita lokacin killacewa mai inganci dangane da lokacin da ya dace, yayin hana waɗanda suka kamu da cutar amma ba su da alamun cutar daga yada cutar ga wasu.
A cikin al'ada, ana buƙatar mutane da ke da haɗari ga, ko kuma kamuwa da cutar su keɓe kansu na kwanaki 14.
Shin, an tsawaita dokar killacewa zuwa kwanaki 24?
Cutar zazzabi ita ce mafi yawan alamun farko da na farko na COVID-19, wanda zai iya faruwa ba tare da wata alama ko wata alama ba kamar tari, numfashi mai ƙyama, ciwon tsoka, kururuwa, ciwon kai, ciwon wuya, rhinorrhea, ciwon kirji, fitsari, vomiting da kuma zubar da jini.
Wasu marasa lafiya suna fama da rashin numfashi da kuma/ko hypoxia mako guda bayan bayyanar cutar.
A cikin matsanancin hali, yanayin mai haƙuri ya ƙaru da sauri zuwa cututtukan numfashi na gaggawa, saurin tashi, ƙwayar cuta da kuma coagulopathy.
Mai fama da zazzabi da/ko bayyanar cututtukan numfashi da kuma zazzabi mai tsanani, ko da ba tare da wani abu ba na daukar hoto na huhu, ya kamata a yi masa tace don cutar don ganewar asali.
Nazarin demographic a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cututtukan sun kasance 98% don zazzabi, 76% don tari, 55% don dyspnea, da 3% don fitsari; 8% na marasa lafiya suna buƙatar taimakon numfashi.
An samu irin wannan binciken a cikin bincike guda biyu na baya-bayan nan na gida da kuma clusters da suka haifar da yaduwar daga mutane marasa alamun cututtuka.
A cikin kwatancen, binciken binciken mutane a shekarar 2012 ya nuna cewa marasa lafiya na MERS-CoV sun kuma sami zazzabi (98%), tari mai bushe (47%), da dyspnea (55%) a matsayin manyan alamun su.
Duk da haka, kashi 80% na su na bukatar taimakon numfashi, fiye da waɗanda ke fama da COVID-19 kuma sun kasance cikin mafi girma daga cikin waɗanda MERS ta kashe fiye da COVID-19.
An kuma lura da ciwon kumburi (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, an nuna cewa zazzabi (99%-100%), tari (29%-75%), dyspnea (40%-42%), fitsari (20-25%), da ciwon wuya (13-25%) sune manyan alamun bayyanar cututtuka kuma taimako na numfashi ya zama dole ga kimanin 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin dari yayin da aka tabbatar da cewa akwai mutane 66,576 a duniya.
A kwatanta, yawan mutuwar SARS zuwa Nuwamba 2002 ya kai kashi 10% na 8,096 da aka tabbatar.
A cikin MERS, bisa ga binciken alƙaluma na Yuni 2012, yawan mutuwar ya kai kashi 37 cikin dari daga cikin 2,494 da aka tabbatar.
Wani binciken da aka fara ya ruwaito cewa R0 na SARS-CoV-2 ya kai 6.47 tare da 95% na amincewa (CI) 5.71-7.23, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4.
Ana nuna kwatancen SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun cututtukan, mutuwar da RO na cutar a cikin Table na Table1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 na da mafi girman damar kamuwa da cutar fiye da MERS-CoV da SARS-CoV, amma ya haifar da ƙananan mutuwar daga waɗannan cututtukan.
Saboda haka, yana da matukar wuya a sarrafa cutar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Ƙungiyoyin ƙungiya sukan fara ne a cikin iyali ɗaya ko daga ƙungiyoyi ɗaya ko motoci kamar jiragen ruwa.
Mai cutar yana da tarihin tafiya ko zama a Wuhan ko wasu yankunan da aka shafa ko kuma ya yi hulɗa da mutum ko mai cutar a cikin makonni biyu kafin cutar ta fara.
Duk da haka, an ruwaito cewa marasa lafiya na iya ɗaukar cutar ba tare da alamun bayyanar cututtuka ba har tsawon makonni biyu kuma marasa lafiya da aka bar gida daga asibiti na iya ɗaukar cutar kuma, wanda ke aika da gargadi don ƙara lokacin killacewa.
Mai haƙuri yana da yawan farfajiyar farfajiyar jini (musamman lymphocytes) wanda ya kasance na yau da kullun ko raguwa a farkon matakin.
Misali, ana samun lymphopenia tare da adadin fararen kwayar jini < 4×109/L ciki har da adadin lymphocytes < 1×109/L, da kuma karuwar matakan aminotransferase aspartate da viremia a cikin marasa lafiya 1,099 na COVID-19.
Ƙarfin ƙwayar cuta da ƙwayoyin cuta da ƙwayoyin cuta da ƙwayoyin cuta sun ƙaru a cikin jinin wasu marasa lafiya, kuma ƙwayoyin C-reactive da kuma sedimentation na erythrocytes sun ƙaru a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, matakin D-dimer, wanda shine samfurin lalacewar fibrin a cikin jini, ya karu, kuma yawan lymphocytes ya ragu sosai.
Ana samun rashin daidaito a cikin hotunan kirji na kirji a cikin yawancin marasa lafiya na COVID-19 kuma ana nuna su ta hanyar inuwa mai ɓoye biyu ko kuma ƙarancin gilashin ƙasa a cikin huhu.
Mai haƙuri yana fama da cutar pneumonia, cutar huhu mai tsanani da kuma cutar shan numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, rashin kulawar da ba a kula da shi ba, tarin ruwa da kuma saurin ƙwayar cuta suna shafar musayar gas sosai.
Rashin aikin huhu na I da II na rage yawan surfactants da kuma ƙara ƙarfin surface, yayin da ragewa da damar huhu don bunkasa da kuma kara hadarin rashin ciwon huhu.
Saboda haka, gano mummunan radiography na kirji yakan dace da mafi munin matakin cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na pathology na COVID-19 ya nuna ƙwayoyin cuta na pneumocytes, samar da membranes na hyaline da kuma shigar da lymphocytes na interstitial da kuma selolin sinthesis na multinucleic a cikin huhu na marasa lafiya da suka mutu daga cutar, daidai da yanayin kamuwa da cutar da ARDS da kuma kama da yanayin marasa lafiya na SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar jujjuyawar rikodin-transcriptional polymerase chain reaction (RT-PCR) an yi amfani da shi azaman babban ma'auni don ganewar asali na COVID-19.
Koyaya, sakamakon yawan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Hakazalika, ana samun irin wannan yanayin a cikin binciken SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen gwaje-gwaje da kuma binciken radiology suna da muhimmanci kuma suna da mahimmanci don yin bincike mai kyau.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana prototype na amfani da fasaha ta SHERLOCK dangane da CRISPR don gano SARS-CoV-2, wanda ke gano SARS-CoV-2 RNA na roba a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kofe kowane microlitre na shigarwa) ta amfani da sandar clamp a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Muna fatan wannan sabuwar fasaha za ta iya inganta ƙwarewar da kuma saukakawa sosai idan aka tabbatar da ita a cikin samfurin asibiti.
Saboda rashin kwarewa da sabon CoV, likitoci na iya samar da magani mai goyan baya ga marasa lafiya na COVID-19, yayin da suke gwada magunguna daban-daban da aka yi amfani da su ko kuma aka ba da shawarar a baya don maganin sauran CoV kamar SARS-CoV da MERS-CoV da sauran cututtukan cutar (Jadu'a (Jadu'a2).2).
Wannan magani ya hada da magani na yanzu da kuma na iya zuwa da maganin rigakafi, maganin rigakafi, steroids, plasma daga marasa lafiya da suka warke, magani na kasar Sin da kuma goyon bayan tunani.
An kuma ba da shawarar yin amfani da jini na marasa lafiya da suka warke don yin magani.
Kamfanonin magunguna suna fafutukar samar da rigakafi da allurar rigakafi ga cutar.
SARS-CoV-2 yakan kai hari ga huhu a farkon matakin kuma yana iya kai hari, a ƙananan matakan, ga sauran gabobin da ke samar da ACE2, kamar gastrointestinal system da koda.
Duk da haka, rashin aiki da kuma rashin numfashi suna da matukar haɗari ga marasa lafiya kuma suna da manyan dalilai na mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci don sauƙaƙe bayyanar cututtuka da kuma ceton rayuka kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai hana haɗari da iska mai haɗari dangane da yanayin cutar.
Mai cutar da ke fama da cututtukan numfashi mai tsanani ya kamata a goyi bayan shi ta hanyar oxygenation na extracorporeal membrane (ECMO), wani fasahar daukar hoto ta cardiopulmonary da aka yi amfani da ita don magance matsalar zuciya ko numfashi.
Bugu da kari, kula da daidaiton electrolyte, rigakafi da magani na kamuwa da cuta ta biyu da kuma mamakin sepsis, da kuma kare muhimman ayyukan gabobin jiki suma suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa tashin cytokine ya haifar da yawan halayen tsarin rigakafi a cikin marasa lafiya na SARS da MERS.
Cytokine tururi wani nau'i ne na tsarin inflammatory response wanda ke nuna sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wannan cytokine yana sa ƙwayoyin rigakafi su saki manyan adadin free radicals wanda shine babban dalilin ARDS da rashin nasarar gabobin gabobin.
Maganin rigakafi yana da muhimmanci wajen magance matsalar sitokin, musamman ga marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tocilizumab, anti-IL6 monoclonal antibodies, don magance cytochrome.
Sauran magungunan rigakafin rigakafi don tsokoki na cytokine sun hada da daidaitaccen amsawar rigakafin T-cell; hana IFN-γ, IL-1, da TNF; JAK tsaurara; blinatumomab; cytokine siginar tsaurara 4; da HDAC tsaurara.
Ana amfani da steroids, a matsayin maganin rigakafi, a cikin maganin SARS don rage mummunan lalacewar kumburi.
Duk da haka, steroids a manyan allurai ba su da amfani ga mummunan rauni na huhu a cikin marasa lafiya na SARS da COVID-19.
A akasin haka, steroids a manyan allurai na iya haifar da mummunan sakamako masu illa, musamman osteonecrosis avascular, yana shafar hangen nesa.
Duk da haka, an ba da shawarar yin amfani da ƙananan zuwa matsakaiciyar sashi na corticosteroids na ɗan gajeren lokaci don yin amfani da hankali ga marasa lafiya masu rikitarwa na COVID-19.
A lokacin da aka rubuta wannan labarin, ba a tabbatar da wani maganin riga-kafi mai tasiri ba.
Duk da haka, an gano cewa yin amfani da remdesivir a cikin intravenous tare da remdesivir, wani analog na nucleotide, yana da tasiri a kan wani mai haƙuri na Amurka da ke da cutar COVID-19.
Remdesivir wani magani ne na riga-kafi wanda Gilead ta kirkiro don maganin cutar Ebola da Marlburg.
Daga bisani, remdesivir ya kuma nuna yiwuwar rarraba wasu kwayoyin RNA guda biyu ciki har da MERS da SARS.
Bisa ga wannan lura, Gilead ta ba da cakuda ga China don gudanar da gwaji guda biyu akan mutane da suka kamu da SARS-CoV-2, kuma sakamakon yana jiran sosai.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar su zama magunguna masu mahimmanci ga marasa lafiya da ke fama da cututtukan numfashi.
Ƙarƙashin zuciya, ƙishirwa, zubar da jini, cutar hanta da sauran sakamako masu illa na iya faruwa bayan an yi maganin lopinavir/ritonavir.
Dole ne a lura da yadda wannan magani yake shafar wasu magunguna da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da antibodies
Ana yin tattara jini daga marasa lafiya da suka warke daga cututtukan da ke kamuwa da cutar don kula da wasu marasa lafiya da ke fama da irin wannan cuta ko kuma don kare lafiyar mutane daga kamuwa da cutar.
Gaskiya ne, marasa lafiya da suka warke suna da yawan adadin rigakafi da ke cikin jininsu.
Antibodies sune immunoglobulin (Ig) wanda B lymphocytes ke samarwa don yaƙar wasu cututtuka da wasu abubuwa masu ƙyama kuma yana gano ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta kuma yana hana su kai tsaye.
Bisa ga wannan, an tattara plasma daga jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an yi musu allura zuwa ga marasa lafiya 10 da ke cikin mawuyacin hali.
A cikin sa'o'i 24, bayyanar cututtukan sun inganta, kuma sun rage yawan kumburi da kuma ƙwayar cutar da kuma ƙara yawan jini.
Duk da haka, ana bukatar tabbaci da kuma bayani don bayar da shawarar yin amfani da wannan hanyar a kan dimbin yawa kafin a yi amfani da maganin musamman.
Bugu da ƙari, saboda tasirin da ake yi a maganin, ya kamata a yi la'akari da wasu abubuwa masu kyau da ke tattare da jini.
Alal misali, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Yawan kwayoyin jini a cikin jini yawanci ba su da yawa kuma ana bukatar jini sosai don kula da marasa lafiya masu tsanani.
Yana da wuya a samu da kuma samar da rigakafi da sauri don yaki da annoba ta duniya.
Saboda haka, yana da muhimmanci sosai kuma ya zama da amfani a ware B-cell daga marasa lafiya da suka warke kuma a gano lambar kwayoyin da ke ƙayyade maganin rigakafi mai tasiri ko kuma tace maganin rigakafi mai tasiri ga muhimman ƙwayoyin cuta.
Wannan zai iya sa mu kara samar da rigakafi.
An yi amfani da TCM wajen magance cututtuka daban-daban a kasar Sin na dubban shekaru.
Duk da haka, tasirin ya dogara da haɗuwa da abubuwa daban-daban a cikin maganganu daban-daban bisa ga ganewar asali na cutar bisa ga ka'idar TCM.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba su da tabbas saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwan ko kuma haɗuwa da su.
A halin yanzu, saboda rashin takamaiman magani mai tasiri ga COVID-19, TCM ya zama ɗayan manyan hanyoyin maye gurbin magani ga marasa lafiya masu sauƙi zuwa matsakaici ko waɗanda suka warke daga mummunan matakin.
Misali, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules sun tabbatar da inganci ga maganin COVID-19.
An ga mafi yawan murmurewa a cikin kula da marasa lafiya na COVID-19 a wasu larduna a China da ke amfani da TCM a cikin kashi 87% na marasa lafiyar su, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, wanda ke amfani da TCM a cikin kusan 30% na marasa lafiya na COVID-19, yana da mafi ƙarancin murmurewa (13%).
Duk da haka, wannan kwatancen yana da wuya saboda akwai wasu dalilai masu tasiri kamar yawan marasa lafiya da kuma matakin tsanani da za a haɗa a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike don kwatanta maganin maganin yamma (WM) kawai da haɗin maganin WM da TCM.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki, rasa bayyanar cututtuka da kuma kula da asibiti ya fi guntu a cikin WM+TCM fiye da WM kadai.
Abin mamaki, yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Duk da haka, inganci da tsaro na TCM suna jiran ƙarin gwaji a kan mafi girma da kuma cibiyoyin.
Yana da ban sha'awa kuma a bayyana yadda ake yin aiki da kuma yadda ake amfani da shi wajen magance cutar ta TCM ko kuma a haɗa ta da magani idan ya yiwu.
Masu cutar da ake zargi da cutar COVID-19 ko kuma da aka tabbatar da cewa suna da ita galibi suna fuskantar mummunan tsoro game da cutar mai saurin kamuwa da ita kuma tana iya haifar da mutuwa, yayin da waɗanda aka killace su kuma suna fuskantar rashin jin daɗi, zaman lafiya da fushi.
Bugu da ƙari, alamun cututtuka kamar zazzabi, hypoxia da tari da kuma mummunan sakamako na magani kamar rashin barci na corticosteroid na iya haifar da damuwa da damuwa na hankali.
A farkon fasalin SARS, an kuma ruwaito cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Gano lamba da ke cikin tilastawa da killacewa, a matsayin wani ɓangare na amsawar lafiyar jama'a ga annobar COVID-19, na iya sa mutane su ji daɗi da laifi game da tasirin kamuwa da cuta, killacewa da kuma lalata iyalansu da abokansu.
Saboda haka, dole ne a ba da kulawar lafiyar hankali ga marasa lafiya na COVID-19, mutane da ake zargi da kuma mutanen da suka yi hulɗa da su da kuma jama'ar da ke bukatar hakan.
Tallafin ilimin halayyar mutum ya kamata ya hada da kafa ƙungiyoyin kula da lafiyar hankali na zamani, sadarwa mai kyau tare da daidaitaccen sabuntawa game da cutar SARS-CoV-2 da tsarin magani da kuma amfani da na'urorin lantarki da aikace-aikacen ƙwararru don guje wa kusanci da juna.
Yin allurar rigakafi mai tasiri yana da mahimmanci don hana sarkar watsawa daga yankin dabbobi da mutane masu kamuwa da cutar zuwa ga masu cutar da ke kamuwa da cutar kuma yawanci yana ba da maganin rigakafi a cikin kula da annobar da cutar ke haifar da ita.
An yi ƙoƙari ta hanyar haɓaka allurar rigakafi ta S-protein don samar da antibodies na tsayayyen lokaci da tasiri da / ko rigakafi wanda ke karewa daga SARS-CoV.
An gwada rigakafin da ke hana cutar a cikin dabbobi don SARS.
Duk da haka, ana bukatar a tantance yadda wadannan masu neman rigakafin za su yi aiki a cikin tsofaffi da kuma yadda za su iya yin amfani da su wajen magance cutar ta zoonotic kafin a fara nazarin asibiti.
Wannan na iya faruwa ne saboda SARS ta ƙare shekaru 17 da suka gabata kuma ba a sami sabbin cututtuka ba tun daga lokacin.
A akasin haka, ana ci gaba da samun cututtukan MERS a cikin Gabas ta Tsakiya da kuma yada su zuwa wasu yankuna saboda ci gaba da samun albarkatun zoonotic a yankunan da suka rage.
An kirkiro dabarun yin allurar rigakafi don MERS ta amfani da ƙwayoyin cuta da ba a kunna su ba, plasmids na DNA, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta kamar su kwayar cuta da kuma subunits na furotin da aka sake yin amfani da su kuma an gwada wasu a cikin samfurin dabba.
Ci gaban allurar rigakafi mai lafiya da inganci akan SARS-CoV-2 ga mutanen da ba su da lafiya aiki ne mai gaggawa da kuma mahimmanci don sarrafa cutar da ke gudana.
Duk da haka, yana da wuyar shawo kan wahalar saboda tsawon lokaci (ma'ana watanni 18) ana buƙatar ci gaban allurar rigakafi da kuma canjin CoV mai ƙarfi.
A matsayin sabuwar cuta, COVID-19 ya nuna hanya mai cike da asibiti a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna warkewa a hankali ba tare da sake kamuwa da cutar ba.
Duk da haka, kamar SARS da MERS, COVID-19 kuma an danganta shi da yawan kamuwa da cuta da mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, gina tsarin tsinkaye na cutar yana da muhimmanci ga hukumomin kiwon lafiya su ba da fifiko ga ayyukansu, musamman a yankunan da ke fama da rashin albarkatu.
Bisa ga binciken asibiti da aka ruwaito zuwa yanzu, wadannan dalilai na iya shafar ko danganta su da hangen nesa na marasa lafiya na COVID-19 (Jaduwa (Jaduwa33):
Shekara: Shekara ita ce mafi muhimmanci wajen gano cutar SARS, wanda kuma ya shafi COVID-19.
COVID-19 yana faruwa ne a tsakanin shekaru 30 zuwa 65 tare da 47.7% na marasa lafiya sun wuce shekaru 50 a cikin binciken da aka ambata a sama na 8,866 na shari'o'in.
Marasa lafiya da ke bukatar kulawa mai kyau sun fi dacewa da samun ɓoyayyun cututtukan da rikitarwa kuma sun tsufa fiye da waɗanda ba su da (a matsakaiciyar shekaru 66 a kan shekaru 51), suna ba da shawarar shekaru a matsayin sanadin sakamako ga marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka ambata a sama.
Comorbidities da rikitarwa: Marasa lafiya da COVID-19 da ke bukatar kulawa mai kyau suna da mafi kusantar samun rauni na zuciya da arrhythmia.
Rashin zuciya kuma yana haifar da mutuwa a cikin marasa lafiya na SARS.
An ruwaito cewa SARS-CoV-2 na iya danganta zuwa ACE2 mai kyau colangiocytes, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya na COVID-19.
An lura cewa shekaru da cututtuka masu ɓoye suna da alaƙa da juna kuma suna iya ɓata juna.
Ganowar Lab: Matsakaicin matakin C-reactive protein (CRP) a cikin jini yana nuna tsanani na kumburi ko rauni a cikin ƙwayoyin halitta kuma an ba da shawarar cewa yana da tasiri ga yanayin cututtuka, amsa ga magani da kuma warkarwa ta ƙarshe.
An kuma yi shawarar danganta matakan CRP zuwa tsanani da kuma hasashen COVID-19.
Bugu da ƙari, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da kuma creatinine kinase (CK) da aka ƙara za su iya taimakawa wajen hango sakamakon.
Ana yin amfani da wannan enzyme sosai a gabobin jiki, musamman a zuciya da kuma zuciya, kuma ana cire shi sa'ad da aka lalata ƙwayoyin jiki.
Saboda haka, ya zama alama ce ta gargajiya don rashin aikin zuciya ko hanta.
Babban alamun asibiti: Radiography na kirji da ci gaban alamun asibiti a tsawon lokaci dole ne a yi la'akari da su tare da sauran al'amuran don hango sakamakon da rikitarwa na COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids suna da kariya daga rigakafi wanda aka saba amfani da shi azaman magani na adjunct ga cututtuka masu yaduwa don rage tsanani na lalacewar kumburi.
Tun da aka yi amfani da corticosteroid a manyan allurai a cikin marasa lafiya masu tsanani na SARS, yawancin tsofaffin marasa lafiya suna fama da osteonecrosis na yau da kullum tare da nakasa da rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsalar hankali: Kamar yadda aka ambata a sama, a lokacin annobar COVID-19 marasa lafiya da yawa sun sha wahala daga matsanancin damuwa saboda yawan lokutan keɓewa da matsanancin rashin tabbas da kuma mutuwar dangi da abokan marasa lafiya.
Yana da muhimmanci a ba da shawara ta tunani da kuma goyon baya na dogon lokaci don taimakawa wannan mai haƙuri ya dawo daga damuwa kuma ya koma ga rayuwarsa ta al'ada.
A cewar binciken da aka yi a kan al'umma, COVID-19 na da halaye daban-daban na cutar daga SARS.
Baya ga ninkawa a cikin ƙananan numfashi, SARS-CoV-2 na iya ninkawa cikin inganci a cikin ƙananan numfashi kuma yana haifar da bayyanar cututtuka mai sauƙi ko babu bayyanar cututtuka a farkon farkon fasalin kamuwa da cuta, kamar sauran CoVs waɗanda ke haifar da mura na yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko lokacin da suka kamu da cutar na iya samar da ƙwayoyin cuta masu yawa yayin gudanar da ayyukan yau da kullun, yana sa ya zama da wahala sosai a sarrafa cutar.
Duk da haka, ana ganin cewa SARS-CoV yana faruwa ne a lokacin da mutum yake da ciwo mai tsanani, yayin da yawancin kamuwa da cutar ba su faru a farkon lokaci ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi muni da kuma wahalar sarrafawa fiye da annobar SARS.
Ana yin aiki mai yawa a kasar Sin ciki har da yin dokar hana fita a Wuhan da garuruwan da ke kewaye da ita da kuma ci gaba da killace kusan dukkanin al'ummar kasar da fatan kawo karshen yaduwar SARS-CoV-2.
Duk da cewa wannan ya yi tasiri sosai a tattalin arzikin kasar da sauran bangarorin kasar, adadin sabbin marasa lafiya ya ragu, wanda ke nuna cewa annobar ta ragu.
Mafi kyawun ƙididdigar ita ce cutar za ta ƙare a ƙarshen Maris kuma za a rage raguwa na watanni 3-4.
Amma, wasu masana ba su da irin wannan begen.
Paul Hunter, et al., sun kiyasta cewa COVID-19, wanda ya fi SARS sauƙi, ba zai ƙare ba a shekara ta 2020.
Ira Longini, et al., sun yi samfurin don hango sakamakon cutar kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wata kungiya ta Kanada ta ruwaito cewa an gano SARS-CoV-2 a cikin duka swabs na turbinate na tsakiya da na makogwaro na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama maimaitawa kamar cutar mura.
Duk da haka, a kasar Sin akwai alamun da suka nuna cewa ana iya samun sakamako mai kyau a kan yawan sababbin cututtuka, wanda ya nuna cewa dabarun da ake amfani da su a yanzu suna iya yin tasiri.
An kiyasta cewa cutar Ebola za ta iya haddasa mutum miliyan daya da mutuwar mutane miliyan rabin.
Amma, da yin rigakafi da kuma yin zaman kaɗaici, an kawar da cutar.
Saboda haka, kamar SARS-CoV, cutar SARS-CoV-2 na iya zama mai rauni kuma a ƙarshe ta ƙare ko kuma ta zama ƙarancin ƙwayar cuta da ke wanzu tare da mutane.
Ana ba da kwatancen tsakanin annobar COVID-19 da SARS da MERS a ƙasa (Figure (Figure55).
SARS-CoV-2 yana da matukar saukin kamuwa da cutar ta hanyar tari ko kumburi, kuma yana iya kamuwa da cutar ta hanyar kai tsaye ta hanyar tuntuɓar kayan da cutar ta riga ta gurbata.
An kuma gano cutar a cikin shara, wanda ya haifar da sabon yiwuwar kamuwa da cutar daga shara zuwa baki.
Wani bincike na kwanan nan da aka yi kan shari'o'i 138 ya nuna cewa kashi 41 cikin 100 na shari'o'in na iya faruwa ne saboda cututtukan nosocomial, ciki har da marasa lafiya 17 da wasu cututtuka da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, dole ne a yi amfani da matakan tsaro masu kyau don kare mutane, musamman ma masu aikin kiwon lafiya, ma'aikatan jin kai, danginmu, abokanmu, har ma da mutanen da ke kan titi da ke hulɗa da marasa lafiya ko waɗanda suka kamu.
Hanyar farko da za a iya amfani da ita don rage haɗarin cututtuka ita ce ta hanyar sanya abin rufe fuska; duka amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (serial # 1860) suna taimakawa wajen hana yaduwar cutar.
Masks na tiyata suna hana ruwa daga mutum mai cutar daga yadawa ta hanyar iska ko mannewa a saman kayan, wanda zai iya yadawa ga wasu.
Duk da haka, kawai N95 masks (series #1860s) na iya kare daga ƙananan inhalation na virion 10 zuwa 80 nm, tare da kawai 5% na virion da zai iya shiga cikin N95 masks; SARS-CoV-2 ya yi daidai da SARS-CoV ta girman inda duka biyu suke da girman kusan 85 nm.
Tun da ƙwayoyin cuta na iya shiga cikin masks biyar na tiyata da aka yi amfani da su tare, ma'aikatan kiwon lafiya da ke da kai tsaye lamba da marasa lafiya suna buƙatar sanya N95 (series #1860s) maimakon masks na tiyata.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya suna bukatar su saka kayan kariya don rage hulɗa da cutar.
Hakanan kwayar cutar tana iya kamuwa da mutum ta hanyar ido.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa ya sanya abin rufe fuska na N95; cutar ta iya shiga jikinsa ta hanyar idanun da ke fama da kumburi.
A wannan yanayin, ma'aikatan kiwon lafiya suna bukatar su saka rigar fuska ko kuma tabarau na tsaro sa'ad da suke hulɗa da marasa lafiya.
Ga jama'a a yankunan da aka shafa ko kuma waɗanda za su iya yin cuta, ana ba da shawara cewa dukan mazauna su wanke hannayensu da sabulu mai kashe kwayoyin cuta a kai a kai, su zauna a gida kuma su rage hulɗa da mutanen da za su iya kamuwa da cutar.
Ana ganin cewa kafa uku ne ya fi dacewa a nisanta mutum daga wani mai haƙuri.
Waɗannan matakan suna da tasiri wajen rage haɗarin kamuwa da cuta ban da hana yaduwar cutar.
Ko da yake SARS-CoV-2 sabon kwayar cuta ce, babban homologue na SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 ya ba da gargadi ga China kamar yadda cutar SARS ta addabi a 2003.
Duk da haka, a ranar 19 ga Janairu 2020 ne kawai, darektan Cibiyar Kula da Cututtuka da Rigakafin Cutar Wuhan ya yi kokarin rage damuwar 'yan kasar ta hanyar cewa kwayar cutar tana da ƙarancin kamuwa da cutar da iyakance haifuwa a cikin mutane da kuma hanawa da kuma hana cutar ba matsala ba ce.
Wannan sakon ya yi nasara wajen rage damuwar jama'a, musamman ma a lokacin da duk kasar ke shirin bikin bazara, kuma ba za a iya maraba da shi ba don hana yaduwar cutar a mafi ƙarancin sikelin Wuhan.
Hukumar kula da cututtuka a kasar Sin za ta iya yin amfani da wannan wajen inganta yanayin a nan gaba.
Alal misali, hukumomin da suka dace sun (1) yi taka tsantsan wajen yin sanarwa ga jama'a tun da kowane daki-daki da aka bayar yana shafar halin da jama'a ke ciki da kuma yanke shawara; (2) sun fi mai da hankali da kuma amsawa ga bayanai masu ban mamaki da aka samu daga asibitoci fiye da jiran rahoto na yau da kullum daga likitoci ko jami'ai; (3) sun fi tsaurara wajen dakile annobar fiye da yadda za a yi wa jama'a shiru; da kuma (4) sun fi sau da yawa gudanar da horo don ƙara wayar da kan jama'a game da cutar da kuma gwadawa da kuma inganta tsarin amsawar jama'a a kai a kai.
Cutar COVID-19 ta kasance ne saboda sabon kwayar cutar SARS-CoV-2 wanda ya fara a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu ko'ina cikin Sin da kuma kusan kasashe 50 a duniya a lokacin da aka rubuta wannan labarin.
Tun da yake cutar ta yi kama da SARS-CoV kuma alamun ta ma sun yi kama da SARS, yaduwar COVID-19 ta haifar da jin cewa cutar SARS ta sake faruwa.
Duk da haka, akwai bambanci mai mahimmanci tsakanin COVID-19 da SARS, wanda ke da mahimmanci wajen hana cutar da kuma kula da marasa lafiya.
COVID-19 na shafar tsofaffi fiye da matasa kuma yana shafar maza fiye da mata, kuma yawan mutuwa da kuma tashin hankali ya fi girma a cikin tsofaffi fiye da matasa.
SARS na da yawan mutuwar da ta fi COVID-19 (10.91% da 1.44%).
Masu cutar COVID-19 na iya yada cutar ba tare da bayyanar cututtuka ba yayin da masu cutar SARS ke yada cutar a cikin rashin lafiya, wanda ke haifar da wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da yasa SARS-CoV-2 ya yi sauri da kuma yaduwa fiye da SARS-CoV.
Sakamakon gwajin RNA na SARS-CoV-2 na iya zama mummunan ga marasa lafiya na COVID-19.
Duk da haka, marasa lafiya da suka warke sun sake samun cutar.
Wannan binciken ya kara hadarin kamuwa da cutar.
Ganin ci gaban da ake samu a binciken COVID-19, har yanzu akwai wasu muhimman batutuwa da za a magance, daga cikinsu akwai:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano kashi 96 cikin 100 na kwayoyin halitta na SARS-CoV-2 da kuma CoVs guda biyu kamar SARS na tsutsa, ba za mu iya kammala cewa SARS-CoV-2 ya fito ne daga tsutsa ba.
Shin dabbobi ne masu rarraba kwayoyin cutar daga gidaje, kamar su tsutsa, zuwa mutane?
Idan ba mu san amsar tambayoyi na 1 da 2 ba, ba za mu iya sanin yadda za a iya magance cutar ba, kuma annobar za ta iya sake faruwa a kowane lokaci.
Ko da yake gwajin kwayoyin halitta da na biochemical model sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya kwayar cutar za ta iya shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje na pathological?
Shin kwayar cutar tana ɗaure kwayoyin ACE2 a wasu gabobin jiki?
Idan ba mu da amsar da ta dace ga wannan tambayar ba, ba za mu iya samun ganewar asali da kuma magani mai kyau ba.
Har yaushe za a ci gaba da wannan annoba?
Ta yaya wannan kwayar ta samo asali ta hanyar kamuwa da ita cikin mutane?
Shin zai zama annoba ce ta duniya, ta ƙare kamar SARS ko kuma ta sake faruwa a kai a kai kamar mura?
Wannan yana da muhimmanci amma zai ɗauki lokaci kafin mu sami amsoshin waɗannan tambayoyin da kuma wasu tambayoyi.
Duk da haka, ko da yaya kudin da za mu kashe, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu zuwa al'ada.
Tushen zoonotic na cutar coronavirus ta mutum
Cutar da kuma daidaitawa sun haifar da juyin halitta tare da coronavirus (CoV) da manyan kwayoyinsa, gami da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa CoV biyu na mutum (HCoV) suna haifar da ƙananan cututtuka, kamar mura.
Cutar cutar ta Acute Respiratory Syndrome (SARS) da ta Middle East Respiratory Syndrome (MERS) sun canza ra'ayi kuma sun bayyana yadda HCoV yake da ban tsoro da kuma barazana ga rayuwa.
Fitowar SARS-CoV-2 a kasar Sin a karshen shekarar 2019 ta jawo hankalinmu ga CoV kuma ta ba mu mamaki da sauki amma rashin kamuwa da cutar ta SARS-CoV.
Cutar HCoV cuta ce ta dabbobi kuma fahimtar asalin dabbobi na HCoV na iya taimaka mana.
Yawancin HCoVs sun fito ne daga kwayoyin halitta marasa cutar.
An san wani matsakaici na HCoVs.
Gano cutar dabba yana da tasiri sosai a rigakafin cututtukan mutum.
Binciken da aka yi game da yadda CoV ke shafar dabbobi ya ba da damar fahimtar muhimmancin cutar CoV a cikin mutane.
A cikin wannan binciken, mun gabatar da cikakken bayani game da ilimin da ake da shi game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da asalin zoonotic da kuma watsa tsakanin jinsuna.
Abu mai muhimmanci shi ne, mun gwada kuma mun bambanta bambancin HCoVs daga hangen nesa na juyin halittar kwayar cutar da kuma sake hada kwayoyin halitta.
Ana magana game da cutar ta COVID-19 a cikin wannan mahallin.
Bugu da kari, an kuma jaddada bukatar samun nasarar musayar hos da kuma tasirin juyin halittar cutar kan yadda cutar take da tsanani.
Coronavirus (CoV) na daga cikin Coronaviridae, wanda ya ƙunshi rukuni na guda, mai kyau, ɓoye RNA ƙwayoyin cuta.
Wannan longitude na genome yana tsakanin 26 zuwa 32 kilobases kuma shi ne mafi girma a cikin kwayoyin RNA kuma an kira shi "CoV" saboda yanayin yanayin da yake kama da kambi a karkashin microscope na lantarki.
A tsarin, CoVs suna da kwayoyin halitta marasa rarrabuwa da ke da tsari iri ɗaya.
An kiyasta kashi biyu bisa uku na wannan kwayar halitta suna da manyan manyan tsarin karatu guda biyu (ORF1a da ORF1b) da ke haɗe da juna, wanda aka fassara zuwa pp1a da pp1ab polyprotein replicase.
Ana sarrafa polyprotein don samar da furotin 16 da ba a tsara su ba, wanda ake kira nsp1~16.
Ragowar kwayoyin halitta sun ƙunshi ORFs don ƙwayoyin da aka tsara, ciki har da ƙwayoyin cuta (S), ƙwayoyin cuta (E), membrane (M) da nucleoprotein (N).
Wasu takamaiman kayan aikin sunadarai na abokin ciniki suna kuma ƙidaya ta hanyar abokan ciniki daban-daban na CoV.
Bisa ga bambancin jerin sunayen sunadarai, CoVs an rarraba su zuwa nau'i hudu (alpha-CoV, beta-CoV, gama-CoV da delta-CoV), inda nau'in beta-Cov ya ƙunshi yawancin HCoVs kuma an rarraba su zuwa nau'i hudu (A, B, C da D).
Shaidar filogenetik ta nuna cewa warts da beraye suna aiki a matsayin tushen gene ga yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban tanadi ga gamma-CoVs da delta-coVs.
A cikin dubban shekaru, CoV ta shawo kan tsayayyar da ke tsakanin jinsuna kuma wasu sun fito a matsayin muhimman cututtukan mutum.
A halin yanzu, an gano mutum bakwai da suka kamu da cutar coronavirus (HCoV).
Daga cikin su akwai HCoV-229E da HCoV-NL63 wanda shine alpha-CoV.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, mawuyacin cututtukan numfashi mai tsanani (SARS-CoV), cututtukan numfashi na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun cututtuka masu matsakaici, kamar mura da/ko fitsari.
A gefe guda, sabon gano SARS-CoV, MERS-CoV da SARS-CoV-2 suna da cututtuka masu yawa, suna haifar da mummunan kamuwa da ƙananan hanyoyin numfashi a cikin marasa lafiya waɗanda ke da babban yiwuwar samun cututtukan numfashi na yau da kullun (ARDS) da bayyanar extrapulmonary.
An ware nau'in HCoV-229E na farko, B814, daga cikin masu cutar mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin zurfin HCoV-229E da HCoV-OC43, duka biyun sun haifar da alamun sarrafa kai.
An yarda da wannan ra'ayi sosai cewa kamuwa da cutar HCoV ba ta da haɗari har sai an fara barkewar cutar SARS.
Cutar SARS ta faru a shekara ta 2003 kuma ta kasance daya daga cikin mummunan bala'i a tarihi, ta kamu da mutane fiye da 8,000 tare da mutuwar mutuwar kusan 10%.
Shekaru goma bayan haka, cutar ta cutar ta rikon numfashi ta Gabas ta Tsakiya (MERS) ta haifar da ci gaba da yaduwar cutar a yankin Larabawa tare da yaduwar cutar zuwa duniya.
HCoV na 2019 (2019-nCoV), wanda aka sake suna da shi SARS-CoV-2, shine wakili na ci gaba da cutar ta annoba ta cutar coronavirus 2010 (COVID-1), wanda ya kashe fiye da 3,120 da kamuwa da cutar fiye da 91,000 mutane har zuwa 3 ga Maris 2020.
An yi gargadi kuma dole ne duniya ta kasance a shirye don cutar SARS-CoV-2.
Dukkanin HCoVs bakwai na zoonotic ne daga bats, ratsan da dabbobi.
Akwai hujjoji da yawa da suka nuna cewa dukkanin HCov sun samo asali ne daga bats, inda kwayoyin suka kasance masu sauƙin daidaitawa kuma ba su da cututtuka amma suna nuna bambancin kwayoyin halitta mai yawa.
Cutar COVID-2019 ta kawo manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da sauran duniya.
Gano asalin HCoV na zoonotic ya ba da tsarin fahimtar tarihin halitta, motsi da kuma ƙuntatawa ga tsalle-tsalle na jinsin.
Wannan na iya kuma jagorantar da sauƙaƙe gano masu karɓar ruwa, masu matsakaici da masu karewa na SARS-CoV-2, tare da mahimman tasirin rigakafin yaduwar nan gaba.
A cikin wannan bita mun gabatar da cikakken bayani game da asalin zoonotic, watsa tsakanin jinsuna da kuma kamuwa da cutar HCoV.
Musamman, mun nuna kuma mun tattauna batun da ya shafi kowa inda virion HCoV ba shi da cutar a cikin ajiyar halitta na hoses amma ya zama mai cutarwa bayan watsawa ta hanyar interspecies zuwa sabon hoses.
Mun kuma sake nazarin yanayin juyin halittar HCoV inda karuwar yaduwar cutar ta bayyana tare da rage cututtukan cututtukan.
Sakamakon ci gaba da barkewar cutar SARS-CoV-2 an tattauna shi a cikin wannan mahallin.
An san dabba da cutar ta CoV tun daga ƙarshen shekarun 1930.
Kafin a fara ware HCoV-229E strain B814 daga nasal discharges na marasa lafiya da ke fama da mura, an ware CoV daban-daban a cikin dabbobi masu kamuwa da cutar, gami da namomin kaza, beraye, shanu, alade, cats da karnuka.
A cikin shekaru da suka gabata, an gano HCoVs bakwai.
Takaitaccen tarihin gano HCoV a cikin tsarin tsarin mulki (Table 1) na iya ba da bayani da koyarwa.
An fara ware nau'in HCoV-229E daga cikin numfashi na marasa lafiya da ke fama da kamuwa da kwayar cutar a cikin hanyoyin numfashi na sama a shekara ta 1966, kuma an daidaita shi don girma a cikin layin WI-38 na ƙwayoyin huhu.
Masu kamuwa da cutar HCoV-229E suna nuna alamun cutar mura, ciki har da ciwon kai, kumburi, kumburi da ciwon wuya, tare da zazzabi da tari ana ganin su a cikin 10 zuwa 20% na lokuta.
Daga baya a 1967, an ware HCoV-OC43 daga cikin kwayoyin halitta sannan aka sanya shi a cikin kwakwalwar da ke shan nono.
Bayanan asibiti na kamuwa da cutar HCoV-OC43 an ga ta yi kama da kamuwa da cutar ta HCoV-229E, wanda ba a iya bambanta shi da cutar ta hanyar cutar ta hanyar numfashi kamar cutar mura A da rhinovirus.
HCoV-229E da HCoV-OC43 sun bazu ko'ina cikin duniya kuma suna iya kamuwa da cutar a lokacin hunturu a yankuna masu matsakaicin yanayi.
Yawancin lokaci, lokacin da waɗannan ƙwayoyin cuta biyu suka warke ya fi mako ɗaya, kuma ana biye da cutar na kimanin makonni biyu.
A cewar wani binciken da aka yi a kan masu aikin sa kai na mutum, lafiyayyen mutane da suka kamu da cutar HCoV-229E sun kamu da mura mai sauƙi.
Wasu marasa lafiya da ke da cutar ta kamuwa da cutar sun nuna cewa suna da ciwon huhu.
SARS, wanda aka fi sani da pneumonia atipical, shine cutar da HCoV ta fara haifar da ita a tarihin ɗan adam kuma wakili na etiological shine SARS-CoV, HCoV na uku da aka gano.
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong a China.
Cutar SARS ta haifar da shari'o'i 8,096 da aka ruwaito tare da mutuwar 774, wanda ya bazu a ƙasashe da nahiyoyi da yawa.
Baya ga yaduwar super, an kiyasta cewa kowane hali na iya haifar da kimanin shari'o'i biyu na biyu, tare da lokacin warkewa tsakanin kwanaki 4 zuwa 7 kuma ƙarancin ƙwayar cuta ya bayyana a ranar 10 na rashin lafiya.
Masu kamuwa da SARS-CoV sun fara nuna myalgia, ciwon kai, zazzabi, zazzabi da sanyi, sannan dispnea, tari da kuma tashin numfashi a matsayin alamun jinkiri.
Lymphophenia, gwajin hanta da kuma karuwar creatine kinase sune wasu cututtukan SARS na yau da kullum.
An kuma lura da lalacewar alveolar da ta bazu, ciwon epithelium da karuwar macrofaucin a cikin marasa lafiya na SARS.
Daga baya, kashi 20 zuwa 30 cikin 100 na marasa lafiya suna bukatar kulawa da kuma iska mai iska.
Baya ga cututtukan ƙananan numfashi, gabobin jiki da dama ciki har da gastrointestinal tract, hanta da koda na iya kamuwa da cutar a cikin waɗannan mawuyacin hali, yawanci tare da hadarin cytokine, wanda zai iya haifar da mutuwa musamman a cikin marasa lafiya masu cutar immunocompromised.
An fara ware kwayar daga wani ɗan'uwa daga cikin ɓarnar huhu na wani mai haƙuri da ke tafiya zuwa Hong Kong daga Guangzhou.
Tun daga lokacin, an yi ƙoƙari sosai don bincike kan HCoV.
An killace HCoV-NL63 daga wani yaro mai wata bakwai daga Netherlands a karshen 2004.
Da farko an gano cewa cutar tana da yawa a cikin yara, 'yan kasuwa da marasa lafiya masu cutar rigakafi tare da cututtukan numfashi.
Kasancewar choriza, conjunctivitis, zazzabi da bronchiolitis suna da yawa a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike na daban ya bayyana irin wannan kwayar cutar daga nasal samfurin wani yaro dan wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, cutar ta bazu ko'ina cikin duniya.
An kiyasta cewa HCoV-NL63 shine tushen kusan 4.7% na cututtukan numfashi na yau da kullun kuma lokutan da cutar ta fi faruwa a lokacin bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da laryngitis na hanawa, wanda aka fi sani da croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi asibiti da cutar huhu da bronchiolitis a Hong Kong.
Baya ga kamuwa da cutar pneumonia da bronchiolitis a cikin al'umma, HCoV-HKU1 an ruwaito yana da alaƙa da matsanancin cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 an samo shi a duk duniya, yana haifar da rashin lafiyar numfashi mai sauƙi.
Dukkanin HCoVs hudu da aka kamu da su a cikin wannan al'umma sun dace da mutane kuma suna da kasawa a gaba ɗaya don canzawa kuma haifar da cututtuka masu cutarwa, kodayake haɗarin ya faru ne don dalilai da ba a sani ba saboda akwai wasu lokuta da yawa na cutar HCoV-NL63, wanda kwanan nan aka ruwaito yana haifar da mummunan kamuwa da cutar ta hanyar numfashi a China.
Gabaɗaya, lokacin da HCoVs suka sami ikon yada su yadda ya kamata kuma su ci gaba da kasancewa cikin jikin mutum, cutar ta zama ƙasa da cutarwa ko kuma cutarwa.
An fara ware MERS-CoV ne a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da haihuwa da ke fama da cutar huhu da kuma rashin karfin koda a Saudiyya.
Duk da cewa yawancin shari'o'in da aka tabbatar da su daga dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ruwaito cewa an shigo da wasu lokuta na biyu zuwa ga wasu kasashen Turai da Tunisia.
Wani annoba na biyu ya faru a Koriya ta Kudu a shekarar 2015 inda aka samu mutane 186 da suka kamu da cutar.
Maganin asibiti na MERS ya yi daidai da SARS, wanda ke nuna ci gaba da cutar huhu.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS suna fama da rashin lafiyar koda, wanda ya zuwa yanzu ya kasance na MERS ne kawai a cikin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na marasa lafiya suna nuna alamun gastrointestinal, kamar fitsari da kumburi.
Ya zuwa 14 ga Fabrairu, 2020, an samu karin mutum 2500 da aka tabbatar da cutar tare da mutuwar mutum 34.4%, wanda ya sa MERS-CoV ya zama daya daga cikin cututtukan da suka fi cutarwa a cikin mutane.
A tsakiyar zuwa karshen watan Disamba na 2019, an gano tarin marasa lafiya na cutar huhu da aka sani a baya dangane da kamuwa da cutar SARS-CoV-2 a Wuhan, Hubei Province, China.
Hukumar Lafiya ta Duniya ta bayyana barkewar cutar ta hanyar huhu ta kasa da ta faru saboda SARS-CoV-2 a matsayin Matsalar Lafiya ta Jama'a a Duniya kuma ta sanya sunan cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an ba da rahoton shari'o'i 90,053 a duk duniya, tare da mutuwar mummunan hali na 3.4%.
A halin yanzu, mutuwar mutum a Hubei, China, ya kai kashi 4.2%, yayin da mutuwar mutum a wajen yankin ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, suna fitowa a matsayin zazzabi, tari da dyspnea.
Wasu marasa lafiya ma suna da ciwon.
Ciwon huhu yana cikin mafi muni kuma yana iya ƙaruwa cikin sauri zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda babban homologue na nucleotide na 82%, kwayar cutar ta kasance cikin rassan daban-daban a cikin bishiyoyin phylogenetic.
SARS-CoV-2 ya zama ƙasa da cututtuka amma ya fi sauƙi fiye da SARS-CoV da MERS-CoV.
An samu rahoton marasa alamar cutar SARS-CoV-2 kuma yana iya haifar da yaduwar cutar a duniya.
Kwatanta da bambance-bambance tsakanin SARS-CoV-2 da sauran HCoV shida ya nuna kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokaci da kuma tsawon lokacin da cutar HCoV ke gudana suna kama da juna.
A wannan yanayin, SARS-CoV-2 ya bi al'amuran sauran HCoV shida.
Na biyu, ci gaban bayyanar cututtukan COVID-19 ya kasance tsakanin SARS-CoV da HCoVs huɗu da aka gano daga al'umma (cth. HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna alamun da aka fi gani yayin kamuwa da cutar ta HCoV da aka samu daga al'umma, gami da kasancewar bayyanar cututtuka marasa mahimmanci, masu sauƙi ko babu bayyanar cututtuka.
A gefe guda kuma, ƙananan ƙananan ƙananan COVID-19 na iya zama kamar yadda ake gani a cikin SARS-CoV, duk da cewa ƙimar ta ɗan ƙasa.
Na uku, yaduwar SARS-CoV-2 ta kuma nuna wani sabon salo mai ban sha'awa ga HCoVs biyu da aka samu daga al'umma da SARS-CoV.
A gefe guda, kamuwa da cutar SARS-CoV-2 ya kasance aƙalla kamar HCoV da aka samu daga al'umma.
A gefe guda, yana da wuya a tabbatar da ko cutar SARS-CoV-2 ta ragu bayan ta shiga cikin mutane kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin ƙazanta.
Ko kuma canja wurin shara zuwa baki don SARS-CoV-2 yana taka muhimmiyar rawa kamar yadda yake a cikin SARS-CoV akalla a ƙarƙashin wasu yanayi suna jiran bayani ta hanyar nazarin gaba.
Yana da ban sha'awa kuma don ganin ko SARS-CoV-2 na iya tashi bisa ga yanayi kamar yadda yake a cikin yanayin HCoV da ke kamuwa da cutar a cikin al'umma.
Koyaya, halaye na SARS-CoV-2 ciki har da kamuwa da cutar, kamuwa da cutar da ci gaba da yaduwa bayan mutum zai shafi ƙarshen barkewar COVID-19 da ke gudana.
Dukkan HCoVs hudu da suka kamu da cutar a cikin al'umma sun haifar da bayyanar cututtuka masu sauƙi sun daidaita da kyau ga mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun saba da HCoVs hudu.
A wasu kalmomi, dukansu sun tsira daga cutar HCoV ta baya.
An cire HCoVs da ke haifar da mummunan cutar a cikin mutane da kuma mutanen da ke fama da cutar HCoV mai tsanani.
Don haka, HCoVs dole ne su ninka a cikin mutane har zuwa isa ya ba da damar tattara mutations masu dacewa waɗanda ke yaki da ƙuntatawa na hosts.
Saboda haka, idan cutar SARS-CoV-2 ta daɗe kuma mutane da yawa sun kamu da cutar, to, cutar za ta iya daidaitawa sosai ga mutane.
Idan cutar ta daidaita da kyau, zai yi wuya a hana ta yaduwa cikin mutane ta hanyar killacewa ko wasu matakan hana kamuwa da cutar.
A cikin shekaru, cov guda hudu da aka kamu da su a cikin al'umma sun bazu cikin yawan mutane, suna haifar da mura na yau da kullum a cikin masu kamuwa da cutar.
Wannan kwayar cutar ba ta bukatar wani tanadi na dabbobi.
A gefe guda, SARS-CoV da MERS-CoV ba su daidaita da mutane ba kuma ba a iya ci gaba da yaduwar cutar a cikin mutane ba.
Dole ne kwayar ta zauna kuma ta yi yawa a cikin adanawar dabbobi da kuma neman damar da za ta iya yadawa ga mutane masu kamuwa da cutar, wataƙila ta hanyar ɗaya ko fiye na masu tsakiya da masu haifuwa.
SARS-CoV-2 yana da halaye iri ɗaya da duka SARS-CoV/MERS-CoV da HCoVs huɗu da suka kamu da cutar a cikin al'umma.
Yana da matukar saukin kamuwa da cutar kamar HCoV da ke kamuwa da cutar a cikin al'umma, aƙalla a yanzu.
Koyaya, cutar ta fi kamuwa da cuta fiye da HCoVs da ke kamuwa da cutar a cikin al'umma kuma ba ta da cutar fiye da SARS-CoV ko MERS-CoV.
Lokaci zai nuna ko cutar ta dace da mutane sosai kuma ta bazu cikin mutane ba tare da wani tanki ko wani dabba ba.
Kafin mu tattauna asalin dabbobi da ke haifar da cutar, ya kamata mu tattauna ma'anar da halayyar juyin halitta, yanayi, tankuna, matsakaici da kuma haifuwa na HCoV.
Wani dabba yana aiki a matsayin mai kawo juyin halitta ga HCoV idan yana da kyakkyawar ma'ana wacce ke da babban homology a matakin nucleotide.
Ana samun kwayoyin halitta masu kyau da ba su da cutar a cikin wannan kwayar.
Hakazalika, masu ruwa da tsaki suna riƙe da HCoV a kai a kai kuma suna riƙe da shi na dogon lokaci.
A lokuta biyu, ana samun cutar ta halitta kuma ita ce hanyar da za a iya kamuwa da cutar HCoV ko virion.
A wani ɓangare kuma, idan an gabatar da sabon HCoV zuwa wani matsakaici kafin ko a kusa da gabatarwarsa ga mutane, cutar ba ta daidaita da sabon cutar ba kuma yawanci cutarwa ce.
Wadannan masu tsakiya na iya zama tushen zoonotic na kamuwa da cutar mutum kuma suna taka rawa a matsayin masu tsirar da kwayar cutar ta hanyar ba da damar cutar ta ninka ta ɗan lokaci sannan kuma ta yada kwayar cutar zuwa mutane don karfafa sikelin kamuwa da cutar mutum.
HCoV na iya kamuwa da cutar ta hanyar mutuwa idan ba zai iya ci gaba da kamuwa da cutar a cikin masu tsakiya ba.
A wani ɓangare kuma, HCoVs na iya daidaitawa zuwa matsakaiciyar hosts kuma suna haifar da kamuwa da cutar na dogon lokaci.
A wannan yanayin, matsakaiciyar makami ta zama mai riƙe da ruwa na halitta.
Bayanai na cututtuka sun nuna cewa SARS yana da tarihin hulɗa da dabbobi masu farauta.
Binciken seroprevalence ya nuna cewa masu sayar da dabbobi suna da mafi girman prevalence na anti-SARS-CoV IgG fiye da jama'a.
An fara gano cewa tsutsotsi (Paguma larvata) da karnuka masu rai a cikin kasuwar dabbobi suna dauke da kwayar cutar kamar SARS-CoV wanda yayi kama da SARS-CoV.
Wannan ya goyi bayan gaskiyar cewa babu wani rahoton SARS bayan an kashe dukan foxes a kasuwa.
Koyaya, an ruwaito cewa laurels daga gandun daji ko gonaki ba tare da fallasa ga kasuwar rayayyun dabbobi ba sun kasance masu cutar SARS-CoV, yana ba da shawarar cewa laurels na iya zama kawai masu karfafawa na matsakaici amma ba na halitta ba na SARS-CoV.
Mafi mahimmanci, tun da 80% na dabbobi daban-daban a kasuwa a Guangzhou suna da antibodies na SARS-CoV, yiwuwar cewa ƙananan nau'ikan dabbobi masu shayarwa na iya zama masu karfafawa na tsakiya ga SARS-CoV ba za a iya watsi da shi ba.
Wannan ya zama sanadiyar mutuwar SARS-CoV.
Wani bincike na gaba na dabba na halitta na SARS-CoV ya gano wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Wannan kabewa ta kasance mai kyau ga antibodies na SARS-CoV da kuma tabbatar da kwayar SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoV sun raba kashi 88-92% na homologous nucleotide-adjustable homology da SARS-CoV.
Wannan binciken ya kafa wani sabon ra'ayi cewa ƙwayoyin cuta suna haifar da cututtukan mutum.
Wasu CoVs kamar SARS (SL-CoVs) an gano su ne daga warts, amma babu wani sai wanda ake kira WIV1 da za a iya ware shi a matsayin kwayar cutar mai rai.
An san mutum da wani abu mai kama da angiotensin 2 (ACE2) mai karɓa don SARS-CoV.
WIV1 da aka samu daga samfurin ƙazantar ƙazanta ya nuna yana amfani da ƙazanta, tsutsa da ACE2 na mutum a matsayin mai karɓa don shigar da ƙwayoyin.
Abin sha'awa, an gano cewa cutar SARS mai warkewa tana iya hana cutar ta WIV1.
Ya zuwa yanzu, WIV1 ya wakilci zuriyar da ta fi dacewa da SARS-CoV a cikin warts, yana raba 95% na homologin nucleotide.
Duk da cewa akwai babban homologue tsakanin wadannan kwayoyin biyu, an yi imani da cewa WIV1 ba shine ainihin asalin cutar SARS-CoV ba kuma wartsakwar ba shine ainihin mai riƙe da SARS-CoV ba.
Binciken filogenetik ya sanya MERS-CoV zuwa rukuni guda kamar CoV-HKU4 da CoV-HKU5 bats.
CoV-HKU4 da MERS-CoV na bats suna amfani da wannan mai karɓar hos, wanda aka rage shi zuwa peptidase 4 (DPP4), don shigar da kwayar cutar.
Rashin amfani da RNA mai dogaro da RNA daga MERS-CoV ya fi kusa da ƙwayar cutar a cikin beta-CoV na gizo-gizo da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a samu wani MERS-CoV mai rai a cikin daji ba.
MERS-CoV da kuma CoV-HKU25 sun kasance mafi kusa da juna a cikin kwayoyin halitta, suna da kashi 87 cikin dari na homologous nucleotide.
Saboda haka, ƙuƙwalwa ba su da wataƙila su ne masu karɓar ruwa na MERS-CoV.
A akasin haka, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Larabawa suna da tasiri mai kyau a kan rigakafin rigakafin MERS-CoV, kamar yadda raƙuman Gabas ta Tsakiya suka kasance daga ƙasashen Afirka daban-daban.
An ware rayayyun MERS-CoVs masu kama da kwayar cutar da aka samu a cikin mutane ta hanyar swab na hanci na raƙuman Larabawa, wanda ya nuna cewa raƙuman suna aiki a matsayin tsarkakakken mai riƙe da MERS-CoV.
Ya kamata kuma a lura cewa a general ana samun bayyanar cututtuka masu matsakaici amma an lura da karuwar cutar a cikin raƙuma da ke kamuwa da cutar MERS-CoV.
Musamman, raƙuma masu kamuwa da cutar suna fitar da ƙwayoyin cutar ba ta hanyar numfashi kawai ba amma ta hanyar bakin ƙura, wanda kuma shine hanyar fitar da ƙwayoyin cutar daga ƙwari.
Koyaya, tambaya ta kasance tun lokacin da yawancin shari'o'in MERS da aka tabbatar ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, yiwuwar alaƙa da hanyar watsawar mutum zuwa mutum ko hanyar watsawa da ba a sani ba wanda ya shafi nau'ikan dabbobi da ba a san su ba waɗanda ke dauke da MERS-CoV.
SARS-CoV-2 ya raba kashi 96.2% na nucleotide homologous da CoV RaTG13 na fuka-fuki wanda aka ware daga fuka-fukan Rhinolophus affinis.
A cikin shari'o'in SARS-CoV da MERS-CoV, rashin daidaituwa tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don ƙayyade alaƙar mahaifa.
Ana iya cewa, ƙwararrun bazai iya zama mafi kusa da masu karɓar ruwa ba ga SARS-CoV-2 amma ana iya gano CoV na ƙwararrun a nan gaba.
Wataƙila, ana iya samun cutar ta hanyar dabbobin da ke tsakanin SARS-CoV-2 daga jinsunan daji da aka sayar da su kuma aka kashe su a Kasuwar Kasuwancin Ruwan Ruwa ta Huanan, wanda ke da alaƙa da yawancin farkon shari'o'in COVID-19, yana nuna yiwuwar faruwar yaduwar dabbobi zuwa mutane.
Wasu binciken da aka yi kwanan nan dangane da tsarin metagenomics sun nuna cewa wani karamin rukuni na masu shayarwa da ake kira garwashin dabbobi (Manis javanica) na iya adana beta-CoV na zuriyar da ke da alaƙa da SARS-CoV-2.
Wannan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Duk da haka, dukansu suna da alaƙa da RaTG13 tare da kusan 90% na ainihi a matakin nukiliotida.
An tattara su cikin ƙananan ƙananan kwayoyin cutar guda biyu kamar SARS-CoV-2 a cikin bishiyar pilogen, ɗayan yana da alaƙa da yankin mai ɗaure mai karɓa (RDB) wanda ya fi kama da SARS-CoV-2, tare da 97.4% na asalin amino acid.
A cikin bambancin da ke bayyane, RBD daga SARS-CoV-2 da RaTG13 sun fi karkata, duk da cewa suna da digiri na homology na gaba.
Wani bincike na baya akan ƙwayoyin cuta na da cutar ya kuma bayar da rahoton gano kwayar cutar daga samfurin huhu, wanda daga baya aka gano yana da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyar tattarawa da kuma zaɓar jerin da aka yi da hannu don samar da wani ɓangare na tsarin ƙwayoyin cuta na ɓangare wanda ya ƙunshi kusan kashi 86.3% na tsarin ƙwayoyin cuta na cikakken ƙwayar cuta.
Ba za mu iya ƙaryata yiwuwar cewa dabba mai tsami yana cikin masu tsakiya ga SARS-CoV-2.
Duk da haka, a halin yanzu babu wata hujja da ke tallafawa SARS-CoV-2 ya fito ne kai tsaye daga tsokoki saboda rashin daidaituwa tsakanin SARS-CoV-2 da beta-CoV da ke da alaƙa da SARS-COV-2 tsokoki.
Bugu da kari, nisan tsakanin SARS-CoV-2 da RaTG13 ya yi gajere idan aka kwatanta da tsakanin SARS-CoV-2 da kuma SARS-COV-2 da ke da alaƙa da beta-CoV.
Har yanzu ana bukatar a gano yadda SARS-CoV-2 ya samo asali a cikin ƙudan zuma, ƙudan zuma da sauran masu shayarwa.
Yayin da aka samu mafi girman homologue a cikin RBD tsakanin SARS-COV-2 da ganglions, beta-CoV yana da alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG12 wanda ke da mafi girman homologue na gaba.
Ana yin hasashe mai karfi cewa babban daidaituwa tsakanin RBDs na beta-CoV dangane da SARS-CoV-2 da SARS-CoV-2 an kori ta ne ta hanyar juyin halitta mai ma'ana.
Wani shawarwari na martani ya goyi bayan sake haɗuwa tsakanin beta-CoVs masu alaƙa da SARS-CoV-2 ganglion da RaTG13 a cikin nau'in dabba na uku.
A matsayin mai karfafa juyin halitta, sake shigarwa yana faruwa a cikin beta-CoV.
Har yanzu ana gudanar da bincike kan asalin zoonotic na SARS-CoV-2.
Baya ga HCoV mai cutar, an kuma yi nazarin asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar filogenetik ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga CoV na warts, yayin da an gano virons HCoV-OC43 da HCov-HKU1 a cikin beraye.
An ruwaito cewa cutar ta CoV ta Arewacin Amurka da aka gano a cikin kwayar cutar ta Arewacin Amurka ta nuna alaƙa ta kusa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa ta hanyar kwayoyin halitta da wani CoV na gizo-gizo, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da camellids kuma an yi zargin su ne matsakaici.
Don ƙarin bayani, an tsara ilimin da ake da shi game da asalin dabbobi na HCoV a cikin Figure 1 da Table 2.
Nazarin filogenetik ya ba da hujja ga abubuwan da suka faru na watsa HCoV tsakanin jinsuna a tarihi.
Lokacin da HCoV-OC43 ya wuce jinsuna don kamuwa da mutane daga dabbobi a kusa da 1890, an rubuta annobar kamuwa da cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna ba shi da tabbas.
Amma an gano alpha-CoV na kwayar cutar da ke da alaƙa da HCoV-229E.
Daga cikinsu akwai alpha-CoV alpaka.
Akwai wasu shaidu da suka nuna cewa cutar tana gudana daga tsuntsaye zuwa mutane kai tsaye.
Na farko, mutane amma ba alpaka ba za su iya samun hulɗa da ƙuƙwalwa a cikin yanayin da ake ciki.
Amma, mutane suna da dangantaka mai kyau da alkeka.
Na biyu, alpha-CoV na warts da ke da alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin warts, yayin da alpha-CoV na alpaka ke haifar da cututtukan numfashi a cikin dabbobi masu cutarwa
A ƙarshe, ba a sami alpha-CoV a cikin dabbobi ba.
Saboda haka, ba za a iya ƙyale yiwuwar alkalan su sami alpha-CoV dangane da HCoV-229E daga mutane ba.
A gaskiya, kwari sune ainihin tushen cututtukan mutum na mutum ciki har da kwayar cutar rabies, Ebola, Nipah da Hendra.
Saboda haka ba abin mamaki ba ne cewa warts za su iya watsa HCoV-229E zuwa ga mutane kai tsaye.
A madadin haka, ko da yake alpha-CoV na tsutsa ya zama asalin HCoV-229E, alpacas da raƙuma na Arabiya na iya zama matsakaiciyar hanyar watsa kwayar cutar zuwa mutane, daidai kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV ya zama misali mafi kyau na watsawa tsakanin jinsuna daga gizo-gizo zuwa raƙuma na Larabawa da kuma daga raƙuma na Larabawa zuwa mutane.
An san asalin MERS-CoV daga bats a farkon gabatarwar kuma an ƙarfafa shi da binciken da ya biyo baya.
A bayyane yake cewa ƙuƙwalwa suna ba da zurfin nau'in kwayar cutar don musayar kwayoyin halitta tsakanin jinsuna da kuma yaduwar tsakanin jinsuna.
Tsawon shekaru, da kuma yawan wuraren da ake zama, da kuma kusantar zamantakewar jama'a da kuma iyawar tashi suna da kyau sosai don yin amfani da su wajen yin amfani da su wajen yaɗa kwayar cutar.
Bugu da ƙari, an gabatar da MERS-CoV ga raƙuman Larabawa na shekaru da yawa.
Ya dace da waɗannan raƙuman da suka sauya daga matsakaici zuwa mai ɗorewa da kuma na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙananan ƙananan mutations a cikin waɗannan dabbobi.
Ana iya samun cutar ta bazuwar zuwa mutane ba tare da an yi niyya ba kuma mutane sun kasance a matsayin masu karɓar MERS-CoV na ƙarshe saboda ba za a iya ci gaba da watsa ta ba.
Ya bambanta da aikin raƙumi a cikin yaduwar MERS-CoV, aikin garken, idan akwai, a cikin yaduwar SARS-CoV-2 ya bambanta.
Musamman, beta-CoV na shinge yana da matukar cutarwa a cikin shinge.
Suna iya zama ƙarshen hosts don beta-CoV dangane da SARS-CoV-2, kamar yadda foxes a cikin SARS-CoV.
Wasu yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabba zuwa mutum dole ne a yarda da su ko a ƙi su a cikin nazarin gaba.
Na farko, ƙuƙwalwa na iya zama mai riƙewa ga ƙwayoyin cuta masu alaƙa da SARS-CoV-2 wanda ya yi daidai da SARS-CoV-2.
Mutane suna iya raba yanayin halittu da su ta hanyar hakowa ko hakar ma'adinai.
Na biyu, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwar ƙwararrun ƙwar.
Mutane suna kamuwa da cutar ta hanyar shan dabbobi da kuma cin dabbobi masu farauta.
Wataƙila dabbobi masu shayarwa da yawa ciki har da dabbobi na gida suna da haɗari ga SARS-CoV-2.
Ana bukatar a duba dabbobi da kuma namomin jeji don gano rigakafi.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaita SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ke da alaƙa da ƙuƙwalwa da ƙuƙwalwa.
Ana ci gaba da bincike kan asalin dabbobi na SARS-CoV-2.
Baya ga nau'ikan dabbobi daban-daban, manyan abubuwa uku na ɓangaren kwayar cutar suna da mahimmanci wajen sauƙaƙa CoV don ƙetare shingen nau'in.
Na farko, suna da yawan juyin halitta a RNA.
Idan aka kwatanta da kwayar RNA guda ɗaya, ana iya ɗaukar ƙididdigar ƙididdigar ƙididdigar CoV a matsayin "mai sauƙi" zuwa "mafi girma" tare da matsakaicin canji na ~10-4 sauyawa a shekara a kowane rukunin 2, dangane da fasalin daidaitawar CoV zuwa sabon mai masaukin baki.
CoV yana da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Abin sha'awa, an san cewa analog na Remdesivir yana hana CoV ninka ta hanyar wannan exoribonuclease da RNA polymerase da ke dogara da RNA.
Remdesivir yana daya daga cikin mafi kyawun wakilai na anti-SARS-CoV-2 da aka gwada a cikin gwaji na asibiti.
Amma, yawan mutancin CoV ya ninka na mai karɓar cutar sau miliyan ɗaya.
Bugu da ƙari, yawanci yawan canjin ya yi yawa idan CoV ba ya daidaita da juna sosai.
Idan aka kwatanta da SARS-CoV tare da yawan yawan canjin, yawan canjin SARS-CoV-2 ya bayyana a ƙasa, yana ba da shawarar matakin daidaitawa mai girma ga mutane.
Wataƙila, ya riga ya daidaita da wasu ƙwayoyin da ke kusa da mutane.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuman Larabawa.
A ka'idar, ba zai yiwu cewa juyin halitta na halitta zai sa alluran rigakafi da rigakafin rigakafi na SARS-CoV-2 su zama marasa tasiri a cikin ɗan gajeren lokaci ba.
Na biyu, mafi girma a cikin kwayoyin RNA a cikin CoV suna amfani da ƙarin filastik a cikin gyare-gyaren kwayoyin halitta don canzawa da sake haɗuwa, yayin da suke ƙara yiwuwar juyin halitta tare tsakanin jinsuna, wanda ke taimakawa wajen fitowar sabon CoV lokacin da yanayi ya dace.
Wannan yana tallafawa da yawa na musamman bude karatu frame da kuma aikin da aka encoded zuwa 3' gefen genomes.
Na uku, CoVs suna canza samfurori ba tare da izini ba kuma suna yin yawa a lokacin da RNA ke ninkawa ta hanyar tsarin "sake-zaɓa" na musamman.
A cikin masu aiki a matsayin masu aiki na cakuda, sauyawar jini yana faruwa sau da yawa yayin rubutun RNA na CoV.
Ana iya sake haɗa RNA mai kama da juna don samar da sabon CoV.
An gano hujja ta phylogenetic na haɗuwa da halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma dabbobi na CoV kamar SL-CoV da CoV-HKU9 na bats.
Hadin gwiwar masu karɓar kwayar cuta yana da alaƙa da kamuwa da cuta.
Baya ga abubuwan da aka ambata a sama, wasu manyan abubuwan da ke shafar yaduwar cutar da ke tsakanin kwayoyin halitta su ne yadda kwayoyin ke hulɗa da masu karɓar hos.
A nan, an dauki SARS-CoV reinfection a matsayin misali na musamman, wanda kuma ya nuna hujja na zaɓi mai kyau yayin taron watsawa tsakanin jinsuna.
Bisa ga nazarin kwatancen tsakanin ƙwayoyin cuta na mutum da SARS-CoV na fuka-fuki, ana tsammanin SARS-CoV yana da saurin daidaitawa a cikin hoses daban-daban, musamman tare da mutation a RBD a cikin furotin S.
A general, RBDs a cikin Protein S a CoV suna hulɗa da kwayoyin kuma suna zaɓa sosai ta hanyar maganin antibody.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 a cikin S1 fragment, wanda ke ɗaurewa zuwa mutum ACE2 da kuma mai karɓar haɗin gwiwa don shigar da kwayar.
RBD na SARS-CoV na iya gano masu karɓar ACE2 daga dabbobi daban-daban, ciki har da bats, foxes, ratsan da karnuka raccoons, yana ba da damar yaduwar cutar tsakanin jinsuna.
A gaskiya ma, an lura da amino acid shida kawai da suka rage a matsayin daban-daban daga ƙwayoyin cuta na mutum da na fuka-fuki a cikin RBD kuma 4 daga cikinsu suna cikin ƙirar mai ɗaurewa don hulɗa da masu karɓar ACE2.
SARS-CoV na fuka-fuki yana da mutations K479N da S487T a cikin RBD, wanda zai iya haɓaka haɗin haɗin haɗin haɗin haɗin kai na ƙwayoyin cuta tare da masu karɓar ACE2 na mutum.
A wasu kalmomi, waɗannan sauyawar amino acid biyu suna iya zama mahimmanci don daidaitawar kwayar cutar zuwa mutum.
Ya kamata a lura cewa SARS-CoV-2 yana da kwayoyin halitta iri ɗaya da SARS-CoV.
Bambancin kashi 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S sun nuna cewa an canza haɗin haɗin wannan S tare da ACE2 na mutum.
A gaskiya ma, binciken cryo-EM ya nuna cewa wannan haɗin yana da sau 10 zuwa 20 fiye da yadda yake tsakanin ACE2 na mutum da kuma SARS-CoV S.
Hakanan yana da ban sha'awa don tantance ko wasu masu karɓar haɗin gwiwa na iya zama dole don yaduwar SARS-CoV-2.
Abin sha'awa, HCoV-NL63 ma yana da alaƙa da ACE2 amma tare da S-sashen daban.
Akwai sauran masu karɓar HCoV da yawa a cikin wanzuwarsu, kamar aminopeptidase N don HCoV-229E, da kuma acetyl sialic acid 9-O don HCoV-OC43.
Yana iya zama abin da ya sa mutane suka yi nasarar daidaita wannan cutar bayan an yi ta yaduwa tsakanin jinsuna daga cikin dabbobi.
Baya ga masu karɓar kwayoyin, sakamakon watsawa tsakanin nau'ikan HCoVs kuma ya dogara da dogaro da hoses da sauran abubuwan hanawa.
Bambancin wannan furotin na hos tsakanin mutane da kuma HCoVs na halitta kamar su bats, raƙuma da kuma rodents na iya haifar da hana yaduwar tsakanin jinsuna.
HCoVs dole ne su kama tushen tushen ƙwayoyin cuta kuma su yi amfani da ƙwayoyin cuta don yaduwar tsakanin jinsunan da suka yi nasara.
A wannan yanayin, ba a gano ko kuma gano ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Yin tacewa a kusa da kwayoyin halitta ba tare da nuna bambanci ba don dogaro da hosts da kuma hanawa na SARS-CoV-2 ta amfani da fasahar CRISPR mai ci gaba na iya haifar da sakamako.
Fitowar sabon HCoV: komawar farko
Bambancin CoV na bats yana ba da dama ga bayyanar sabon HCoV.
A wannan yanayin, CoV na warts yana aiki kamar tarin kwayoyin HCoV.
Bugu da ƙari, saurin juyin halitta da kuma sake haɗuwa da kwayoyin halitta sun kuma haifar da juyin HCoV kuma suna aiki a matsayin muhimman matakai biyu a cikin wannan tsari.
Alal misali, saye ko rasa wani sabon furotin mai ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙ
Daga cikin kayan aikin SARS-CoV, an yi la'akari da ORF8 a matsayin mai mahimmanci a cikin daidaitawa da mutane, saboda an ware SARS-CoV-related warts da aka gano amma an gano yana ɓoye furotin ORF8 mai ƙyama.
An gano alamar kashewar SARS-CoV-29 nucleotide a cikin nau'in da aka keɓe a farkon annobar mutum.
Wannan kashewa ya raba ORF8 zuwa ORF8a da ORF8b kuma an yi la'akari da shi a matsayin gyare-gyare na gyare-gyare wanda ke inganta musayar hos.
Bugu da kari, SARS-CoV yana da tarihin sake haɗuwa da zuriyar CoV alpha da gama, wanda aka gano yawancin ƙananan yankunan sake haɗuwa a cikin RNA-daidaitaccen RNA polymerase.
An kuma gano wuraren da aka sake haɗuwa a cikin nsp9, mafi yawan nsp10 da kuma wani ɓangare na nsp14.
Hakazalika, an nuna cutar MERS-CoV tana fuskantar sake haɗuwa tsakanin zuriya daban-daban, wanda ya faru a cikin raƙuman Larabawa a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an lura da sake haɗuwa a cikin sauran HCoVs, wanda ya ga HCoV ya sake haɗuwa da CoV na sauran dabbobi a cikin gene ba tsarinsa ba.
Ya kamata kuma a yi gargadi cewa zaɓin ƙarya na iya haifar da canje-canje na gangan a cikin kwayar cutar, wanda zai iya haifar da sakin kwayar daga matsin zaɓin da aka sanya, kamar na tsarin garkuwar jiki.
Wani misali na wannan tasirin shine rasa cikakken tsawon ORF4 a cikin HCoV-229E prototype, sakamakon kashewar nucleotides biyu.
Yayin da aka lura da ƙarfin ORF4 a cikin kwayar cutar da ake danganta da HCoV-229E, alpha-CoV alpaka yana nuna shigar nucleotide guda ɗaya, wanda ke haifar da ɓarkewar ƙira.
A ƙarshe, juyin halitta na HCoVs na zamani an kuma motsa shi ta hanyar matsin lamba a cikin masu riƙe su.
An gano rashin bayyanar cututtuka ko kuma bayyanar cututtuka kawai lokacin da ake kamuwa da CoV a cikin warts, wanda ke nuna cewa akwai daidaitaccen aiki tsakanin CoV da warts.
Da alama ƙuƙwalwa sun saba da CoV sosai a fannin ilimin lissafi da na tunani.
Alal misali, lalacewar da ke tattare da kunna amsawar pro-inflammatory a cikin warts yana rage cututtukan da CoV ke haifar da su.
Bugu da ƙari, an hana ayyukan kwayoyin halitta masu kisa a cikin warts saboda karuwar ƙwayar cuta na kwayoyin halitta masu kisa NKG2/CD94 da kuma ƙananan matakan bayyanawa ga kwayoyin aji 1 na babban tsarin histokeserase.
Bugu da ƙari, yawan adadin oxygen mai aiki (ROS) da aka samar daga ayyukan metabolism na kwayoyin cuta na iya hana CoV ninkawa da kuma hana karatun prof da exoribonuclease ke yi, yayin da yake ba da matsin lamba ga zaɓin kula da nau'in cutar da ke da matukar cutarwa lokacin da aka gabatar da shi ga sababbin hosts.
Ƙari ga haka, wasu nau'ikan CoV masu cutarwa na iya samo asali ta hanyar sake haɗuwa, yana haifar da sabon furotin ko kuma fasalin furotin don daidaitawar hos.
Saboda haka, ba zato ba tsammani ne cewa sababbin HCoVs guda uku sun bayyana a cikin shekaru biyu da suka gabata.
CoV ba shi da cututtuka ko kuma yana haifar da bayyanar cututtuka a cikin jijiyoyin ajiyarsu kamar su bats da raƙuma.
Yana ninka cikin sauri ba tare da ya haifar da amsa mai ƙarfi ba.
Wannan shi ne ainihin dalilin da ya sa ake ganin marasa alamar cutar kuma shi ne dalilin da ya sa mutane suke kamuwa da cutar.
Abubuwan da suka fi tsanani a cikin jiki sun fi yawa ne sakamakon hawan jiki na jiki da kuma tashin hankali na cytokine inda idan mutum ya yi fama da cutar, zai iya samun lalacewar huhu.
A wani ɓangare kuma, a cikin masu ɗaukar marasa alamar cututtuka, an kawar da amsawar rigakafi daga CoV ninka.
Irin wannan dabarun da ke magance amsawar rigakafi na iya samun sakamako mai amfani a maganin cutar SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin ƙudan teku.
Saboda haka, ba da interferon type 1 aƙalla a farkon farkon fasalin kamuwa da SARS-CoV-2 a cikin mutane ya kamata ya kasance mai amfani.
Bugu da ƙari, kunna ƙwayoyin cuta a cikin warts ba shi da tasiri.
Saboda haka, yin amfani da NLRP3 inflammatory system tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Wannan ya biyo bayan bayyanar SARS-CoV-2 da kuma MERS-CoV.
Duk da cewa an gano beta-CoV na gizo-gizo wanda ya raba kashi 95% na homology na nucleotide tare da SARS-CoV, akwai kuma CoV na gizo-gizo wanda ya raba kashi 96% na homology na nucleotide tare da SARS-CoV-2.
Ko da yake an gano cewa foxes da sauran dabbobi a kasuwa suna da kwayar cutar da ta yi kama da SARS-CoV, ba a gano wani matsakaici na SARS-CoV-2 ba.
An gano beta-CoV na garuruwa wanda yake da kamanceceniya da SARS-CoV-2, yana nuna cewa garuruwa na iya zama ɗayan masu tsakiya ko kuma beta-CoV na garuruwa na iya ba da gudummawar wani yanki na gene ga ƙarshen SARS-CoV-2.
Duk da cewa akwai tambayoyi, babu wata hujja cewa SARS-CoV-2 na mutum ne ko kuma ba da gangan ba.
CoV ya koma cikin hankali sakamakon annobar SARS-CoV-2 kwanan nan.
Binciken CoV a cikin alƙalai da sauran dabbobi ya canza tunaninmu game da muhimmancin zoonotic da kuma tanadin dabbobi ga HCoV a cikin yaduwar mutum.
Akwai hujjoji da suka nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun fito ne daga kwayoyin halittar da aka watsa zuwa mutane ta hanyar hoses.
Tun da yake kamuwa da cutar SARS-CoV ta fito ne daga tuntuɓar mutane da farar fata a kasuwa, rufe kasuwar ruwa da kashe farar fata ya kamata ya kawo ƙarshen cutar SARS yadda ya kamata.
Saboda wannan dalili, dole ne a cire magungunan daga kasuwannin ruwa don hana yaduwar zoonotic, saboda gano yawancin zuriyar beta-CoV na magungunan da ke da alaƙa da SARS-CoV-2.
Duk da haka, yanayin da kuma yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar tsutsa da sauran dabbobi masu shayarwa zai zama dole a bayyana shi a cikin bincike na gaba.
A wani bangare, MERS-CoV ya kasance a cikin raƙuman Larabawa na dogon lokaci.
Wannan motar ta zama muhimmin kayan sufuri da kuma babban tushen nama, madara, fata da kayan fur don al'ummomin yankin.
Ana samun su a duk Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a yi sadaukar da dukkan raƙuman don hana MERS ba, kamar yadda aka yi a kasuwar dabbobi a kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake yaduwar cutar ta MERS, dole ne a dauki cikakken tsarin samar da maganin rigakafi mai inganci don magance MERS-CoV ga raƙuma, wanda ya haɗu da sauran matakan sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da cutar ba, sabon nau'i na kwayoyin halitta zai iya haifar da annoba.
An samu tarin kwayoyin cutar CoV a cikin daji.
Musamman, CoV na tsuntsaye da ke da damar zoonotic sun bambanta sosai.
Akwai dama ga wannan CoV na dabbobi su samo asali kuma su sake haɗuwa, suna haifar da sabon CoV wanda zai iya kamuwa da cutar kuma/ko kuma kashe mutum a nan gaba.
A wasu wurare a kasar Sin, ana bukatar a daina cin dabbobi don rage yawan mutane da dabbobi.
Da yake an samu mummunan sakamako daga SARS, MERS da COVID-19, an yi shiri da kuma tsara yadda za a amsa.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniyar nan tun da daɗewa.
Wannan kwayar ta kasance a cikin wani ruwa har sai da ta samu damar kamuwa da ita.
Ko da yake ƙuƙwalwa suna da halaye da yawa da ke sauƙaƙa yaduwar cutar, ana iya rage damar da mutane suke da shi na yin hulɗa da ƙuƙwalwa da sauran jinsunan dabbobin daji idan aka horar da al'umma don su guje wa waɗannan dabbobi.
Ana bukatar ci gaba da saka idanu a kan dabbobi masu shayarwa don samun fahimtar yanayin halittu na CoV da kuma na kwayoyin halitta, wanda zai taimaka wajen hana dabbobi kamuwa da mutane da kuma cututtuka a nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar zoonotic ita ce ta mutane su nisanta su daga yanayin yanayin yanayin yanayin ajiyar kwayoyin halitta don cutar zoonotic.
Wasu batutuwa da suka shafi asalin SARS-CoV-2 har yanzu ba a amsa su ba.
Da farko, idan ƙuƙwalwa ta ba da kwayar cutar SARS-CoV-2 ga ƙuƙwalwa, zai zama da ban sha'awa ganin yadda ƙuƙwalwa da ƙuƙwalwa za su iya raba wannan yanayin muhalli.
Na biyu, idan tsutsa suna taka rawa wajen yaduwa zuwa mutane, dole ne mu gano yadda mutane ke samun hulɗa da tsutsa.
Na uku, idan dabbobi masu shayarwa na uku suna aiki a matsayin ainihin matsakaici, dole ne a bayyana yadda suke hulɗa da jinsuna daban-daban ciki har da mutane, da algae da kuma garuruwa.
A ƙarshe, saboda yawancin dabbobi masu shayarwa ciki har da dabbobi masu ban mamaki na iya zama masu saurin kamuwa da SARS-CoV-2, dole ne a gudanar da lura da kamuwa da cutar ta gwaji.
Ko dai kwayar cuta, ƙuda ko wasu dabbobi masu shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma irin wannan kwayar cutar mai kama da ita za a iya gano ta a cikin gidajen halitta a nan gaba.
Binciken da ake yi a wannan yanki zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da muhimman abubuwan da ke tattare da rigakafi da kula da COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idodin bincike na "abubuwan da ake zargi" da "abubuwan da aka tabbatar" don COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganewa da kuma kula da kamuwa da cutar coronavirus ta 2019 (2019-nCoV), kuma wannan jagorar ta ba da kwarewarmu ta zama kyakkyawan tunani don magance cutar a duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali dangane da binciken da ake gudanarwa da kuma kwarewar aikin asibiti; saboda haka, ana sabunta hanyoyin bincike da magani akai-akai.
A cikin wannan wasiƙar, mun amsa wani bita kan jagorarmu kuma mun samar da sabbin ƙa'idodin bincike na "abubuwan da ake zargi" da "abubuwan da aka tabbatar" bisa ga Sabon Jagorar Gano da Kula da COVID-19 (sarrafa ta bakwai) da Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disambar 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da annobar, wanda yanzu aka sanya masa sunan cutar coronavirus 2019 (COVID-19) kuma an sanya wa cutar suna cutar ta coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-10 a matsayin annoba.
Don yaki da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawarwari masu sauri kuma an buga jagororin a cikin Nazarin Kiwon Lafiya na Sojoji na 06 ga Fabrairu 2020.
Wannan littafin ya jawo hankali sosai tun lokacin da aka wallafa shi.
Duk da haka, a lura cewa COVID-19 sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali dangane da binciken da ake yi a yanzu da kuma kwarewar ayyukan asibiti; saboda haka, ana buƙatar sabunta hanyoyin bincike da magani koyaushe.
Misali, Jagorar Maganin Gwaji da Magani ga COVID-19 da Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/), ya fitar tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, ya fitar da bugu bakwai tare da wasu mahallin da aka canza.
Yanzu da muka samu shawarwarin Zhou et al., sun gabatar da shawarwari masu sauki dangane da kwarewarsu ta asibiti.
Aikin su na ƙara sabon hujja ga ƙa'idodinmu kuma ya zama abin da ya dace da cutar a duniya.
Muna godiya da ƙoƙarce-ƙoƙarcen da suka yi.
Duk da haka, kokarin su na bukatar sabuntawa bisa ga sabuwar Jagorar Maganin Gwaji da Magani ga COVID-19 (Gwaji na bakwai) da kuma sabon binciken.
A cewar fitowar ta bakwai (3 ga Maris 2020), don tabbatar da wani abu da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwan da ke cikin tarihin ilimin cututtuka tare da abubuwa biyu na bayyanar cututtuka don samar da cikakken bincike, ko kuma ya kamata ya cika abubuwa uku na bayyanar cututtuka idan babu bayyanannen tarihin cututtuka:
Tarihin cututtukan cututtuka: (1) Tarihin tafiya ko zama a garin Wuhan da yankin da ke kewaye da shi, ko wasu al'ummomin da aka ruwaito shari'ar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) tarihin tuntuɓar kamuwa da cutar SARS-CoV-2 (tare da gwajin da ya dace da nucleic acid); (3) tarihin tuntuɓar marasa lafiya da zazzabi ko alamun numfashi daga garin Wuhan da kewaye da shi, ko wasu al'ummomin da aka ruwaito COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) tarihin tuntuɓar kwayar cutar da aka tabbatar da cutar: ((> 2 lokuta da zazzabi da/ko alamun numfashi sun faru a cikin makonni 2 a cikin ƙananan wurare, kamar gidaje, ofis, aji a makaranta, da sauransu).
Bayanan asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da siffofin daukar hoto na kamuwa da COVID-19; (3) yawan adadin fararen kwayar jini ya nuna daidaitaccen, lalacewa, ko raguwar yawan lymphocytes a farkon matakin farawa.
Dole ne a tabbatar da binciken da aka yi a kan wani abu da ake zargi da cutar ko kuma a kan wani abu na serological kamar haka: (1) gwajin PCR na ainihi mai kyau ga SARS-CoV-2; (2) allon kwayoyin halitta na dukkanin kwayar cutar ya nuna babban homogeneity ga sanannun coronavirus; (3) tabbatacce ga IgM antibodies da IgG antibodies na musamman ga SARS-CoV-2 a cikin magani; ko SaRS-CoV-2 na musamman IgG antibodies na canzawa daga mummunan zuwa tabbatacce, ko karuwa a titer > 4 sau a cikin sake dawowa a kan mataki na gaggawa.
Za mu iya ganin cewa an kara gwajin PCR na ainihin lokaci don nucleic acid a cikin numfashi ko samfurin jini zuwa bugu na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An sanya binciken cututtukan jini daga samfurin jini a cikin bugu na huɗu (27 ga Janairu 2020) da na biyar (8 ga Fabrairu 2020); sannan an sanya tabbacin serology a cikin bugu na bakwai.
Wannan gyare-gyare ya dogara ne akan ci gaba da aikin masu bincike na gano kayan gano nucleic acid masu kyau don ganowa nan take, da kuma samfurori daga hanyoyin numfashi ciki har da samfurin jini, wanda ke haɓaka wadatar samfurori daban-daban, da kuma tallafawa kawo sakamako mai kyau na antibody na musamman zuwa ingantattun ƙa'idodi.
Bugu da ƙari, akwai ƙarin tabbaci da ke gargaɗe mu mu yi hankali da marasa lafiya masu alamun bayyanar cututtuka ko marasa alamun cututtuka.
Saboda haka, ya kamata a sabunta jadawalin kwararru daga Zhou et al., saboda sun rarraba invidivu ba tare da alamun asibiti ba a matsayin "ƙarancin haɗari".
Hakanan za a tabbatar da tsarin ƙimar a cikin ayyuka da kuma nazarin asibiti na gaba.
A ƙarshe, muna fatan ƙarin hujjoji na kai tsaye za su zo kuma su gayyaci masu karatu su ba da ra'ayoyi.
Don ganewar asali ga "masu zargin" da "masu tabbatar da" mu na ba da shawarar ganowa da kuma bin sababbin ka'idojin ƙasarsu.
Ƙungiyarmu za ta sabunta jagororinmu daga lokaci zuwa lokaci don ba da taimako.
Bangladesh ta samu sabbin mutuwar mutane biyar sakamakon COVID-19, wanda ya kai matsakaicin adadin a kowace rana
Jiya, Bangladesh ta tabbatar da wasu mutane biyar da suka mutu sakamakon COVID-19 a wannan rana.
Wannan shi ne adadin mutuwar da aka samu a rana da aka yi da cutar.
A ranar Talata, Cibiyar Kula da Cututtuka, Kulawa da Binciken Bala'i ta Bangladesh (IEDCR) ta ba da rahoton adadin adadin kamuwa da cutar da aka samu ciki har da mutane 114 da suka kamu da cutar da suka warke da kuma mutane 33 da suka warke daga cutar.
An samu mutuwar mutane 17.
A wani labarin da aka wallafa a shafin yanar gizo, darektan IEDCR, Dakta Meerjady Sabrina Flora, ta ce mutuwar ta shafi maza hudu da mata daya.
A cewar Dr Meerjady, mutum biyu sun wuce shekaru 60, biyu daga cikinsu 51 da 60, kuma 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda aka kashe sun kasance daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID 19 a matsayin annoba a ranar 11 ga Maris.
Jami'an asibitin sun shaida wa wata majiyar labarai ta Anadolu cewa daya daga cikin wadanda suka kamu da cutar shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ake kula da shi a asibitin Maitree na Kuwait.
A ranar Asabar, a cikin wani sanarwar bidiyo ta yanar gizo, Ministan Sufuri da Sassan Hanyar Bangladesh Obaidul Quader ya ce zirga-zirgar jama'a za ta rufe fiye da yadda aka tsara, har zuwa ranar Asabar mai zuwa.
An fara rufe zirga-zirgar jiragen sama a ranar 26 ga Maris kuma an shirya su a ranar Asabar, 4 ga Afrilu.
Ana iya kawo kayayyakin da ake bukata, kamar magunguna, man fetur da abinci.
An fara samun kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar daya daga cikinsu.
A ranar 19 ga Maris, dukansu sun warke.
SARS-CoV-2 ya kai kamuwa da cutar miliyan daya a duniya.
A ranar Alhamis, jimlar adadin kamuwa da cutar coronavirus SARS-CoV-2 ta wuce miliyan ɗaya a duniya, a cewar bayanan daga Jami'ar Johns Hopkins.
Akalla mutuwar dubu 52 na da alaƙa da COVID-19, annobar da ta haifar da coronavirus.
Wannan mizani ya zo a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko kuma Zambia ta samu mutuwar farko da ta shafi coronavirus.
Koriya ta Arewa ta ce, har zuwa ranar Alhamis, ta kasance daga cikin 'yan kasashen da ba su da cutar coronavirus.
A ranar Talata, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da suka kamu da cutar, ciki har da mutane 79,332 a cikin awanni ashirin da hudu kafin 10 na safe na Watan Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu karin mutane 244,000 da suka kamu da cutar coronavirus, wanda ya haifar da mutuwar mutane 5,900.
Labaran CBS sun ruwaito, suna karbando bayanan jami'ar Johns Hopkins, cewa sama da mutuwar 1,000 a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana annobar yaduwa.
A ranar Alhamis, shugaban birnin Moscow, Sergie Sobyanin, ya kara wa birnin rufewa har zuwa ranar 1 ga watan Mayu.
A fadin kasar, Shugaba Vladimir Putin ya bayyana cewa, 'yan kasar Rasha za su iya ci gaba da karbar albashin su ba tare da sun tafi aiki ba har zuwa ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta kada kuri'a don tsawaita dokar ta baci zuwa kwanaki 15; an amince da kuri'un 215 a goyon baya, goma a wajen, kuma daya a kan.
Saudiyya ta kara dokar hana fita a cikin biranen Makka da Madina zuwa yini; a baya, dokar hana fita tana aiki ne kawai tsakanin 3 na yamma da 6 na safe.
Thailand ta shirya yin dokar hana fita tsakanin 10 na dare da 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta kara dokar hana fita zuwa ranar 1 ga Mayu.
Shagunan Australiya sun rage yawan kayayyakin wanka da aka yi amfani da su.
A daren Lahadi da Asabar, shagon sayar da kayayyaki na Australiya Woolworths da Coles sun rage ƙuntatawa kan sayen kayan wanka zuwa biyu da ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗaya-ɗ
ALDI ta kuma gabatar da iyakar kunshin guda daya, a ranar Litinin.
An saka wannan a matsayin saƙo a jerin sunayen masu fita, da kuma shafin Facebook na sarkar.
An ruwaito masu siye suna sayen kaya saboda tsoron COVID-19 idan mutum ya yi zaman kansa.
A ranar Laraba, kamfanin Woolworths ya kuma rage yawan kayan wanka don sayen kaya zuwa wani kunshin a kowane tsari.
Wannan canjin ya biyo bayan takunkumin kunshin hudu don kowane ma'amala da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris.
Coles, a cikin wata sanarwa ta kafofin watsa labarai a ranar 8 ga Maris, ya ruwaito cewa tare da aiwatar da takunkumin kunshin guda hudu, "manyan shagunan har yanzu suna cikin ajiya a cikin sa'a guda bayan aikawa", kuma ya bayyana bukatar a matsayin "ba a taɓa faruwa ba", yayin da ALDI, a cikin sakon Facebook a ranar Talata, ya kira shi "ba zato ba tsammani".
Kayan tallace-tallace sun karu a "ƙaruwa mai ban mamaki" a makon da ya gabata, a cewar wani kakakin kamfanin Woolworths.
Costco's a Canberra ta kuma iyakance adadin da aka ba da izinin zuwa fakiti biyu a makon da ya gabata.
Don ci gaba da rage rashi, Coles ya ba da umarni ga manyan fakitoci daga masu samarwa da haɓaka yawan aikawa, Woolworths ya ba da umarni ga ƙarin kaya, yayin da ALDI ta samar da kaya don shirin na musamman na Laraba wanda za'a iya samunsa da wuri.
Russell Zimmerman, darektan zartarwa na kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki suna kokarin kara yawan kayayyaki amma takunkumin da majalisar ta kafa a lokacin da ake jigilar kayayyaki ta hanyar manyan motoci ya sa hakan ya yi wuya.
Ya yi tsammanin farashin samfurin zai karu, yayin da masu samarwa ke ƙoƙarin biyan buƙata, kuma kadan ne na musamman.
A ranar Talata, ALDI ta sanar da cewa saboda farkon fitar da kayayyaki, wasu shagunan ba za su iya gudanar da abubuwan da suka dace ba a ranar Laraba.
A cikin wani rahoto daga News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shaguna suna cike da kayayyaki a kowace dare.
Ya gaya masa cewa kayan wanka suna da yawa, suna kawo ƙananan adadi a kan yawan kaya, kuma, lokacin da aka sayar, suna barin ɗakunan ajiya masu yawa, suna ƙara ƙara jin rashin.
Coles da Woolworths sun ce idan akwai abubuwa da yawa a kan ɗakunan ajiya, idan ana iya sayen kayayyaki kamar kayan wanka da kayan wanka, kuma ana iya samun adadi mai yawa, za ka iya rage tsoro, in ji Russell Zimmerman a ABC News.
Masu samar da kayan wanka sun sake yin amfani da su a ranar Laraba.
Kimberly-Clark, wanda ya kirkiro Kleenex Tissue, da Solaris Paper wanda ya kirkiro Sorbent, sun tabbatar da cewa suna aiki 24/7 don kiyaye wadatar, a cewar rahoton New.com.au.
Domain.com, wani shafin yanar gizon ƙasa, ya ruwaito wasu masu sayar da ƙasa suna ba da kayan wanka kyauta ga masu rarraba na farko a zaman gwanjon a Melbourne, lokacin da aka gudanar da ƙananan gwanjo saboda masu siye suna fuskantar hutu a lokacin hutu na ranar ma'aikata.
Labarin ranar Alhamis na News NT, wallafe-wallafen yau da kullum a Darwin, ya haɗa da ƙarin takarda guda takwas da ake nufi don yankewa da amfani da su azaman kayan wanka.
Shagunan sun ƙi yin hakan, a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris wanda ya ga sun ce ba su da shirin gabatar da iyakancewar sayayya.
Russell Zimmerman ya ƙara da cewa wasu kayayyakin suna da matukar bukatarsu, ciki har da masks, kayan shafawa, abinci mai bushewa, kayan wanke hannu da kuma bene.
Hakazalika, a waje da Ostiraliya, a ranar Lahadi da yamma, an ga babban kasuwar kan layi na Ocado ta iyakance sayen kayan wanka na Andres zuwa fakitin 12 na kayan wanka.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana barkewar cutar COVID-19 a matsayin annoba.
Ko da yake kalmar "zazzabin cuta" tana nufin kawai yadda cutar ta yadu, ba yadda hatsarin wannan yanayin yake ba, WHO ta fahimci bukatar ta bukaci gwamnatoci su dauki mataki:
Dukkanin kasashe na iya canza yanayin annobar.
Idan kasashe sun gano, gwada, kula, ware, bi da bi da kuma motsa al'ummarsu su dauki mataki, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna matukar damuwa game da matakan yaduwar da kuma tsanani da ke damun mu da kuma matakin rashin aiki da ke damun mu.
A cewar Dr. Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amirka, annobar "ba ta taɓa faruwa ba".
A wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce, "ban da cutar mura, ba a gano wani kwayar cutar numfashi ba daga bayyanar da ta kai ga yaduwar cutar a duniya".
Ghebreyesus ya yi irin wannan furucin, yana cewa "ba mu taɓa ganin annobar coronavirus ba".
Ya ci gaba da cewa, "kuma ba mu taba ganin annobar da za a iya sarrafawa a lokaci guda ba".
Sabuwar matsayin annobar ta biyo bayan shawarar WHO a watan Janairu na bayyana annobar a matsayin gagarumin matsalar lafiyar jama'a a duniya.
Darakta Anthony Fauci, shugaban Cibiyar Kula da Cututtuka da Cututtuka ta Ƙasa ta Amirka, ya ce game da annobar, "a takaice dai, za ta ƙara muni".
A ranar Alhamis, Associated Press ta ruwaito akwai akalla shari'o'i 126,000 na COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar coronavirus ta 201920 annobar cutar coronavirus ta 2019 (COVID-19) ce da ke gudana, saboda cutar ta shan numfashi mai tsanani coronavirus 2 (SARS-CoV-2).
An gano cutar a Wuhan, China, a watan Disambar 2019, an sanar da ita a matsayin Babban Taron Kiwon Lafiya a Duniya a ranar 30 ga Janairu, 2020, kuma an bayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, wanda ya haifar da mutuwar kusan 97,000.
An warkar da mutane 364,000.
An kiyasta yawan mutuwar mutane da kashi 4 cikin 100 a kasar Sin, yayin da a duniya, yawan mutuwar mutane da ke cikin Algeria ya kai kashi 13.04 cikin 100 a kasar New Zealand.
Alamun da suka fi kowa a cikinmu sun haɗa da zazzabi, tari da kuma numfashi.
Abubuwan da za su iya faruwa sun haɗa da cutar huhu da kuma ciwon hanta na numfashi.
Lokaci daga fallasawa zuwa bayyanar cututtuka yana da kusan kwanaki biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu takamaiman maganin rigakafi ko maganin rigakafi da aka sani.
Maganin farko shi ne maganin bayyanar cututtuka da tallafi. Abubuwan da ake ba da shawara na rigakafi sun haɗa da wanke hannu, rufe baki yayin tari, kiyaye nesa da wasu, da kuma kula da kansu da keɓewa ga waɗanda suke zargin kansu da cutar.
Hukumomi a duk faɗin duniya sun amsa da aiwatar da takunkumin tafiye-tafiye, killace mutane, umarnin hana su shiga, hana haɗari a wuraren aiki da rufe wuraren aiki.
Wannan annoba ta haifar da rikice-rikice na zamantakewar duniya, jinkirta ko soke ayyukan wasanni, addini, siyasa da al'adu, da kuma rashin wadataccen wadata wanda ke haifar da cinikin firgita.
Makarantu da jami'o'i sun rufe ko dai a kasa ko a gida a kasashe 193, suna shafar kashi 99.4 cikin dari na yawan daliban duniya.
Bayanai marasa kyau game da cutar sun bazu a kan layi, kuma akwai wasu lamuran rashin jin dadin jama'a da nuna bambanci ga Sinawa, wasu da ke da zuriya da kuma bayyanar Asiya ta Gabas da kudu maso gabashin, da kuma wadanda suka fito daga yankunan da ke da alamun cutar.
Saboda rage yawan tafiye-tafiye da kuma rufe masana'antun nauyi, an samu raguwar gurɓataccen iska da kuma sakin carbon.
Hukumomin lafiya a Wuhan, China (babban lardin Hubei) sun ba da rahoton clusters na cututtukan cutar pneumonia daga asalin da ba a san su ba a ranar 31 ga Disamba, 2019, kuma an fara binciken a farkon Janairu, 2020.
Yawancin cututtukan sun shafi kasuwar Huanan Seafood Wholesale Market kuma hakan ya sa ake zargin cutar tana da asalin zoonotic.
An gano sabon kwayar cutar da ke haifar da annobar a matsayin SARS-CoV-2, wanda ke da alaƙa da kwayar cutar coronavirus, coronavirus na garken kaza, da SARS-CoV. An gano cewa farkon mutumin da aka sani da alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma mutumin bai da alaƙa da alamar da ke tattare da kumfa mai ruwan sha ba.
Ga farkon tarin shari'o'in da aka ruwaito a watan Disambar 2019, kashi biyu bisa uku an gano suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris, 2020, wani rahoto da ba a tabbatar ba daga South China Morning Post ya nuna cewa wani hali da aka gano a ranar 17 ga watan Nuwamba, 2019, a cikin wani mai shekaru 55 da haihuwa mai haƙuri daga lardin Hubei, na iya zama farkon hali. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da aka ba da rahoton sabbin shari'o'i a China amma ba zato ba tsammani ya karu a Italiya, Iran da Koriya ta Kudu, adadin sabbin shari'o'in a waje da China ya zarce adadin sabbin shari'o'in a China a karon farko.
Akwai yiwuwar samun adadin wadanda ba a ruwaito ba, musamman a tsakanin wadanda ke da alamun rashin lafiya.
Har zuwa 26 ga Fabrairu, an samu rahotanni kaɗan a cikin matasa, tare da waɗanda shekarunsu 19 zuwa ƙasa da haka suna da kashi 2.4% na cututtuka a duk duniya. Babban mai ba da shawara kan kimiyya na United Kingdom, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya dole ne su kamu da cutar kafin a sami rigakafin rukuni mai tasiri.
Maganganun suna nufin yawan mutanen da aka gwada su don COVID-19, kuma waɗanda aka tabbatar da gwajin su tabbatacce bisa ga tsarin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin dari na yawanta, kuma ƙasashe da yawa sun riga sun yi manufofin da ba za a gwada waɗanda ke da alamun bayyanar cututtuka ba, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani binciken da aka buga a ranar 16 ga Maris ya gano cewa a kasar Sin, har zuwa 23 ga Janairu, an kiyasta kashi 86% na kamuwa da COVID-19 ba a gano ba, kuma cewa wannan kamuwa da cutar da ba a rubuta ba ita ce tushen kashi 79% na kamuwa da cutar.
Nazarin kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cuta a Italiya ya fi yawan wadanda aka ruwaito.
Matsayin farko na karuwa (R0) don COVID-19 shine 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa wannan zai iya zama 5.7.
Yawancin mutanen da suka kamu da COVID-19 sun warke.
Ga wadanda ba su san ba, tsawon lokacin da za su ci gaba da bayyanar cututtuka har zuwa mutuwa ya kai kwanaki 6 zuwa 41, kuma mafi yawan kwanaki 14 ne.
Ya zuwa ranar 10 ga Afrilu, 2020, kimanin mutuwar 97,000 an danganta su da COVID-19.
A kasar Sin, kamar yadda aka samu a ranar 5 ga Fabrairu, kimanin kashi 80% na mutuwar sun kasance a cikin wadanda suka wuce shekaru 60, kuma kashi 75% suna da matsalolin kiwon lafiya na yanzu ciki har da cututtukan zuciya da ciwon sukari.
Yawan mutuwar da ake samu daga COVID-19 na iya zama mafi girma, domin ba za su hada da wadanda suka mutu ba tare da an gwada su ba - misali a gida, a cibiyoyin kulawa, da dai sauransu.
Bayanai na ɓangare daga Italiya sun gano cewa yawan mutuwar wuce haddi a lokacin annobar ya wuce ƙididdigar mutuwar COVID ta hukuma ta hanyar 4-5x.
Wata mai magana da yawun cibiyar kula da cututtuka ta Amurka (CDC) ta ce "Mun san cewa [ƙididdigar mutuwar] ba ta da kyau", wani bayani da rahotanni suka goyi bayan game da rashin lissafi a Amurka. Irin wannan rashin kuɗi yana faruwa sau da yawa a cikin annobar, kamar lokacin cutar sankarar cutar H1N1 2009 H1N1.
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da 12 a kowace kasa a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga Maris, fiye da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a kowace nahiya sai dai Antarctica.
Wannan adadi ya bambanta daga yanki zuwa yanki da lokaci, kuma yana shafar yawan gwaje-gwaje, ingancin tsarin kula da lafiya, zaɓin magani, lokacin da ya fara barkewar cutar, da halayen yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar da ake samu a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Lambar ta bambanta da yankin.
A kasar Sin, kiyasta yawan mutuwar da ake samu daga kashi 17.3 cikin dari (ga wadanda suka fara da bayyanar cututtuka a ranar 1 ga Janairu 2020) ya ragu zuwa kashi 0.7 cikin dari (ga wadanda suka fara da bayyanar cututtuka a ranar 1 ga Fabrairu 2020). Sauran matakan sun hada da yawan mutuwar shari'a (CFR), wanda ke nuna yawan wadanda aka gano sun mutu sakamakon cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan wadanda suka kamu (suna gano da wadanda ba a gano ba) suka mutu sakamakon cutar.
Wannan kididdigar ba ta da alaƙa da lokaci kuma tana bin wani ƙididdigar yawan mutane daga kamuwa da cuta ta hanyar warwarewar shari'a.
Wasu masana kimiyya sun yi kokarin lissafa wannan adadi ga wasu al'ummomi.
Cibiyar Kula da Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin cutar gaba ɗaya ya kasance tsakanin 0.1% da 0.39%.
Babban kimantawa ga wannan zangon ya kasance bisa ga sakamakon gwajin farko na bazuwar COVID-19 a Jamus, da kuma nazarin kididdiga wanda ke nazarin tasirin gwajin akan kimantawar CFR.
WHO ta tabbatar da cewa za a iya sarrafa cutar.
Lokaci da kuma lokacin da cutar ta kai ba a san shi ba kuma zai iya bambanta daga wuri zuwa wuri.
Maciej Boni daga Jami'ar Penn State ya ce, "An bar cutar ba tare da an bincika ba, cutar tana da saukin kamuwa da cuta kuma tana ci gaba da lalacewa idan cutar ta ƙare gidajen da ake da su.
Amma, ba za mu iya yin tsinkaya ba a yanzu game da lokacin da hakan zai faru".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin Zhong Nanshan ya yi jayayya cewa "za a iya kawo karshen annobar nan da watan Yuni" idan dukkan kasashe za su iya motsawa su bi shawarar WHO game da matakan da za a dauka don dakatar da yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magunguna ta London ya bayyana cewa SARS-CoV-2 "zai ci gaba da yaduwa, watakila shekara guda ko biyu".
A cewar wani bincike da aka gudanar a Kwalejin Imperial wanda Neil Ferguson ya gudanar, za a bukaci a yi wa jiki horo da kuma wasu matakai "har sai an samu allurar rigakafi (watakila watanni 18 ko fiye)".
William Schaffner daga Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba domin coronavirus yana da matukar saukin kamuwa da cutar ya tafi gaba daya" kuma "yana iya zama cuta ta yanayi, yana sake bayyanawa a kowace shekara".
Wannan zai iya faruwa ne idan an sami rigakafin da ya shafi ƙungiyar da kuma yanayin juyin halitta.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma waɗanda suka kamu da cutar na iya zama marasa bayyanar cututtuka.
Abubuwa biyu da suka fi kowa a cikin cututtuka sune zazzabi (88%) da kuma tari (68%).
Sauran alamun sun hada da gajiya, samar da sputum na numfashi (ƙuƙwalwa), rashin jin ƙanshi, numfashi mai ƙyama, ciwon tsoka da haɗin gwiwa, ciwon wuya, ciwon kai, sanyi, zubar da jini, fitsari ko ciwon huhu. WHO ta ce kusan mutum ɗaya cikin shida yana samun rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) na Amurka sun lissafa alamun gaggawa a matsayin wahalar numfashi, ciwo ko damuwa a kirji, rikicewar mamaki, wahalar tashi daga barci, da idanu ko lebe zuwa launin shuɗi; ana ba da gaggawa ga likita idan waɗannan alamun sun kasance. Ƙarin cutar na iya haifar da mummunan huhu, cutar ta numfashi mai tsanani, sepsis, septic shock da mutuwa.
Wasu mutane da suka kamu da cutar na iya zama marasa alamar cututtuka, ba su da alamun asibiti amma sakamakon gwajin da ya tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda suka yi kusa da mutanen da suka kamu da cutar su kamata a lura da su sosai kuma a bincika su don tabbatar da cewa ba su da kamuwa da cutar.
Kasar Sin ta kiyasta cewa rashin bayyanar cututtuka na iya tashi daga kashi 44 zuwa kashi 100.
Lokaci na warkewa na yau da kullum (lokacin da ke tsakanin kamuwa da cuta da fara bayyanar cututtuka) ya kasance daga kwana ɗaya zuwa 14; mafi yawanci kwanaki biyar. A matsayin misali na rashin tabbas, an kiyasta kashi na mutanen da ke fama da COVID-19 da suka rasa ƙanshi da farko 30% sannan ya ragu zuwa 15%.
Har ila yau, ana iya gano wasu bayanai game da yadda cutar take yaduwa.
An yi imanin cewa cutar tana yaduwa ne musamman a lokacin da aka yi kusa da shi kuma ta hanyar ƙananan saukad da aka samu yayin tari, yin kumburi, ko magana; tare da kusanci yana da nisan mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Nazarin ya gano cewa tari marar kyau zai sa ciwon ai ya tashi daga mita 4.5 (15 feet) zuwa mita 8.2 (27 feet).
Wasu sun bayar da shawarar cewa cutar za ta iya wucewa ta hanyar ƙananan saukad da ke kasancewa na tsawon lokaci a cikin iska, wanda zai iya haifar da lokacin magana. Saukad da numfashi na iya haifar da lokacin numfashi, gami da lokacin magana, kodayake kwayar cutar ba ta da iska.
Za a iya samun saukowa a bakin ko a hancin mutumin da ke kusa da shi ko kuma a yi numfashi.
Wasu hanyoyin likita kamar intubation da cardiopulmonary resuscitation (CPR) na iya haifar da zubar da numfashi kuma ta haka ne ya haifar da yaduwar iska.
Hakanan cutar za ta iya yaduwa idan mutum ya taɓa wani yanki mai ƙazanta, ciki har da fata, sannan ya taɓa idanunsa, hanci ko bakinsu.
Duk da cewa akwai damuwa cewa cutar za ta iya yaduwa ta hanyar shara, ana ganin wannan haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta musanta yiwuwar watsa shara zuwa bakin SARS-CoV-2.Kasuwancin yana da saukin kamuwa da cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma kamuwa da cutar na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan da suka gabata na cutar.
Idan mutum ya gwada cutar a kwanaki uku kafin bayyanar cututtuka, hakan na nuna cewa za a iya kamuwa da cutar kafin bayyanar cututtuka.
Rahotanni kaɗan na asymptomatic casewares da aka tabbatar da lab sun wanzu, amma an gano rashin bayyanar cututtuka ta hanyar wasu ƙasashe yayin binciken gano lamba.
Cibiyoyin Turai don Rigakafin Cututtuka da Kulawa (ECDC) sun ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar tana zaune na awanni zuwa kwanaki a farfajiya.
Musamman, an gano cewa cutar tana iya ganowa har zuwa kwanaki uku a kan filastik (polypropylene) da karfe 304, kwana ɗaya a kan katako, da kuma har zuwa sa'o'i hudu a kan tagulla.
Wannan, duk da haka, ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun taɓa samun COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya canja wurin kwayar cutar zuwa mutane, amma hukumomin Birtaniya sun ba da shawarar cewa a wanke hannayensu bayan sun taɓa dabbobi, kamar bayan sun taɓa wasu farfajiyar da waɗanda suka kamu da cutar suka taɓa.
Cutar cutar coronavirus ta 2 (SARS-CoV-2) ita ce sabuwar cutar, da aka fara ware daga mutane uku da ke fama da cutar huhu da ke da alaƙa da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin sabbin halaye na SARS-CoV-2 suna faruwa dangane da coronavirus a cikin yanayi. A waje da jikin mutum, kwayar cutar tana kashe ta ta sabulu na gida, wanda ke lalata rigar rigarta.
Ana ganin cewa cutar ta zo daga cikin halittu.
Nazarin kwayoyin halitta ya nuna cewa coronavirus ya danganci kwayoyin halitta da genus Betacoronavirus, a cikin subgenus Sarbecovirus (zuriyar B) tare da ƙwayoyin cuta biyu da aka samo daga kwayoyin cuta.
Wannan kwayar cutar ta kasance 96% kamar ta sauran kwayoyin cuta na kwayar cutar BatCov RaTG13.
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya na amino acid a cikin wani bangare na tsarin genomic tsakanin kwayar cutar daga garke da kwayar cutar daga mutum.
Bambancin genomic ya zuwa yanzu ya gano cewa aƙalla kashi 92% na kwayoyin halitta sun kasance tsakanin coronavirus na garuruwa da SARS-CoV-2, wanda bai isa ya tabbatar da garuruwa a matsayin gida na matsakaici ba.
Ana iya gano kamuwa da cutar ta wucin gadi ta hanyar bayyanar cututtuka, ko da yake ana iya tabbatar da shi ta hanyar yin kwafin kwayar cutar ta polymerase chain reaction (rRT-PCR) don kwayar cutar da aka kamu da ita ko kuma yin CT.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ta fi tsananin saurin PCR, ko da yake ba ta da ƙwarewa, tare da yawancin siffofin yin hotonsa suna da alaƙa da tsarin cutar huhu da sauran cututtuka.
Har zuwa Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "ba a yi amfani da CT don tacewa ko a matsayin gwajin farko don gano COVID-19 ba".
WHO ta wallafa wasu takardun shaida na gwajin RNA don SARS-CoV-1, tare da na farko da aka fitar a ranar 17 ga Janairu.
Wannan gwajin ya yi amfani da ainihin lokacin rikodin rikodin polymerase chain reaction (rRT-PCR).
Ana iya yin wannan gwajin a kan jini ko kuma a cikin numfashi.
Ana samun sakamakon gwajin a cikin 'yan sa'o'i zuwa kwanaki.
Ana yin gwajin ne da nasopharyngeal swab amma ana iya amfani da na'urar ta'addanci.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan gwaje-gwajen da suka tabbatar da isa don amincewa don amfani da su a ko'ina.
A Amurka, gwajin serology da Cellex ta samar an amince da shi don amfani da gaggawa ta hanyar takaddun shaida kawai.
Abubuwan da ke nunawa a cikin radiograph da kuma CT na masu cutar da ke nuna alamun sun hada da rashin asymmetrical glazing da kuma rashin pleural effusion.
Kungiyar Radiology ta Italiya tana tattara bayanai a kan layi na intanet don neman hotunan da za a iya tabbatar da shari'ar.
Saboda rashin daidaito da sauran cututtuka kamar adenovirus, rigakafin da ba a tabbatar da PCR ba yana da iyakantaccen ƙwarewa wajen gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da na PCR kuma ya nuna cewa duk da cewa daukar hoto bai dace da kamuwa da cuta ba, wannan hanya tana da sauri kuma tana da matukar damuwa, yana ba da shawarar yin la'akari da wannan hanyar a matsayin kayan tacewa a yankin annobar.
An kirkiro cibiyar sadarwa ta juyin halitta ta hanyar fasaha don gano hotunan kwayar cuta ta hanyar daukar hoto da CT.
Hanyoyi na hana kamuwa da cutar sun hada da kiyaye tsabtace jiki gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannayensu marasa wankewa, da kuma tari ko kumburi a cikin kayan da ke ciki sannan a saka kayan kai tsaye cikin kwandon shara.
An shawarci waɗanda suka kamu da cutar su saka abin rufe fuska a wuraren da jama'a suke.
An kuma ba da shawarar yin amfani da matakan tsare jiki don hana yaduwar cutar. Gwamnatoci da yawa sun hana ko kuma ba da shawara don kauce wa duk balaguron da ba su da mahimmanci zuwa da daga ƙasashe da yankunan da cutar ta shafa.
Duk da haka, cutar ta kai ga yaduwar al'umma a yawancin duniya.
Wannan yana nufin cewa cutar ta bazu cikin al'umma, kuma wasu membobin al'umma ba su san inda ko yadda suka kamu ba. Masu ba da kula da lafiya da ke kula da wanda zai iya kamuwa da cutar suna ba da shawarar yin amfani da ƙa'idodin tsaro, matakan tsaro na tuntuɓar, da kuma kariya ta ido. Gano tuntuɓar yana da mahimmanci don gano tushen kamuwa da cutar da kuma hana ƙarin yaduwa.
Amfani da gwamnati da bayanan wuri daga wayoyin salula don wannan dalili ya haifar da damuwa game da tsare sirri, tare da Amnesty International da fiye da kungiyoyi 100 da suka fitar da sanarwa suna neman a takaita wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an ba da shawarar su don amfani da su na son rai, kuma kamar yadda aka yi a ranar 7 ga Afrilu, 2020, fiye da dozin ƙungiyoyin masana suna aiki akan mafita mai amfani da sirri, kamar amfani da Bluetooth don yin rajistar kusa da mai amfani tare da wayar salula ta wani.
Masu amfani suna karɓar saƙonni idan sun yi hulɗa da wani wanda ya gwada tabbatacce ga COVID-19. Ana samun ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cuta; alal misali, wanke hanci da kuma yin tawaye da maganin shafawa ba su da tasiri.
Babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da dama suna aiki don samar da allurar.
Ana ba da shawarar wanke hannu don hana yaduwar annobar.
CDC ta ba da shawarar cewa jama'a su wanke hannuwansu da sabulu da ruwa a kai a kai na akalla na tsawon sa'o'i ashirin, musamman bayan sun je gidan wanka ko kuma idan hannuwansu sun yi gurɓata; kafin su ci abinci; da kuma bayan sun yi ta numfashi, sun yi tari, ko sun yi amai.
Wannan shi ne saboda a waje da jikin mutum, sabulu na gida ya kashe kwayar, wanda ya lalata kumfa mai kare ta.
CDC ta ba da shawarar yin amfani da maganin hana shan giya na hannu tare da aƙalla 60% barasa bisa ga abun ciki lokacin da sabulu da ruwa ba su samuwa don amfani ba.
Hukumar ta WHO ta shawarci jama'a da su guji taɓa idanunsu ko hancinsu ko bakinsu da hannayensu da ba a wanke su ba.
Surfaces na iya zama masu gurɓataccen bayani (a cikin minti daya na bayyanar cututtuka ga farfajiyar bakin karfe), ciki har da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidon-iodin.
Sauran maganin, kamar benzalkonium chloride da gluconate croxidin, ba su da tasiri sosai.
Hukumar ta CDC ta ba da shawarar cewa idan ana zargin ko kuma an tabbatar da wani mutum da cutar COVID a wurare kamar ofishi ko cibiyar kula da mutane ta yau da kullun, a yi wa dukkan wuraren da aka kewaye kamar ofishi, dakunan wanka, wuraren jama'a, kayan lantarki da aka raba kamar kwamfutar hannu, allon taɓawa, kwamfutar hannu, na'urorin sarrafawa na nesa da na'urorin ATM da marasa lafiya ke amfani da su, a yi musu allurar rigakafi.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da hannayensu ko kuma na hanji a lokacin tari ko kumburi, kuma su kawar da duk wani nama nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, saboda saka abin rufe fuska na iya iyakance yawan da kuma nisan da za a iya samun saukowar numfashi yayin magana, yin kumburi, da kuma tari.
WHO ta fitar da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska ga mutanen da ke da lafiya idan suna da haɗari, kamar waɗanda ke kula da mutanen da ke da COVID-19, kodayake sun kuma yarda cewa yin amfani da abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Wasu ƙasashe sun fara ƙarfafa amfani da abin rufe fuska ta hanyar membobin al'umma.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na likita wanda ba a yi shi da masana'anta ba. China ta ba da shawarar musamman amfani da abin rufe fuska na likita da aka yi amfani da shi ta hanyar masu lafiya, musamman idan suna da kusanci (1 mita (3 feet) ko ƙasa da haka) da wasu.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata yayin amfani da sufuri na jama'a ko kasancewa a cikin wani wuri mai cike da jama'a.
Jami'an lafiya na Thailand sun ƙarfafa mutane su yi amfani da masks a gida kuma su wanke su kullum.
Jamhuriyoyin Czech da Slovakia sun haramta fita a wuraren jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska a lokacin da ya je wuraren jama'a don kare kansa da kuma wasu.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga kantin sayar da kayayyaki ya kamata ya saka abin rufe fuska.
Isra'ila ta bukaci dukan mazauna ta sa abin rufe fuska a wuraren da jama'a ke.
Taiwan, wadda ta samar da masks miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas na tsakanin birane su sa masks a ranar 1 ga Afrilu.
Panama ta sanya dokar sanya abin rufe fuska a waje, yayin da ta kuma bada shawarar yin abin rufe fuska a gida ga wadanda ba za su iya siyan abin rufe fuska ba.
An kuma yi amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Rashin zaman lafiya (wanda kuma ake kira zaman lafiya na jiki) yana tare da matakan hana kamuwa da cuta da ke nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyi sun haɗa da killacewa; ƙuntatawa na tafiya; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko cibiyoyin sayayya.
Mutane za su iya yin amfani da tsarin tsare-tsaren zamantakewa ta wajen kasancewa a gida, taƙaita tafiye-tafiye, kauce wa wuraren da ke da yawa, ta yin amfani da kayan ado marasa taɓawa, da kuma ware kansu daga wasu.
Yawancin gwamnatoci a yanzu suna ba da umarni ko kuma suna ba da shawarar yin zaman tsare a yankunan da cutar ta shafa.
Matsakaicin girman taron da hukumomin gwamnatin Amurka da kungiyoyin kiwon lafiya suka ba da shawarar an rage shi daga mutane 250 (idan babu sanannen yaduwar COVID-19 a yankin) zuwa mutane 50, sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taron jama'a na mutane fiye da biyu. Manya tsofaffi da waɗanda ke da matsalolin kiwon lafiya masu ɓoye kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma tsarin rigakafi suna fuskantar haɗarin haɗari ga cututtuka masu tsanani da rikitarwa kuma an shawarci CDC da su zauna a gida gwargwadon iko a yankunan da ke da barkewar cutar. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "ajiyar zamantakewa" da "ajiyar jiki", don bayyana cewa makasudin shine rage taɓawa ta jiki yayin da ke riƙe da alaƙar zamantakewa, ko dai ta hanyar sadarwar zamani ko ta nesa.
Amfani da kalmar "ajiyar zamantakewa" ya haifar da ma'anar cewa mutane dole ne su shiga cikin cikakken keɓewar zamantakewa, maimakon ƙarfafa su su ci gaba da tuntuɓar wasu ta hanyar madadin. Wasu bangarori sun fitar da jagororin kiwon lafiyar jima'i don amfani a lokacin annobar.
Wannan ya haɗa da shawarar yin jima'i da wanda yake zaune tare da ku kawai, wanda ba shi da cutar ko alamun cutar.
An ba da shawarar keɓe kansu a gida ga waɗanda aka gano suna da COVID-19 kuma waɗanda ake zargin sun kamu da cutar.
Hukumomi da dama sun ba da umarni ko kuma sun ba da shawarar yin zaman kansu ga dukan mutanen da ke zaune a yankunan da aka shafa.
An ba da umarnin yin rigakafin kai tsaye ga waɗanda ke cikin rukunin haɗari.
Wadanda suka iya kasancewa sun kamu da wani da COVID-19 kuma waɗanda suka yi tafiya a baya zuwa ƙasar ko yanki tare da yaduwar yaduwar cutar an shawarce su da su keɓe kansu na kwanaki 14 daga lokacin yiwuwar ganowa.
Dabarun da ake amfani da su wajen hana annoba su ne su hana su ko kuma su hana su.
Ana gudanar da rigakafin a farkon barkewar cutar kuma ana nufin bin diddigin waɗanda suka kamu da cutar da ware su da kuma gabatar da wasu matakan hana kamuwa da cutar da allurar rigakafi don hana cutar yaduwa zuwa sauran mutanen.
Lokacin da ba za a iya hana yaduwar cutar ba, sai a yi shiri don yin shiri: a ɗauki matakan da za a rage yaduwar da kuma tasirin da za ta yi a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya yin amfani da haɗuwa da matakai na dakatarwa da na ragewa a lokaci guda.
Matsalar ta bukaci karin tsauraran matakai don dakatar da annobar ta hanyar rage yawan adadin da aka samar a kasa da 1. Wani bangare na yadda ake sarrafa yaduwar cututtukan da ake kamuwa da su shine kokarin rage yawan annobar, wanda ake kira daidaita cutar ta cutar.
Wannan yana rage haɗarin samun ƙarin sabis na kiwon lafiya kuma yana ba da ƙarin lokaci don haɓaka allurar rigakafi da magani.
Hanyoyin da ba na magani ba ne da za su iya sarrafa yaduwar cutar sun hada da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da kuma keɓe kai; matakan jama'a da ke da niyyar tsare jiki kamar rufe makarantu da soke taron taro; shigar da jama'a don ƙarfafa karbuwa da shiga cikin irin waɗannan ayyukan; da kuma matakan muhalli kamar tsabtace farfajiyar. An ɗauki ƙarin matakan da aka yi niyya don hana yaduwar cutar a China bayan da cutar ta bayyana, misali, yin keɓewar birni da kuma tilasta hana zirga-zirga.
Sauran ƙasashe ma suna ɗaukar matakai da yawa don hana yaduwar cutar.
Koriya ta Kudu ta gabatar da manyan matakai na tacewa da killace mutane a gida, da kuma yin gargadi game da motsi na mutane masu kamuwa da cutar.
Singapore ta ba da tallafi na kuɗi ga waɗanda suka kamu da cutar da ke keɓe kansu kuma ta ɗora wa waɗanda suka kasa yin hakan manyan lamura.
Taiwan ta kara yawan samar da abin rufe fuska da kuma hana a hana a samar da magani. Simulations ga Great Britain da Amurka sun nuna cewa rage (ragewa amma ba a dakatar da yaduwar cutar ba) da kuma hana (dakatar da ci gaban cutar) suna da manyan kalubale.
Kyakkyawan tsarin rage yawan za su iya rage yawan bukatun kiwon lafiya zuwa kashi biyu bisa uku da mutuwar da rabi, amma har yanzu suna haifar da dubban dubban mutuwar da kuma wahalar da tsarin kiwon lafiya.
Ana iya ɗaukar matakan na zaɓi amma dole ne a ci gaba da yin hakan muddin cutar ta bazu cikin yawan mutane (ko har sai an sami allurar rigakafi, idan ta zo da farko), saboda yaduwar za ta sake tashi da sauri lokacin da aka sauƙaƙe matakan rigakafi.
Matsayi mai tsawo na dakile annobar ya haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafi da aka amince da shi don COVID-19, amma ana ci gaba da ci gaba da ci gaba, gami da gwada maganin da ke akwai.
Yin amfani da maganin mura da aka ba ka a kantin sayar da abinci, shan ruwa da kuma shakatawa zai taimaka wajen rage alamun.
Dangane da tsanani, ana iya bukatar maganin oxygen, ruwa mai shiga cikin jini da kuma taimakon numfashi.
Yin amfani da steroids zai iya sa sakamakon ya yi muni.
Wasu sinadarai da aka amince da su a baya don maganin wasu cututtukan kwayar cutar suna cikin binciken don amfani da su wajen magance COVID-19.
WHO ta kuma bayyana cewa wasu "al'adu na gargajiya da na gida" na iya ba da taimako ga bayyanar cututtuka da SARS-CoV-19 ke haifarwa.
WHO ta bayyana karuwa da daidaitawar kula da lafiya ga bukatun marasa lafiya na COVID-19 a matsayin matakin mayar da martani na annoba.
ECDC da ofishin WHO na yankin Turai sun fitar da jagororin ga manyan asibitoci da sabis na kiwon lafiya don motsa albarkatu a matakai daban-daban, gami da mayar da hankali ga sabis na dakin gwaje-gwaje zuwa gwajin COVID-19, soke zaɓin hanyoyin lokacin da ya cancanta, warewa da keɓe marasa lafiya masu cutar COVID-19, da haɓaka ikon kula da lafiya ta hanyar horar da ma'aikata da haɓaka yawan masu iska da gadaje da ke akwai.
Akwai ka'idoji da yawa game da inda aka fara samun cutar (wanda ake kira marasa lafiya marasa lamba) daga.
An gano cewa mutum na farko da aka gano ya kamu da cutar korona ya koma ranar 1 ga watan Disamba na 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin masu dauke da cutar korona a Hubei ya karu.
Wannan lamari yafi danganta da Huanan Seafood Wholesale Market, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'ida ita ce cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko, a wasu kalmomin, tana da asalin zoonotic. An lura da tarin cututtukan huhu wanda ba a san dalilinsa ba a ranar 26 ga Disamba kuma likita Zhang Jixian ya kula da shi a asibitin Hubei Regional, wanda ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wani rukuni na likitoci a asibitin Wuhan na tsakiya sun sanar da abokan aikin su game da "corowan korona kamar SARS".
Likitoci takwas, ciki har da Li Wenliang, sun yi gargadin 'yan sanda don yada jita-jita, kuma wani, Ai Fen, ya yi wa shugabansa ba'a don ya tayar da wannan batu.
Hukumar Lafiya ta Wuhan ta fitar da sanarwar a ranar 31 ga watan Disamba kuma ta sanar da WHO.
Ba a san isasshen cututtukan huhu ba da aka ruwaito ga hukumar lafiya a Wuhan don fara bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta bazu zuwa sauran yankunan kasar Sin, tare da gudun hijira na Sabuwar Shekara ta kasar Sin da Wuhan zuwa cibiyar sufuri da kuma manyan wuraren musayar jiragen kasa.
A ranar 20 ga watan Janairu, kasar Sin ta samu kusan sabbin mutane 140 a rana, ciki har da mutane biyu a Beijing da kuma daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar a ranar 20 ga Janairu 2020.Tun da 26 ga Maris, Amurka ta zarce China da Italiya tare da mafi yawan adadin masu cutar da aka tabbatar a duniya.Tun da 9 ga Afrilu, 2020, an sami sama da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Kasashe da yankuna 200 sun riga sun yi rashin lafiya.
Sakamakon annobar a Turai, ƙasashe da yawa a yankin Schengen sun iyakance motsi da kuma aiwatar da iyakokin iyaka.
Sakamakon haka, an yi amfani da matakan hanawa kamar su killace mutane (wanda ake kira dokar hana fita, dokar hana fita, ko dokar hana fita) da kuma dokar hana fita. Kamar yadda aka yi a ranar 2 ga watan Afrilu, kusan mutane miliyan 300, ko kusan kashi 90 cikin dari na yawan jama'a, suna karkashin wani nau'in gaggawa a Amurka, fiye da mutane miliyan 50 suna cikin gaggawa a Philippines, kimanin mutane miliyan 59 suna cikin gaggawa a Afirka ta Kudu da kuma mutane biliyan 1.3 suna cikin gaggawa a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani yanayi na gaggawa, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu -- kusan kashi daya bisa uku na yawan duniya.
An gano mutum na farko da aka tabbatar da COVID 19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya kasance a ranar 17 ga Nuwamba.
Likita Zhang Jixiang ya lura da tarin cututtukan cutar huhu da ba a san dalilinsa ba a ranar 26 ga watan Disamba, sannan asibitin ya sanar da CDC Wuhan Jianghan a ranar 27 ga watan Disamba.
Gwajin farko na kwayoyin halitta ga samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar coronavirus kamar SARS.
Hukumar Lafiya ta Wuhan ta ba da sanarwar a ranar 31 ga Disamba.
WHO ta sanar da hakan a wannan rana.
A lokacin da aka sanar da hakan, 'yan sanda sun gargadi likitoci a Wuhan don " yada jita-jita" game da annobar.
Hukumar Lafiya ta kasar Sin ta ce babu "babban shaida" na yaduwar cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yakin neman zabe mai zurfi wanda shugaban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin "yaƙin jama'a" don hana yaduwar cutar.
A cikin abin da ake kira "babban killace a tarihin 'yan adam", an sanar da kulle-kullen killace a ranar 23 ga Janairu wanda ya dakatar da zirga-zirga zuwa da kuma fita daga Wuhan, wanda aka kara zuwa birane 15 a Hubei, yana shafar mutane akalla miliyan 57.
An haramta amfani da motocin sirri a cikin birni.
An soke bikin bikin Sabuwar Shekara ta Sin (25 ga Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda za a kammala a cikin kwanaki 10.
An gina wani asibiti kuma bayan haka, wato, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabon asibitin da aka gina, kasar Sin ta kuma sauya wasu wurare 14 a Wuhan kamar cibiyar taron da kuma filin wasa, zuwa asibiti na wucin gadi. A ranar 26 ga Janairu, gwamnati ta fara matakan da suka biyo baya don dakile annobar COVID-19, ciki har da fitar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu a fadin kasar ma sun rufe.
Ƙasar Hong Kong da Macau sun fara wasu matakai, musamman ma game da makarantu da jami'o'i.
An fara aiki a wasu yankunan kasar Sin.
An yi shirin hana zirga-zirga a cikin birnin Hubei da wajensa.
An yi amfani da sufuri na jama'a, kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin na ɗan lokaci.
An gudanar da kula da motsi na jama'a a birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (sama da rabin yawan jama'a) suna fuskantar wasu nau'ikan ƙuntatawa na waje. Bayan yaduwar ta shiga fasalin duniya a watan Maris, gwamnatin China ta ɗauki tsauraran matakai don hana kwayar daga " shigowa " daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar killace-killace na kwanaki 14 ga duk matafiya na duniya da suka shiga birnin. A ranar 23 ga Maris, kasar Sin ta yi sanadiyar kamuwa da cutar guda daya a cikin kwanaki biyar, a wannan misalin matafiya ta koma Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an dakatar da yaduwar cutar ta gida kuma kasar Sin ta sarrafa yaduwar.
An sassauta dokar hana zirga-zirga ta kwana daya a Hubei, banda Wuhan, watanni biyu bayan an fara dokar ta baci. Ministan harkokin wajen kasar Sin ya sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shiga ta hanyar biza ko mai riƙe da izinin zama daga ranar 28 ga Maris zuwa gaba, ba tare da cikakken bayani game da lokacin da wannan manufar za ta ƙare ba.
Duk wanda yake son shiga kasar Sin dole ne ya nemi takardar visa a ofishin jakadancin kasar Sin ko kuma a ofishin jakadancin kasar.
Gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu da su sake budewa a ranar 30 ga Maris, da kuma samar da wani kudade mai karfafa gwiwa ga kamfanoni. Majalisar Dinkin Duniya ta bayyana ranar makoki da za ta fara da minti uku na shiru a karfe 10:00 na yamma a ranar 4 ga Afrilu, daidai da bikin Qingming, duk da cewa gwamnatin tarayya ta bukaci iyalan su nuna girmamawa ta yanar gizo a matsayin bin tsare-tsaren jiki don hana barkewar cutar COVID-19 sake dawowa.
An tabbatar da cewa COVID-19 ta bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar kula da lafiya ta kasa ta ruwaito karuwar adadin wadanda aka tabbatar da cutar a ranar 20 ga watan Fabrairu, wanda ya fi dacewa da taron da aka yi a Daegu na sabon addini da ake kira Church of Jesus Shincheonji.
Shincheonji da suka ziyarci Daegu daga Wuhan sun yi zargin cewa sun kamu da cutar.
A ranar 22 ga watan Fabrairu, daga cikin masu bin cocin 9,336, mutane 1,261 ko kusan 13% sun ba da rahoton alamun cutar. Koriya ta Kudu ta ba da sanarwar mafi girman matakin gargadi a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan gwajin da aka yi ya tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin kamfanonin jiragen sama kuma saboda haka an canza jadawalin. Koriya ta Kudu ta gabatar da abin da ake kira mafi yawan shirye-shirye da aka tsara a duniya don tace yawan mutane don gano cutar, kuma ware duk wani mutum da ya kamu da cutar da kuma bin sawun da kuma killace mutanen da suka yi hulɗa da su.
Hanyar tacewa ta hada da bayar da rahoton kai tsaye na alamun bayyanar cututtuka ta hanyar sababbin isowa na duniya ta hanyar aikace-aikacen hannu, gwajin cutar mai wucewa tare da sakamakon da ke samuwa a rana mai zuwa, da kuma ingantaccen gwajin gwaji wanda ke ba da damar gwada mutane 20,000 a kowace rana.
Koriya ta Kudu ta yi nasara wajen hana annobar cutar duk da cewa ba ta sanya ta a cikin birni ba.
Yawancin 'yan Koriya sun sanya hannu kan takardar ko dai don neman a sallami Moon bisa abin da suka yi zargin gwamnati ta yi wa annobar, ko kuma suna yaba wa yadda ta amsa.
A ranar 23 ga Maris, an ruwaito cewa Koriya ta Kudu tana da mafi karancin adadin masu cutar a cikin mako hudu.
A ranar 29 ga Maris an ruwaito cewa daga 1 ga Afrilu duk sabbin masu shigowa daga kasashen waje za a killace su na tsawon makonni biyu.
Kamar yadda kafofin yada labarai suka ruwaito a ranar 1 ga Afrilu, Koriya ta Kudu ta karbi buƙatun taimako na gwajin cutar daga ƙasashe 121 daban-daban.
Iran ta ba da rahoton kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda ta ga, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu sun mutu a wannan rana.
Matakan rigakafin da gwamnati ta sanar sun hada da sokewa na kide kide da sauran abubuwan al'adu, wasanni, da kuma sallah na Juma'a, da kuma rufe jami'o'i, cibiyoyin ilimi, da makarantu.
Iran ta ba da tarayyar tiriliyan biyar na riyal don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kuma za a killace mutane ne kawai.
An sanar da shirin rage zirga-zirgar zirga-zirga tsakanin birane a watan Maris, duk da cewa an ci gaba da samun karamin zirga-zirga tsakanin birane kafin Nuwruz na Sabuwar Shekara ta Farisa.
Abincin Shi'a a Qom ya kasance a bude ga baƙi har zuwa 16 ga Maris 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
Duk da zargin cewa an rufe cutar a Iran, fiye da kasashe goma sun gano cewa sun dawo Iran a ranar 28 ga Fabrairu, wanda ya nuna cewa cutar ta iya zama mafi muni fiye da shari'o'in 388 da gwamnatin Iran ta ruwaito zuwa wannan ranar.
An rufe majalisar dokokin Iran, inda aka ruwaito cewa 23 daga cikin 290 da ke cikin majalisar sun tabbatar da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki 'yan kare hakkin bil adama da aka tsare saboda zanga-zangar lumana ba tare da wata sharudda ba, kuma su sake dukkan fursunoni da suka cancanci a wucin gadi.
Ya ce akwai babban hadarin kamuwa da cutar a cikin cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, wanda kuma ba a kula da lafiyarsu sosai.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana, wanda ya fi yawan mutane da aka samu a kasar tun bayan barkewar cutar.
Akalla 'yan siyasa 12 da jami'an gwamnati ko tsoffin jami'an gwamnati sun mutu sakamakon cutar har zuwa 17 ga Maris.
A ranar 23 ga watan Maris, Iran ta samu sabbin mutane 50 a kowace awa da kuma sabon mutuwar coronavirus a kowane minti 10.
Jami'an WHO sun ce, akwai yiwuwar samun adadin mutane biyar a Iran fiye da yadda aka ruwaito.
Ya kuma nuna cewa takunkumin da Amurka ta dauka kan Iran na iya shafar karfin tattalin arzikin kasar wajen mayar da martani ga annobar.
Hukumar kare hakkin bil'adama ta Majalisar Dinkin Duniya ta bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da cewa cutar ta bazu zuwa Italiya a ranar 31 ga Janairu, lokacin da matafiya biyu na kasar Sin suka tabbatar da cutar SARS-CoV-2 a Rome.
An samu karuwar shari'o'i da sauri, wanda ya bukaci gwamnatin Italiya ta dakatar da dukkan jiragen zuwa da daga kasar Sin da kuma sanar da dokar ta baci.
An gano wasu cututtukan COVID-19 da ba su da alaƙa ba, farawa da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Ikilisiyar Ministoci ta sanar da sabon dokar dokar hana yaduwar cutar, ciki har da killace mutane sama da 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A cikin yankin annobar, ba za a yarda da shiga da fita ba.
An kuma ba da umarnin dakatar da ayyukan aiki da wasanni a yankin".A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar lokacin da Italiya ta kai mutuwar 100.
Duk manyan wasanni, ciki har da wasannin kwallon kafa na Serie A, ya kamata a rufe su har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni gaba ɗaya don aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai manyan kasuwanni da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiyanci ta Anaesthesia, Analgesia, Resuscitation and Therapy of Rape (SIAARTI) ta wallafa shawarwarin ka'idojin likita game da hanyoyin da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta fi China gaba a matsayin ƙasa da ta fi yawan mutuwar coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 daga annobar.
A ranar 22 ga Maris, an ruwaito cewa Rasha ta tura jiragen saman soja tara da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an tabbatar da shari'o'i 128,948, mutuwar 15,887, da kuma warkewar 21,815 a Italiya, tare da yawancin lokuta a lardin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan mutanen da ke da yawa a Italiya da rashin iyawar gwada duk waɗanda suka kamu da cutar har zuwa yau na iya zama abin da ya haifar da yawan mutuwar.
Amsar da Burtaniya ta bayar game da cutar ta fara bayyana a matsayin daya daga cikin kasashen da suka fi fama da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya wani nau'in tsare-tsaren zamantakewa ko matakan killace jama'arta ba.
A sakamakon haka, gwamnati ta fuskanci zargi saboda ganin rashin hanzari da kuma rashin gaskiya a cikin amsawa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwar da ke ba da shawara ga kauce wa duk balaguron da ba su da mahimmanci da kuma hulɗar zamantakewa, yana ba da shawarar mutane suyi aiki daga gida idan sun iya kuma su guji wuraren kamar mashaya, gidajen cin abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnatin ta sanar da cewa dole ne a rufe wuraren shakatawa kamar pubs da gyms da wuri-wuri, kuma ta yi alkawarin biyan har zuwa 80% na albashi na ma'aikata har zuwa iyakar £2,500 a wata don kauce wa rashin aikin yi a cikin rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da matakan tsare-tsaren zamantakewa, ya hana taron mutane fiye da biyu da kuma iyakance tafiya da ayyukan waje zuwa abin da aka ƙayyade da gaske.
Ba kamar matakan da aka dauka ba, 'yan sanda sun tilasta musu yin hakan ta hanyar gabatar da kara da kuma soke taron.
Yawancin kasuwancin suna rufewa, tare da musayar kasuwancin da aka ɗauka "mafi mahimmanci", gami da manyan kasuwanni, kantunan magani, bankuna, shagunan kayan aiki, tashoshin mai, da kuma ɗakunan karatu.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da ya kamu da cutar COVID-19 a jihar Pacific Northwest Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
An kafa rukunin White House Coronavirus Task Force a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta sanar da dokar ta baci ta kiwon lafiya ta jama'a, kuma ta sanya takunkumi kan shiga ga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta manyan cibiyoyin kiwon lafiya na gwamnati ta Amurka ta sanar da cewa sun ci gaba da yin gwajin kansu.
Duk da haka, Amurka ta fara jinkirin gwadawa, wanda ke kare ainihin yanayin annobar a wannan lokacin.
Gwajin ya shafar rigakafin gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnati ga kayan gwajin da ba na gwamnati ba (samar da ilimi, kamfanoni da asibitoci) har zuwa karshen Fabrairu, da kuma tsauraran ka'idoji don mutane su cancanci yin gwaji har zuwa farkon Maris (ana buƙatar umarnin likita bayan haka).
A ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 4,000 a Amurka.
A ranar 13 ga Maris, jaridar Atlantic ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da ke fama da cututtukan da kuma umarnin likitoci sun jira na sa'o'i ko kwanaki don gwaji". Bayan an ruwaito mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya sanar da dokar ta baci, wani mataki da wasu jihohi suka bi ba da daɗewa ba.
Makarantun da ke yankin Seattle sun soke aji a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, Amurka ta ba da hasashen sabon tasirin coronavirus a cikin ƙasar ta hanyar ƙungiyar masana cututtukan cututtuka a Kwalejin Imperial na London.
A wannan ranar ne Shugaba Trump ya sanya hannu kan Dokar Ƙarin Gudanarwa don Shirya da Amsawa ga Coronavirus, wanda ya samar da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin gwamnati don amsa cutar.
Kamfanoni sun sa an hana ma'aikatan tafiya, sun soke taron, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanar da cewa za a dakatar da tafiye-tafiye na yawancin Turai, ban da Burtaniya, na kwanaki 30, daga ranar 13 ga Maris.
Washegari, ya faɗaɗa wannan takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga Maris, ya sanar da dokar ta baci ta kasa, wanda ya sanya kudaden tarayya a samuwa don amsawa ga rikicin.
Tun daga ranar 15 ga Maris, an rufe ko kuma rage yawan kasuwancin a duk fadin Amurka don kokarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a duk jihohi 50 da kuma yankin Columbia. A ranar 23 ga Maris, an ruwaito cewa New York City tana da shari'o'in coronavirus 10,700, fiye da adadin shari'o'in a Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya ce, tsare-tsaren zamantakewar jama'a na da tasiri sosai, lokacin da aka fara jinkirta yawan adadin wadanda suka kamu da cutar daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, an tabbatar da cewa akwai mutane 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu saboda cutar. A ranar 26 ga Maris, an ruwaito cewa Amurka ta sami karin mutane da suka kamu da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya.
Kamar yadda kafofin yada labarai suka ruwaito a ranar 30 ga Maris, Shugaba Trump ya yanke shawarar tsawaita ka'idodin tsare-tsaren zamantakewar al'umma har zuwa 30 ga Afrilu.
A wannan rana, jirgin USNS Comfort, wani asibiti mai asibiti mai dakuna 1,000, ya sauka a birnin New York.
A ranar 3 ga watan Afrilu, Amurka ta samu adadin mutuwar mutane 884 sakamakon cutar coronavirus a cikin awanni 24.
A jihar New York, an kai adadin mutane 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda rage barazanar da kuma sarrafa saƙon ta hanyar umarci jami'an lafiya da masana kimiyya su daidaita sanarwa da kuma wallafa jama'a game da cutar tare da ofishin mataimakin shugaban kasar Mike Pence.
Dukkanin amincewar Trump game da rikicin ya kasance yana taɓarɓarewa a kan layin raba gardama.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu muhimmanci, ciki har da kayayyakin kiwon lafiya masu muhimmanci, daga kasar Sin.
An yi amfani da nazarin yanayin tafiye-tafiye na iska don tsarawa da kuma hango yanayin yaduwar cutar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar watan Janairu 2020.
Bisa ga bayanan 2018 daga International Air Transport Association, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan masu yawon bude ido daga Wuhan.
Dubai, Sydney, da kuma Melbourne sun kuma bayar da rahoton zama sanannun wurare ga waɗanda ke tafiya daga Wuhan.
An ruwaito cewa Bali ta kasance mafi ƙasƙanci a cikin shahararrun biranen 20 mafi yawan wurare a cikin wadatarwa, yayin da biranen Ostiraliya suka kasance mafi ƙarancin wadatarwa. Ostiraliya ta fitar da Shirin Amsa na Gaggawa don Kwayar cutar Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa akwai sauran abubuwan da ba a sani ba game da COVID-19, kuma cewa Ostiraliya za ta ba da fifiko ga kula da iyakoki da sadarwa a cikin amsa ga annobar.
A ranar 21 ga Maris, an bayyana gaggawa ga lafiyar dan Adam a Ostiraliya.
Ganin aiwatar da killace zirga-zirgar jama'a a Wuhan da Hubei, wasu kasashe sun shirya don fitar da 'yan kasarsu da ma'aikatan diflomasiyya daga yankin, galibi ta hanyar jiragen da kasar ta haya, tare da izinin hukumomin kasar Sin.
Kanada, Amurka, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus, da Thailand sun kasance daga cikin kasashe na farko da suka shirya don fitar da 'yan ƙasarsu.
Pakistan ta ce ba za ta yi wa 'yan kasar Sin gudun hijira ba.
A ranar 7 ga watan Fabrairu, Brazil ta yi wa 'yan Brazil 34 ko kuma danginsu gudun hijira ban da' yan Poland hudu, dan kasar Sin daya, da kuma dan kasar Indiya daya.
An saukar da mutanen Poland, China, da Indiya a Poland, inda jirgin Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da suka tafi Wuhan a sansanin soja kusa da Brasilia.
A wannan ranar, an kwashe 'yan kasar Kanada 215 (176 daga jirgin farko, da 39 daga jirgin na biyu da gwamnatin Amurka ta haya) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama da ke dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun kwashe mutane 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka canza aiki zuwa matsayin cibiyar killacewa, inda suka zauna har tsawon kwanaki 14.
Jirgin jigilar New Zealand ya isa Aukland a ranar 5 ga Fabrairu; an killace fasinjojinsa (ciki har da wasu daga Australia da Pacific) a sansanin soja a Whangaparoa, arewacin Aukland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta tura Amurkawa zuwa jirgin ruwa na Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama dauke da 'yan kasar Kanada 129 da aka kwashe daga Diamond Princess ya sauka a Trento, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta haya ya dawo da mutane 112 daga Afirka ta Kudu.
An yi gwajin lafiyar kafin a saki, kuma an bar 'yan Afirka ta Kudu hudu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka yi gwajin rashin lafiya ne kawai aka tura gida.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji waɗanda, a matsayin matakin tsaro, an sanya su a karkashin kulawa da keɓewa na kwanaki 14 a The Ranch Resort.
A watan Maris, Amurka ta fara janye wasu sojojinta daga Iraqi saboda annobar.
A ranar 5 ga watan Fabrairu, Ministan Harkokin Wajen China ya bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako zuwa China.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen tura agaji zuwa yankunan da cutar ta shafa a kasar Sin, tare da kungiyoyin hadin gwiwa a yankin Chicago da suka fi girma sun samu nasarar tura kayan rufe fuska na N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da dala miliyan 100 ga WHO don tallafawa bincike kan alluran rigakafi da kokarin magance juna don kare "ƙungiyoyin da ke cikin haɗari a Afirka da Kudancin Asiya".
Kamfanin Interaction ya ruwaito cewa gwamnatin kasar Sin ta ba da kyautar makamai 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya tura makamai miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta sanar da cewa za ta tura tallafin da ya kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da takardar rufe fuska miliyan daya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta ba da sanarwar bayar da kayan aikin likita miliyan 18 zuwa China, Jamus ta ba da kayayyakin likita da suka haɗa da tufafi 10,000 na Hazmat, kuma Amurka ta ba da tan 17.8 na taimakon likita ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a cikin taimakon kuɗi ga ƙasashen da suka shafi. Bayan da shari'o'in suka daidaita a China, kasar ta aika da taimako zuwa ƙasashe da yawa da cutar ta shafa.
A watan Maris, kasar Sin da Cuba da Rasha sun aika da taimakon likita da kuma kwararrun masana don taimakawa Italiya wajen magance annobar coronavirus.
Wani dan kasuwa mai suna Jack Ma ya tura kayan gwaji miliyan 1.1 da masks miliyan 6 da riguna 60,000 zuwa Addis Ababa, Habasha don kungiyar tarayyar Afirka ta rarraba.
Daga nan sai ya tura kayan gwaji 5,000, masks 100,000 da kuma na'urori masu iska 5 zuwa Panama.
Ma ta kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun bayyana damuwarsu game da masks da kayan gwajin da kasar Sin ta yi.
Misali, Spain ta dawo da kayan gwajin coronavirus 58,000 na kasar Sin tare da daidaito na kashi 30 cikin dari, yayin da Netherlands ta dawo da masks na kasar Sin 600,000 da suka lalace.
Belgium ta cire masks 100,000 da ba za a iya amfani da su ba, wadanda aka samo daga China, amma a gaskiya daga Colombia.
A wani bangaren kuma, an samu karbar taimakon kasar Sin a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da wani shiri na gaggawa na tallafawa kasashe masu tasowa.
Hukumar ta WHO ta yaba wa kokarin da gwamnatin kasar Sin ke yi wajen sarrafa cutar.
WHO ta lura da bambanci tsakanin annobar SARS ta 2002-2004, lokacin da aka zargi gwamnatin China da yin ɓoye-ɓoye don hana rigakafin da kuma kula da ayyukanta, da kuma rikicin da ke faruwa a yanzu wanda ya ga gwamnatin tsakiya "ta ba da sabuntawa na yau da kullun don kauce wa firgita kafin hutun Sabuwar Shekarar Sin".
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da gwamnatin tarayya ta yanke na aiwatar da takunkumin sufuri a Wuhan, wakilin WHO Gauden Galea ya bayyana cewa yayin da "ba lallai ba ne shawarar da WHO ta bayar", shi ma "babban mahimmin alama ne ga sadaukarwa don sarrafa cutar a inda ta fi yawa" kuma ya kira ta "ba a taɓa yi ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan tabbatar da watsawa daga mutane zuwa mutane a waje da China da karuwar adadin shari'o'i a wasu ƙasashe, WHO ta ayyana cutar a matsayin Babban Taron Kiwon Lafiya na Duniya (PHEIC), PHEIC na shida tun lokacin da aka fara aiwatar da matakin lokacin annobar cutar kwayar cutar a shekarar 2009.
Babban darektan WHO Tedros Adhanom ya ce PHEIC sakamakon "hadarin yaduwar duniya ne musamman ga ƙasashe masu karamin da matsakaitan kudade ba tare da ingantaccen tsarin kiwon lafiya ba.
A cikin martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili ga matakan da ba dole ba don dakatar da tafiye-tafiye da kasuwancin duniya" kuma "WHO ba ta ba da shawarar hana kasuwanci da motsi".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen dabarun a ƙasashen da ke da ƙananan kuɗaɗe, ta bayyana muhimmancin tallafawa ƙasashen da "ba su da tsarin da za su iya gano mutanen da suka kamu da cutar, idan ta bayyana".
Tedros ya ci gaba da yin bayani yana mai cewa "mu ne mafi rauni a cikin sarkarmu" kuma ya bukaci al'ummar duniya da su " zuba jari a yau ko su biya a baya". A ranar 11 ga Fabrairu, WHO a taron manema labarai ta sanya COVID-19 a matsayin sunan cutar.
A wannan rana, Tedros ya ce babban sakataren Majalisar Dinkin Duniya Antonio Guterres ya amince da ba da "dukan ikon tsarin Majalisar Dinkin Duniya a matsayin martani".
A sakamakon haka an kunna tawagar kula da rikicin Majalisar Dinkin Duniya, wanda ya ba da damar daidaita tsarin amsa na Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "daidaita kansu kan amsawar lafiya yayin da sauran hukumomi za su iya ba da kwarewarsu don ɗaukar tasirin tasirin tasirin zamantakewa, tattalin arziki da ci gaba da annobar ta haifar".
A ranar 14 ga watan Fabrairu, an kunna wani Kwamitin Gudanar da Harkokin Kasashen Sin da WHO ke jagorantar don samar da kwarewar kasa da kasa da WHO a filin a kasar Sin don taimakawa wajen gudanar da ayyukan gida da kuma tantance "karatuwar cutar" ta hanyar gudanar da bita da tarurruka da manyan cibiyoyin kasa da kuma gudanar da ziyara ta ziyara don tantance "sakamakon ayyukan amsawa a gundumar da kauyuka, gami da birane da yankunan karkara". A ranar 25 ga watan Fabrairu, WHO ta bayyana cewa "duniya ta kamata ta yi karin aiki don shirya don yiwuwar annobar coronavirus" ta hanyar bayyana cewa duk da yake har yanzu yana da wuri don kiran cutar, kasashe masu shiri dole ne su kasance "a cikin fasalin manema labarai".
A cikin martani ga annobar da ke tasowa a Iran, WHO ta tura wani Kwamitin Jakadancin zuwa wurin don tantance halin da ake ciki.A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara darajar barazanar coronavirus a duniya daga "mafi girma" zuwa "mafi girma", matakin gargadi da kuma kimanta hadarin.
Mike Ryan, darektan gudanarwa na shirin gaggawa na WHO, ya yi gargadin cewa "Wannan shi ne ainihin abin da zai faru ga kowace gwamnati a duniya: Tashi.
Wannan kwayar cutar tana iya faruwa kuma dole ne ku kasance a shirye, ku yi hanzarin cewa matakin da ya dace zai iya taimaka wa duniya ta guji "mafi muni".
Ryan ya ci gaba da cewa bayanan da ke nan ba su ba da izinin jami'an kiwon lafiya na duniya su bayyana wani abu na duniya ba, kamar yadda wata sanarwa ta ce "mu a zahiri mun yarda cewa dukkan mutane a duniya za su iya kamuwa da cutar".
A ranar 11 ga Maris, WHO ta bayyana cewa cutar coronavirus ta zama annoba.
Darakta Janar ya ce WHO "ta damu ƙwarai da matakan kamuwa da cuta da kuma matakan rashin aiki da ke damunta". WHO ta fuskanci mummunan zargi ga abin da ake ganin rashin kula da cutar, ciki har da jinkirin sanar da lafiyar gaggawa na kiwon lafiya da kuma rarraba cutar a matsayin annoba.
An samu karbar bakuncin babban darektan WHO Tedros Adhanom, wanda ya yi murabus, wanda mutane 733,000 suka sanya hannu har zuwa 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, ƙwararrun masanan kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada hakkoki na kowane lokaci na mutum yayin annobar COVID-19.
Kungiyar ta ce kowa yana da hakkin ya sami taimakon da zai ceci rayuka kuma gwamnati tana da wannan hakkin.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba dalili bane na nuna bambanci ga wasu kungiyoyi.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, 'yan ƙasa, iyaye, waɗanda aka ware, masu hijira, waɗanda ke zaune cikin mawuyacin yanayi, fursunoni, da 'yan gudun hijira da sauran kungiyoyin da ke bukatar taimakon gwamnati.
Kungiyoyin gwamnatoci na duniya suna magance tasirin rikicin COVID-19 akan tattalin arziki da zamantakewa.
Kungiyar Tattalin Arziki da Ci gaban Kasuwanci ta kaddamar da dandamali don samar da ingantaccen bayani a kan lokaci da kuma cikakkiyar bayani game da ra'ayoyin manufofi a cikin ƙasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofin karfafa lafiyar duniya da tattalin arzikin duniya zuwa tattauna tasirin gaggawa da takunkumin tafiye-tafiye, cibiyar dijital ta hada da National Policy Detector, kuma tana nufin taimakawa kasashe su koya daga juna da kuma sauƙaƙe daidaitaccen amsawar duniya ga kalubalen coronavirus.
Gwamnatin kasar Sin ta fuskanci sukar Amurka, Ministan Birtaniya don ofishin majalisar wakilai Michael Gove da dan Shugaban Brazil Jair Bolsonaro Eduardo Bolsonaro kan yadda ake gudanar da annobar, wadda ta fara ne a lardin Hubei, kasar Sin.
Wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) sun kori wasu jami'an yankin saboda hanyoyin da ake gudanar da killace mutane a tsakiyar kasar, a matsayin nuna rashin jin dadin yadda kungiyoyin siyasa ke mayar da martani ga yaduwar cutar a yankin.
Wasu masu sharhi sun yi imanin cewa wannan motsi na nufin kare Babban Sakataren Jam'iyyar Kwaminisancin kasar Sin Xi Jinping daga fushin jama'a daga yaduwar cutar coronavirus.
Wasu jami'an kasar Sin, cth. Zhao Lijian sun musanta sanarwar farko cewa annobar coronavirus ta fara ne daga Wuhan, suna yarda da ka'idar ta'addanci game da COVID-19 daga Amurka ko Italiya.
Gwamnatin Amurka karkashin Donald Trump ta kira coronavirus "virus na kasar Sin" ko "virus na Wuhan" ta ce "Cinese ta samar da wani virus wanda yanzu ya zama annoba ta duniya", wanda daga baya wasu masu sukar suka soki shi da nuna wariyar launin fata da kuma "ƙoƙarin kawar da hankali daga gazawar gwamnatinsa wajen dakile cutar".
The Daily Beast ta samu wata tashar gwamnatin Amurka da ta bayyana magudi a harkokin sadarwa da ke da tushe a majalisar tsaro ta kasa, tare da wannan dabarar da ake kira "Dukkanin game da China ne.
An sanar da mu cewa za mu yi kokarin tabbatar da cewa an bayyana wannan sakon ta kowace hanya, ciki har da taron manema labarai da kuma fitowar ta talabijin. "Kasuwanci kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da kasar Sin ke yi na tura tallafi ga kasashen da cutar ta shafa na daga cikin kokarin da ta yi na yada labaran da za su shafi duniya.
Shugaban harkokin wajen EU Josep Borrell ya yi gargadin cewa akwai "wani bangare na geopolitics ciki har da gwagwarmaya don samun tasiri ta hanyar juya baya da kuma 'yancin siyasa'.
Borrell ya kuma ce "China tana tura sakon cewa, ba kamar Amurka ba, ita ce abokiyar da za a iya dogara da ita".
China ta kuma bukaci Amurka ta janye takunkunta daga Syria, Venezuela da Iran, yayin da ta ke aika da taimako ga kasashen biyu na baya.
An hana kyautar mask 100,000 daga Jack Ma ga Cuba ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da tura tallafin da wasu ƙasashe ke bayarwa zuwa ƙasashensu.
Kuma an samu rahoton rikice-rikice game da abin rufe fuska tsakanin wasu kasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiya ta ƙwace ɗaruruwan na'urorin numfashi da ke zuwa ƙasar Sifen.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin gwiwar Tarayyar Turai da Italiya da cutar coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a EU, ya ce: "China ce kawai ke ba da amsa ta biyu.
Wannan ba kyakkyawan alama ba ce ta hadin kai na Turai".
A ranar 22 ga watan Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya umarci sojojin Rasha da su tura sojojin soja, motocin kashe-kashe na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani "babban jami'in siyasa" da ba a ambaci sunansa ba, inda ta ce kashi 80 cikin 100 na taimakon da Rasha ta ba ta "ba da amfani ko kuma ba ta da amfani ga Italiya".
Majiyar ta zargi Rasha da yin "aikin siyasa da na diplomasiyya" da ya yi.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun musanta rahoton kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura jiragen da ke dauke da kayayyaki zuwa Amurka.
Kakakin gwamnatin Kremlin Dmitry Peskov ya ce "lokacin da ya ba da taimako ga abokansa a Amurka, [Putin] ya ɗauka cewa idan masana'antun na'urorin likita da na Amurka suka samu karbuwa, za su iya ba da taimako idan ya cancanta".
An shirya shirin NATO na "Defender 2020" a Jamus, Poland da kasashen Balkan, wanda shi ne mafi girma a NATO yaƙin motsa jiki tun karshen Cold War, za a gudanar a kan karami.
Sakatare Janar don Kamfen din kawar da makaman nukiliya Kate Hudson ta soki aikin Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana barazana ga rayukan ba kawai sojoji daga Amurka da sauran kasashen Turai da ke shiga ba amma har da mazaunan kasashen da suke aiki". Gwamnatin Iran ta sha wahala sosai daga cutar, tare da kusan 'yan majalisa biyu da kuma wasu manyan jami'an siyasa guda goma sha biyar na yanzu ko na baya.
Shugaban Iran Hassan Rouhani ya rubuta wani sako mai bude ido ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana cewa kasarsa tana gwagwarmaya don yaki da annobar sakamakon rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka akan Iran.
Masu nazarin siyasa sun yi imanin cewa wannan zai shafi yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta tabarbare sakamakon annobar.
Koriya ta Kudu ta soki "matsayin da ba a bayyana ba da kuma aikin killace mutane" bayan da Japan ta sanar da cewa za a killace duk wanda ya zo daga Koriya ta Kudu na tsawon makonni biyu a wuraren da gwamnati ta tsara.
A lokacin da aka fara, jama'ar Koriya ta Kudu ba su da tabbacin yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a sallami Moon saboda abin da ake ganin ba daidai ba ne a kula da annobar, ko kuma suna yaba da yadda ya amsa.
Wasu masu sharhi sun nuna damuwa cewa wannan matakin zai ba gwamnati damar karfafa karfin ikonsu.
A Hungary, majalisa ta amince da izinin firaministan kasar Viktor Orbán ya yi mulki bisa ga doka, ya dakatar da majalisar dokoki da kuma zaben, kuma ya hukunta wadanda ake zargi da yada kuskuren bayanai game da cutar da kuma yadda gwamnatin ke kula da rikicin.
An yi zargin cewa cutar coronavirus ta haifar da karancin kayayyaki, saboda amfani da kayan aiki don magance barkewar cutar a duniya, sayen firgici, da kuma tsangwama ga masana'antu da ayyukan kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da na'urorin likita sakamakon karuwar bukatar masu amfani da kuma rikicewar samarwa.
Wasu yankuna kuma sun ga sayen kayayyaki da suka sa aka yi ta yin amfani da kayan da ake bukata kamar abinci, kayan wanka, da kuma ruwan kwalba, wanda ya sa aka yi rashin wadata.
Masana'antun fasaha sun yi gargadin cewa za a yi jinkirin aikawa da kayan lantarki.
A cewar babban darektan WHO Tedros Adhanom, bukatar kayan kariya ta mutum ta ninka sau 100.
Wannan bukatar ta haifar da karin farashin har zuwa sau ashirin na farashin yau da kullun kuma ta haifar da jinkirin samar da kayayyakin kiwon lafiya na watanni hudu zuwa shida.
Wannan kuma ya haifar da karancin kayan kare mutum a duniya, tare da WHO ta yi gargadin cewa hakan zai iya cutar da lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen daigou su sayar da kayayyakin Ostiraliya zuwa China.
Wannan aikin ya haifar da karancin kayan abinci ga jarirai a wasu manyan kasuwanni kuma an hana shi daga gwamnatin Australiya a baya. Duk da yawan yawan cututtukan COVID-19 a Arewacin Italiya da lardin Wuhan, da kuma ci gaba da bukatar kayayyakin abinci, yankunan biyu sun tsira daga mummunan karancin abinci.
Matakan da kasar Sin da Italiya suka ɗauka don magance tarin kayayyaki da kuma sayar da kayayyaki masu muhimmanci sun yi nasara, suna hana rashin abinci mai yawa da ake tsammani a Turai da kuma Arewacin Amirka.
Arewacin Italiya tare da samar da kayan lambu mai mahimmanci ba ta ga raguwa mai yawa ba, amma farashin na iya tashi bisa ga wakilan masana'antu.
Rukunin abinci da ke babu abinci na wucin gadi ne, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin ke sakin kayayyakin ajiya don tabbatar da isasshen abinci ga jama'a.
Hakazalika, dokar da ta yi amfani da ita a Italiya ta bukaci masana'antun abinci su ajiye kayayyaki don irin wannan gaggawa.
An ji lalacewar tattalin arzikin duniya a kasar Sin: a cewar rahoton kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na shekarar 2020 sakamakon matakan da gwamnati ta dauka na hana yaduwar cutar, kuma tallace-tallace na kiri sun ragu da kashi 20.5%.
Tun da kasar Sin ce babbar cibiyar tattalin arziki da samarwa, an ga annobar ta haifar da barazanar da ke damun tattalin arzikin duniya.
Agathe Demarais daga Cibiyar Nazarin Tattalin Arziki ta yi hasashen cewa kasuwar za ta ci gaba da yin tawaye har sai an samu karin haske game da sakamakon da za ta samu.
A watan Janairun 2020, wasu masu bincike sun kiyasta cewa matsalar tattalin arziki da annobar ta haifar a ci gaban duniya na iya wuce yanayin annobar SARS a 2002-2004.
Wani ƙididdiga daga masana a Jami'ar Washington a St. Louis ya nuna cewa tasirin dala biliyan 300 ne a kan sarkar samar da kayayyaki a duniya wanda zai iya wuce shekaru biyu.
Kungiyar kasashen da ke fitar da man fetur (OPEC) ta ruwaito cewa ta yi "bacin rai" bayan da farashin man fetur ya ragu sakamakon karancin bukatar kasar Sin.
Kasuwancin jari na duniya ya fadi a ranar 24 ga Fabrairu sakamakon karuwar adadin shari'o'in COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, sakamakon tashin hankali game da yaduwar cutar coronavirus, wasu alamun jari na Amurka ciki har da NASDAQ-100, S&P 500 Index, Dow Jones Industrial Average sun ba da rahoton mafi muni a cikin shekara ta 2008, tare da faɗuwar Dow ta maki 1,191, mafi girma a cikin rana ɗaya tun lokacin rikicin kuɗi na 2007-08.
Dukkanin alamun sun ƙare da raguwa fiye da kashi 10 cikin ɗari.
A ranar 28 ga Fabrairu, Kamfanin Skop GmbH ya tabbatar da yiwuwar darajar darajar darajar China, amma ya ci gaba da yin mummunan bita.
Kasuwancin ya ragu saboda tsoron coronavirus, mafi girma a cikin 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai yi sanyi.
Wani masanin tattalin arziki mai suna Mohamed El-Erian ya yaba da matakin gaggawa da bankin tarayya da na jihohi suka dauka a kan kari.
Babban bankin ya yi sauri fiye da yadda ya yi a lokacin koma bayan tattalin arzikin 2008.
Yawon shakatawa shine ɓangaren da ya fi fama da tasirin hana tafiya, rufe wuraren jama'a gami da abubuwan jan hankalin masu yawon buɗe ido, da shawarwarin gwamnati na kada su yi tafiya a duk faɗin duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen saboda karancin buƙatu, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanonin jiragen sama na yankin a cikin British Flybe suka yi ritaya.
Sakamakon da ake samu a masana'antar jiragen ruwa ya kai ga wani matakin da ba a taɓa gani ba.
An rufe wasu tashoshin jirgin kasa da tashar jiragen ruwa.
Cutar ta faru ne ta hanyar haɗari a lokacin Chunyun, lokacin da ake yin balaguro da yawa da ke da alaƙa da hutun Sabuwar Shekara ta Sin.
Wasu abubuwan da suka shafi jama'a an soke su ta hanyar jihohi da gwamnatocin larduna, ciki har da bikin Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu suna rufe shagunan su da kuma jan hankalin masu yawon bude ido kamar Disneyland Hong Kong da Disneyland Shanghai.
Yawancin abubuwan da ake yi na Sabuwar Shekara ta Watanni da abubuwan jan hankali na yawon bude ido an rufe su don kauce wa taro, ciki har da Taron Haramtaccen Birni a Beijing da kuma bukukuwa a cikin haikalin gargajiya.
A cikin 24 daga cikin larduna 31 na kasar Sin, birane da yankuna, hukumomi sun kara hutun Sabuwar Shekara zuwa 10 ga Fabrairu, suna umurtar dukkan wuraren aiki da kada su sake budewa har zuwa wannan ranar.
Wannan yanki yana wakiltar kashi 80% na GDP na kasar da 90% na fitarwa.
Hong Kong ta kara yawan adadin masu kamuwa da cutar zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke bikin Sabuwar Shekara.
Ziyarar masu sayar da kayayyaki a Turai da Latin Amurka ta ragu da kashi 40%.
Kasashen Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar kashi 50-60%.
Wannan kuma ya haifar da raguwar 33-43% a cikin zirga-zirgar da ke tafiya zuwa shagon a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cinikayya a duk faɗin duniya suna aiwatar da ƙarin matakan, misali, inganta tsabtace jiki, shigar da na'urorin bincike na zafin jiki don bincika yanayin zafin baƙi, da soke taron. A cewar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da annobar ta haifar na iya haifar da ƙarin mutane 14 zuwa 22 miliyan da ke fama da matsanancin talauci a Latin Amurka fiye da waɗanda ke cikin halin da ba a da cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi fice a birnin Wuhan, kimanin mutane miliyan biyar a kasar Sin sun rasa ayyukansu.
Yawancin ma'aikatan da ke cikin kasar Sin sun yi kusan miliyan 300 a cikin gidajensu a cikin karkara ko kuma a cikin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar coronavirus na iya lalata ayyukan yi miliyan 47 a Amurka kuma ƙimar rashin aikin yi na iya kaiwa 32%, a cewar kimantawar Babban Bankin Tarayya na St. Louis. Wani gaggawa a Indiya ya haifar da dubban miliyoyin ma'aikatan kasashen waje a Indiya (wanda ake biya ta hanyar albashi na yau da kullun) ba su da aiki. Binciken daga Cibiyar Angus Reid ya gano cewa 44% na gidajen Kanada suna fuskantar rashin aikin yi. Kusan 900,000 ma'aikata sun rasa ayyukansu a Spain tun lokacin da ta shiga cikin gaggawa a tsakiyar Maris 2020.
A tsakiyar watan Maris, ma'aikata 4 na Faransa sun nemi amfanin rashin aikin wucin gadi kuma ma'aikata 1 na Burtaniya sun nemi tsarin bashi na duniya. Kusan rabin miliyan kamfanoni a Jamus sun tura ma'aikatansu zuwa tsarin ma'aikata na gajeren lokaci wanda gwamnati ke tallafawa da ake kira Kurzarbeit.
Faransa da Birtaniya sun yi amfani da makaman biyan kuɗin aiki na ɗan gajeren lokaci.
Masana'antu da kuma al'adun gargajiya na al'adu sun yi matukar tasiri a kan annobar, yana shafar ayyukan kungiyoyi da kuma mutane - duka suna aiki a kan albashi da kuma aikin kai - a duk duniya.
Kungiyoyin fasaha da al'adu suna ƙoƙari su haɓaka ayyukansu (sau da yawa suna samun kuɗi na jama'a) don samar da damar samun damar al'adun al'adu ga al'umma, kiyaye lafiyar ma'aikatansu da al'umma, da tallafawa masu fasaha idan ya yiwu.
Har zuwa Maris 202, a duk faɗin duniya da kuma a matakan daban-daban, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu sun rufe nune-nunen, an soke kuma an jinkirta taron da kuma nune-nunen har zuwa wani lokaci mara tabbas.
A cikin martani, akwai matakan da aka ɗauka don samar da sabis na madadin ta hanyar dandamali na dijital. Wani sabon raguwa da ya ƙara raguwa sakamakon annobar shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa na kiɗa da kide kide, taron fasaha, da kuma nunin kayan ado.
An kuma yi sanadiyar cinye-shanen fina-finai, kuma an sanar da cewa an soke bikin Lahadi Mai Tsarki a Roma, wanda ya faru a makon karshe na Lent na lokacin tuba na Kirista.
Yawancin bishops sun ba da shawarar dattawa su zauna a gida maimakon halartar Misalai na Ikilisiya a ranar Lahadi; wasu majami'u sun gudanar da sabis na coci ta hanyar rediyo, kai tsaye kan layi ko talabijin yayin da wasu ke ba da sabis na jagora a baya.
Tare da bishop Roman Katolika na Roma ya rufe majami'u da ƙananan majami'u da kuma yankin St. Peter da aka raba daga ikilisiyoyin Kirista, sauran kungiyoyin addini sun soke ayyukan kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, haikalin da kuma ɗakin karatu.
Ministan lafiya na Iran ya sanar da soke sallar Juma'a a yankunan da cutar ta shafa da rufe kaburbura, yayin da Saudiyya ta hana masu bautar baƙi da mazaunanta shiga wuraren tsarki a Makka da Madina.
Wannan annoba ta haifar da mummunan rikici a cikin kalandar wasanni a duk faɗin duniya tun lokacin Yaƙin Duniya na Biyu.
Yawancin manyan wasanni na wasanni an soke ko kuma an dakatar da su, ciki har da gasar zakarun Turai 201920, gasar zakarun Turai 201920, gasar zakarun Turai 2020, gasar zakarun Turai 201920, gasar zakarun Turai 201920, da kuma gasar zakarun Turai 201920.
Wannan annoba ta shafi shirin wasannin Olympics na bazara na shekarar 2020, wanda aka fara shirya a karshen watan Yuli; Hukumar Olympic ta kasa da kasa ta sanar a ranar 24 ga watan Maris cewa za a "sake shirya taron zuwa ranar bayan shekarar 2020 amma ba bayan bazara ta 2021 ba".
Wannan ya haifar da yawancin kafafun caca suna canzawa zuwa kan layi, tare da yawancin shafukan caca na kan layi suna ba da rahoton ƙaruwa mai yawa a cikin sabon rajistar su. Duniya ta nishaɗi ma ta sha wahala, tare da ƙungiyoyin kiɗa da yawa suna dakatar da ko soke waƙoƙin yawon shakatawa.
Yawancin manyan gidajen wasan kwaikwayo kamar su gidan wasan kwaikwayo na Broadway sun dakatar da duk wasan kwaikwayon.
Wasu masu fasaha sun gano hanyoyin da za su ci gaba da samar da kuma raba aikin ta hanyar intanet a matsayin madadin ga wasan kwaikwayon kai tsaye na gargajiya, kamar wasan kwaikwayo na kai tsaye ko ƙirƙirar "ƙungiya" ta yanar gizo don masu fasaha su gabatar, rarraba da gabatar da ayyukansu.
A kan layi, yawancin abubuwan da ke faruwa a Intanet game da coronavirus sun bazu yayin da mutane da yawa ke juyawa zuwa ga barkwanci da nishaɗi duk da rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar nuna bambanci, ƙiyayya da wariyar launin fata a kan mutanen da ke fitowa daga kasar Sin da Asiya ta Gabas, da kuma a kan mutanen da ke fitowa daga wurare masu zafi a Turai, Amurka da sauran ƙasashe.
An lura da abubuwan tsoro, shakku, da kuma rashin tausayi a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka da kuma yankin Asiya-Pacific.
Rahotanni daga watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ba su da iyaka a China) sun ba da rahoton ra'ayin wariyar launin fata da aka nuna a cikin ƙungiyoyi daban-daban a duniya cewa Sinawa sun cancanci samun kwayar cutar ko karɓar abin da ake zargi a matsayin sakamako mai kyau.
Wasu ƙasashen Afirka ma sun ga karuwar motsin rai na ƙin China.
Yawancin mazaunan Wuhan da Hubei sun ba da rahoton nuna bambanci bisa ga yankinsu na asali.
Akwai goyon baya ga kasar Sin, a cikin layi da kuma wajen layi, da kuma ga wadanda ke cikin yankunan da cutar ta fi tsanani.
Bayan barkewar cutar zuwa sabuwar kasar da ke cikin yankin zafi, mutanen Italiya, kasar Turai ta farko da ta fara fuskantar mummunan cutar COVID-19, na iya zama wadanda ake zargi da cutar da kuma cutar xenophobia.
A Japan, an yi amfani da Twitter don yin amfani da tagar #ChineseDontComeToJapan.
Kasashen Sin da kuma sauran kasashen Asiya a Birtaniya da Amurka sun ruwaito cewa an samu karuwar rashin adalci da kuma tashin hankali.
Shugaban Amurka Donald Trump ya fuskanci zargi saboda kiran coronavirus "Cinese Virus", wani lokaci da masu sukar suka dauka yana da wariyar launin fata da kuma adawa da Sin.
Masu zanga-zangar a Ukraine sun kai hari kan bas din da ke dauke da 'yan kasar Ukraine da kuma 'yan kasashen waje daga Wuhan zuwa Novi Sanzhary.
Dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya sun ba da rahoton samun matsala dangane da annobar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal Dilip Ghosh ya ce kasar Sin ta lalata muhalli kuma "saboda haka Allah ya rama musu".
Bayan haka, ofishin jakadancin kasar Sin a Kolkata ya soki wannan furucin, yana cewa "ba daidai ba ne". A kasar Sin, cutar ta kara tsananta wa baƙi da nuna wariyar launin fata ga mutanen da ba 'yan kasar Sin ba, tare da bayyana baƙi a matsayin "washe na baƙi" kuma ana nufin "sake zubar da su".
Yawancin jaridu da aka biya sun fitar da shi don wasu ko duk labaran da suka yi game da cutar coronavirus.
Masu wallafa kimiyya da yawa suna yin takardun kimiyya game da annobar da ke samuwa a buɗe.
Wasu masana kimiyya sun zaɓi su raba sakamakon su nan da nan a kan sabobin buga takardu kamar bioRxiv.
Cutar da ta taso  Cutar da ta taso da wani abu mai cutar, yawanci sabon abu ne a cikin annobar ko kuma yanayin watsawa
Duniya da cututtuka  Bayani na duniya da kuma yaduwar cututtuka
Jerin annoba da annoba - Jerin adadin mutuwar cututtuka masu yaduwa
Cin hanci da rashawa da kuma cutar dabbobi - Hadarin kiwon lafiya da ke tattare da cinikin dabbobi
Gwajin dakin gwaje-gwaje don cutar coronavirus ta numfashi ta 2019 (COVID-19) da kuma cutar SARS-CoV-2 da aka danganta sun haɗa da hanyoyin gano kasancewar cutar da hanyoyin gano maganin rigakafi da aka samar a cikin amsa ga kamuwa da cuta.
Ana tabbatar da kasancewar cutar a cikin samfurin ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 virus.
Ana amfani da wannan gwajin don gano sabon ko kuma cutar da ke aiki.
Ana iya amfani da gano antibodies (serology) don tantancewa da kuma lura da yawan jama'a.
Gwajin rigakafi ya nuna yawan marasa lafiya da suka kamu da cutar, ciki har da waɗanda alamun su ba su da sauƙi a bayar da rahoto ko kuma marasa bayyanar cututtuka.
Ana iya tantance adadin mutuwar da ake samu daga cutar da kuma matakin rigakafin da ake samu a cikin al'umma daga sakamakon gwajin.
Sakamakon ƙarancin gwaje-gwaje, har zuwa Maris 2020 babu wata ƙasa da ke da bayanan da za a iya tsammanin game da yaduwar cutar a cikin yawan su.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawan jama'arta, kuma akwai bambancin da yawa a yawan gwaje-gwajen da aka yi a kowace ƙasa.
Wannan bambancin zai iya shafar yawan mutuwar da aka ruwaito, wanda zai iya zama da yawa a wasu ƙasashe.
Ana iya yin gwaje-gwaje ta hanyar amfani da rikodin rikitarwa na polymerase chain reaction (rRT-PCR) a cikin samfurori na numfashi da aka samu ta hanyoyi daban-daban, ciki har da nasopharyngeal swab da kuma samfurin sputum.
Ana iya yanke shawara a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya amincewa da gwajin RT-PCR da aka yi da gogewar ƙashin ƙugu a farkon makon rashin lafiya.
Daga nan sai cutar ta fita daga cikin wuyansa yayin da take ci gaba da ninkawa a cikin huhu.
Ga wadanda suka kamu da cutar da aka gwada a karo na biyu, za a iya cire samfurin daga cikin iska ta hanyar amfani da catheter ko kuma a yi amfani da sputum.
An kirkiro gwajin PCR na farko a Charité a Berlin a watan Janairun 2020 ta amfani da rikodin rikodin polymerase-reaction reverse transcription (rRT-PCR), kuma ya zama tushen kayan aikin 250,000 don rarraba su ta Hukumar Lafiya ta Duniya (WHO).
Har ila yau, Burtaniya ta haɓaka gwajin zuwa 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya haɓaka COVID-19 na SARS-CoV-2 bisa PCR, na asibiti (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
Ya gano wani nau'i na "E" da dukkan beta-coronavirus ke rabawa, da kuma wani nau'i na RdRp wanda ke da alaƙa da SARS-CoV-2. A China, BGI Group na ɗaya daga cikin kamfanonin farko da suka sami izinin amfani da gaggawa daga Hukumar Kula da Samfuran Likita ta China don kit ɗin gano SARS-CoV-2 na PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) sun rarraba RT-PCR 2019-Novel Coronavirus (2019-nCoV) Real-Time Diagnostic Panel zuwa dakunan gwaje-gwaje na jama'a ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsohuwar sigar kayan gwajin ya haifar da sakamakon rashin tabbas sakamakon lalacewar reagent, da gwajin kwalban kwalban a CDC a Atlanta; wannan ya haifar da a kan matsakaici kasa da 100 samfurori a kowace rana an yi nasarar sarrafa su a cikin Fabrairu 2020;
Ba a tabbatar da cewa ana iya yin gwajin da aka yi da abubuwa biyu ba har zuwa 28 ga Fabrairu, 2020, kuma kafin haka, ba a ba da izinin fara gwajin ga jihohi da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin dokar hana amfani.
Har zuwa 5 ga Maris 2020 LabCorp ta sanar da kasancewar gwajin COVID-19 bisa RT-PCR a duk faɗin ƙasar.
Quest Diagnostics ta kuma samar da gwajin COVID-19 a duk fadin kasar nan daga ranar 9 ga Maris, 2020.
Babu iyakar adadin da aka sanar; ana bukatar a tattara samfurin da kuma sarrafa shi bisa ga bukatun CDC.
A Rasha, gwajin COVID-19 ya ci gaba kuma ya samar da Cibiyar Nazarin Virology da Biotechnology ta VECTOR.
A ranar 11 ga Fabrairu 2020 an yi rajistar gwajin ta Hukumar Kula da Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, Clinic Mayo ta ruwaito ta ci gaba da gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin sa'o'i 3.5 a cikin babban adadin, yayin da ta ba da izinin inji ɗaya don yin kimanin gwaje-gwaje 4,128 a cikin sa'o'i 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji akan tsarin m2000 na Abbott; FDA ta riga ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma karɓi EUA daga FDA don gwajin da ya ɗauki kimanin minti 45.
Hukumar ta FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da ba a bukatar jerin zagayen zafin jiki masu canji ba, wannan hanyar tana iya ba da sakamako mai kyau a cikin minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na'urori a cikin Amurka kuma Abbott na tsammanin hanzarta samarwa don aikawa da gwaje-gwaje 50,000 a rana. Gwaje-gwaje da ke amfani da antibodies na monoclonal waɗanda ke da alaƙa da ƙwayoyin nucleocapsid (N protein) na sabon coronavirus suna ci gaba a Taiwan, tare da fatan gwajin zai iya ba da sakamako a cikin minti 15 zuwa 20 kamar gwajin sauri na mura.
A watan Maris na shekarar 2020 wani bita na rubuce-rubuce ya kammala cewa "radio-radiograph na kirji yana da ƙarancin ƙimar ganewar asali a farkon matakin, yayin da gano CT [tomography na komputa] na iya kasancewa a nan har ma kafin bayyanar cututtuka ta fara".
Abubuwan da ke cikin CT na yau da kullum sun haɗa da nau'in gilashin ƙasa na multilobar da aka yi amfani da shi tare da shimfiɗa na gefe, asymmetric, da posterior.
Domincin subpleural, buɗewa mai ban mamaki da haɗuwa sun samo asali yayin da cutar ta samo asali.
Wani binciken da ya kwatanta PCR zuwa CT a Wuhan a farkon farkon annobar ta yanzu ya nuna cewa CT ya fi tsananin tsananin PCR, kodayake ba shi da ƙwarewa, tare da yawancin siffofin daukar hoto suna aiki tare da tsarin pneumonia da sauran cututtuka.
Har zuwa Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "ba a yi amfani da CT don tacewa ko a matsayin gwajin farko don gano COVID-19 ba". Har zuwa Maris 2020, CDC ta ba da shawarar PCR don tacewa na farko.
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta shine samar da rigakafi ciki har da IgM da IgG.
Ana iya amfani da shi don gano kamuwa da cuta a cikin mutum daga kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma a cikin sa ido kan yawan jama'a. Ana iya yin kimantawa a cikin dakin gwaje-gwaje na tsakiya (CLT) ko ta hanyar gwajin kulawa (PoCT).
Tsarin atomatik mai zurfi a cikin dakunan gwaje-gwaje da yawa na asibiti zai iya yin wannan kimantawa amma kasancewa a shirye zai dogara da yawan samarwa ga kowane tsarin.
A cikin CLT ana amfani da jini guda ɗaya na jini, ko da yake ana iya amfani da jini na jini don bin tsarin rigakafi.
A cikin PoCT, ana samun jini guda ɗaya ta hanyar hakowa a fata.
Ba kamar yadda tsarin PCR ba ne, ba a buƙatar matakan tsarawa kafin kimantawa. A ranar 26 ga Maris, 2020, FDA ta sanya sunayen kamfanoni 29 da suka ba da bayanai ga hukumomi kamar yadda ake buƙata kuma saboda haka yanzu suna iya rarraba gwajin rigakafin su.
Har zuwa 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kit ɗin gwajin su, wanda zai iya gano IgG da IgA antibodies ga ƙwayoyin cuta a cikin samfurin jini.
Ƙarfin gwajin yana da daruruwan samfurori a cikin 'yan sa'o'i kaɗan kuma saboda haka ya fi sauri fiye da kimantawar PCR na al'ada don RNA na kwayar cuta.
Ana iya gano rigakafin bayan kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Birtaniya ta gano cewa babu wani kayan gwajin rigakafin da aka saya da ya dace da amfani.
Hong Kong ta samar da tsarin da ke kallon marasa lafiya da ake zargi da zama a gida, "ma'aikatan gaggawa za su ba da bututun samfurin ga marasa lafiya", suna fesawa cikin bututun, suna aikawa da sakamakon gwajin ba da daɗewa ba. NHS ta Burtaniya ta sanar da cewa tana yin aikin majagaba na shirin don gwada abubuwan da ake zargi da gida, wanda ke cire haɗarin marasa lafiya na kamuwa da wasu idan sun je asibiti ko kuma dole ne su hukunta motar asibiti idan an yi amfani da su. A cikin gwajin tuki na COVID-19 don abubuwan da ake zargi, ma'aikacin kiwon lafiya ya ɗauki samfurin ta amfani da matakan tsaro masu dacewa.
Cibiyar ta taimaka wa Koriya ta Kudu ta gudanar da wasu gwaje-gwaje da suka fi sauri, mafi zurfi fiye da sauran ƙasashe. A Jamus, Kungiyar Kwararru ta Kasa ta Kula da Lafiya ta Asusun ta ce a ranar 2 ga Maris, cewa suna da damar yin gwaje-gwaje 12,000 a rana a cikin yanayin asibiti kuma an gwada 10,700 a makon da ya gabata.
Asusun inshorar lafiya ne zai biya kuɗin idan likita ya nemi a yi masa gwaji.
A cewar shugaban cibiyar Robert Koch, Jerrman yana da iyawar gwaji 160,000 a mako.
Tun daga ranar 19 ga watan Maris, an ba da gwajin tuki a wasu manyan birane.
Har zuwa 26 ga Maris, 2020 ba a san adadin gwaje-gwajen da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
Binciken farko na dakin gwaje-gwaje ya nuna cewa har zuwa makon kalandar 12/2020 an gwada aƙalla samfura 483,295 ciki har da makon 12/2020 kuma an gwada samfura 33,491 (6.9%) don SARS-CoV-2. A Isra'ila, masu bincike a asibitin Technion da Rambam sun haɓaka da gwada hanyoyin da za a gwada samfura daga marasa lafiya 64 a lokaci guda, ta hanyar tattara samfura da ci gaba da gwaji idan an sami samfurin da aka haɗa. A Wuhan, dakin gwaje-gwaje na gaggawa na gaggawa na mita 2000 mai suna "Hou-Yan" (Cina: ko "Idan wuta" a Turanci) an buɗe shi a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya sarrafa samfura sama da 10,000 a rana.
Tare da gina da wanda ya kafa BGI Wan Jian ya lura da shi kuma ya dauki kwanaki 5, samfurin ya nuna cewa shari'o'in a Hubei za su kasance 47% mafi girma kuma kudin da ya dace don gudanar da killace zai ninka idan ƙarfin gwajin bai kai ga burin ba.
Nan da nan aka kammala aikin Wuhan Lab da Hou Yan Lab a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk faɗin China.
Har zuwa 4 ga Maris, 2020 jimillar gwajin yau da kullun ya kai 50,000. An samar da wani bude tushen, zane mai yawa wanda Origami Assays ya bayar wanda zai iya gwada samfurori 1122 na marasa lafiya don COVID19 ta amfani da ƙimar 93 kawai.
A watan Maris, rashin isasshen kayan aiki da kuma rashin isasshen kayan aiki sun sanya gwaji mai yawa a cikin EU da Birtaniya da Amurka.
Wannan ya sa wasu marubuta su binciki tsarin shirya samfurin wanda ya shafi dumama samfurin a 98 C (208 F) na minti 5 don fitar da kwayoyin RNA don gwaji na gaba. A ranar 31 ga Maris an sanar da cewa UAE na gwada yawancin mutanenta don Coronavirus a kan kowane mutum fiye da kowace ƙasa, kuma yana kan hanyar da ta dace don haɓaka ƙimar gwajin don isa ga mafi yawan jama'a.
Wannan shi ne ta hanyar hadawa da ikon jagora na baya, da kuma sayen manyan dakunan aiki na yawan jama'a daga Group 42 da BGI (wanda ya dogara da dakin gwaje-gwaje na gaggawa "Hou-Yan" a kasar Sin)
An gina shi a cikin kwanaki 14, kuma wannan dakin gwaje-gwaje na iya gudanar da dubban gwaje-gwaje na RT-PCR a kowace rana kuma shi ne na farko a duniya a wannan sikelin da za a gudanar a wajen kasar Sin.
An gudanar da gwaje-gwaje daban-daban da suka shafi sassa daban-daban na kwayoyin halittar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta amince da amfani da hanyar Jamus don samar da kaya da aka aika zuwa ƙasashe masu karamin kudin shiga ba tare da albarkatun da za su ci gaba da samar da kaya ba.
An buga hanyar Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta haɓaka ba ta wanzu ba har zuwa 28 ga Janairu, yana jinkirta gwajin da ke akwai a Amurka. China da Amurka suna da matsala game da amincin kayan gwajin a farkon lokacin da aka shirya, kuma ƙasar da Ostiraliya ba su iya samar da isasshen kayan aiki don biyan buƙatu da shawarwari don gwaji ta hanyar masana kiwon lafiya.
A gefe guda, masana sun ce shirye-shiryen Koriya ta Kudu na yin gwaji na taimakawa wajen rage yaduwar cutar coronavirus.
Yawancin gwajin sun kasance a cikin dakin gwaje-gwaje na masu zaman kansu, wanda gwamnatin Koriya ta Kudu ta gina a cikin 'yan shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga karfafa shirye-shiryen gwaji a matsayin hanya mafi kyau don rage saurin cutar COVID-19. Babban buƙatar gwaji sakamakon yaduwar cutar ya haifar da jiran ɗaruruwan dubban gwaje-gwaje a cikin dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da safa da rigakafin sunadarai sun zama iyakance.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton cewa akwai matsala a kan daidaito a cikin kayan gwajin ta.
A Amurka, kayan gwajin da CDC ta haɓaka suna da "launin"; gwamnati ta sake fitar da takunkumin da suka hana gwajin mutum.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya faruwa ba ne saboda rashin samun samfurin ko yin amfani da kayan aikin da ya dace.
Ma'aikatar kasar ta Spain ta ce za ta janye kayan aikin da suka dawo da sakamakon da bai dace ba, kuma za ta maye gurbin su da wasu kayan aikin gwaji daban-daban da Shenzhen Bioeasy ta samar.
Firayim Minista Matovic ya ba da shawarar cewa a jefa wannan kit ɗin a Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "ƙimar kuskure" kuma ba sa "amfani da su".
Gwaje-gwajen, biye da killace wadanda suka tabbatar da cewa sun samu karbuwa da kuma gano wadanda suka yi alaka da mutanen da suka samu karuwar SARS-CoV-2, sun bada sakamako mai kyau.
Masu bincike da ke aiki a garin Vo a Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje guda biyu a kan kusan mutane 3,400, a tsakanin kwanaki goma.
Kusan rabin mutanen da suka samu cutar ba su da wata alama, kuma an killace duk wadanda aka gano.
Ta hanyar hana zirga-zirga, ya kawar da sabon kamuwa da cuta gaba daya.
Tare da gano lamba mai tsanani, takunkumin shiga, gwaji, da killacewa, annobar coronavirus ta 2020 a Singapore ta yi tafiya a hankali fiye da sauran ƙasashe masu tasowa, amma ba tare da takunkumi masu ƙarfi kamar tilasta rufe gidajen abinci da shagunan sayar da kayayyaki ba.
An soke taron da yawa, kuma Singapore ta fara ba da shawarar 'yan kasar su zauna a gida a ranar 28 ga Maris, amma za a sake bude makarantu a kan lokaci bayan hutu a ranar 23 ga Maris.
Wasu ƙasashe kuma sun yi amfani da masu binciken ta hanyar gano lamba da ƙarfi, ƙuntatawa, gwaji da killacewa, amma tare da umarnin gaggawa, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa kasashen da suka yi karin gwaje-gwaje, dangane da yawan mutuwar, sun samu karancin mutuwar, wataƙila saboda wadannan kasashen sun fi iya gano wadanda ke da alamun rashin lafiya ko kuma marasa aibu.
WHO ta ba da shawarar cewa kasashen da ba su da damar gwaji da kuma dakin gwaje-gwaje na kasa tare da iyakantaccen gogewa game da COVID-19 su aika da samfurori biyar na farko masu kyau da samfurori goma marasa kyau na COVID-19 zuwa ɗayan dakunan gwaje-gwaje na WHO guda 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje guda 16, bakwai suna cikin Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostiraliya.
A cikin jadawalin da ke gaba, ginshiƙan "Abin da ke da kyau a matsayin % na gwaji" yana rinjayar manufofin gwaji na ƙasa.
Kasashen da suka gwada mutanen da aka kwantar da su asibiti ne kawai za su samu sakamako mai kyau a matsayin kashi na gwaji fiye da na ƙasashen da suka gwada dukan mutane, ko suna nuna alamun cutar ko a'a, sauran sun kasance iri ɗaya.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, aikin tsabtace hannu ne wanda aka yi don kawar da ƙasa, kitse, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Yin wanka da sabulu a kai a kai a wani "lokaci mai muhimmanci" na rana yana hana kamuwa da cututtuka da yawa, kamar fitsari da kuma ciwon baya, wanda ke yadawa ta hanyar hanyar da aka yi zuwa bakin.
Mutane kuma za su iya kamuwa da cututtukan numfashi kamar mura ko mura ta yau da kullum, misali, idan ba su wanke hannuwansu kafin su taɓa idanu, hanci, ko baki (cth., mucosa).
Abubuwa biyar masu muhimmanci a lokacin rana da suka shafi wanke hannu da sabulu suna da muhimmanci: kafin da bayan wanke ruwa mai yawa, bayan wanke baya ko canza lamuni, kafin ciyar da yaro, kafin cin abinci da kuma kafin da bayan shirya abinci ko sarrafa nama mai naman, kifi ko tsuntsu.
Idan babu ruwa da sabulu, za a iya wanke hannuwanku da toka.
Kafin, a lokacin, da kuma bayan da aka shirya abinci.
Kafin da kuma bayan da kake kula da marasa lafiya.
Bayan canza layin ko tsabtace yara da suka yi amfani da gidan wanka.
Bayan an tsage hanci, cough ko sneezing.
Bayan ka taɓa dabba, abincin dabba, ko kuma ƙazantar dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace jiki da suka shafi tsarin likita.
Yin wanka kafin ka yi amfani da magani ko kuma ka guji yin amfani da magani zai iya hana ko rage yawan kamuwa da cutar.
Babban manufar maganin wanke hannu shine don tsabtace hannayen daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da kuma sunadarai waɗanda zasu iya haifar da haɗari ko cututtuka.
Wannan yana da muhimmanci musamman ga mutanen da ke kula da abinci ko kuma waɗanda ke aiki a fannin likita, amma kuma yana da muhimmanci ga al'umma.
Wanke hannu yana da fa'idodi masu yawa ga lafiyar mutum, ciki har da rage yaduwar mura, coronavirus da sauran cututtukan da ke kamuwa da cuta; hana kamuwa da cututtukan cuta; rage kamuwa da cutar numfashi;
kuma rage yawan mutuwar jarirai a lokacin haihuwar gida.
Wani bincike a shekarar 2013 ya nuna cewa yin wanka da hannu da kyau zai haifar da karamin karuwa a cikin girma na yara a karkashin shekara biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da kuma fitsari ta hanyar sauya wasu halaye masu sauƙi, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwar da ake yi daga cutar zuwa kusan kashi 50.
Yin amfani da wanka na hannu zai iya rage yawan cututtukan fitsari da kashi ɗaya bisa uku, kuma wannan zai iya kwatanta da samar da ruwa mai tsabta a yankunan da ba su da isasshen kuɗi.
Ruwa da sabulu shine kawai hanyar da ta dace da kuma ba ta da tsada don hana fitsari da cututtukan numfashi (ARI), kamar yadda ake yi a gidaje, makarantu da al'ummomi a duk duniya.
Ciwon huhu, babban abin da ke kashe yara, shi ne sanadiyar mutuwar yara a ƙarƙashin shekara biyar, yana kashe yara miliyan 1.8 a kowace shekara.
A kowace shekara, ana kashe kusan yara miliyan 3.5 a sakamakon ciwon huhu da kuma ciwon huhu.
A cewar UNICEF, yin amfani da sabulu kafin cin abinci da bayan wanka zai iya ceton rayuka fiye da allurar rigakafi ko kuma maganin da aka haɗa, rage mutuwar da ke tattare da fitsari da kusan rabin, da kuma mutuwar da ke tattare da cututtukan numfashi da kusan kashi huɗu.
Ana yin amfani da wanke hannu a hade da wasu ayyukan tsabtace jiki a matsayin wani ɓangare na shirin ruwa, tsaftacewa da tsaftacewa (WASH).
Yin wanka a hannu kuma zai iya kāre ka daga shan iska da ke motsawa ta hanyar kai tsaye.
Ƙananan sakamako mai illa idan aka wanke hannuwanmu sau da yawa shi ne cewa wanke hannuwanmu da ƙarfi zai iya haifar da lalacewar fata daga bushewar fata.
Wani bincike daga Denmark a shekara ta 2012 ya gano cewa wanke hannu sosai zai iya haifar da ciwo, yanayin fata mai launin fata wanda aka sani da eczema na hannu ko dermatitis na hannu, wanda ya zama ruwan dare a cikin ma'aikatan kiwon lafiya.
Yin wanka da hannu sau da yawa yana nuna cewa yana da alaƙa da rashin tausayi.
Akwai lokatai guda biyar na yau da kullum da wanke hannu da sabulu ke da muhimmanci wajen rage yawan cutar ta bakin: bayan yin amfani da wanka (tash, shaye-shaye), bayan wanke bayan yaro (canja layin), kafin cin abincin yaro, kafin cin abinci da kuma kafin/bayan shirya abinci ko sarrafa nama mai naman kaza, kifi ko tsuntsu.
Sauran lokutan da za a yi amfani da wanke hannu don hana kamuwa da cutar sun haɗa da kafin da bayan da aka yanke ko kuma aka ji rauni; bayan da aka yi mani suwu, tari, ko kuma suka yi hanci; bayan da suka taɓa ƙazantar dabba ko suka yi aiki da dabba; da kuma bayan da suka riƙe shara.
Yawan wanke hannu da sabulu yana da ƙaranci a yawancin ƙasashe.
A shekarar 2015, wani bincike na wanke hannu a kasashe 54 ya gano cewa a matsakaita 38.7% na iyalai suna wanke hannu da sabulu. A shekarar 2014, wani bincike ya nuna cewa Saudi Arabia tana da mafi yawan kashi 97 cikin dari; Amurka tana kusan tsakiyar da kashi 77 cikin dari; da China a mafi karancin kashi 23 cikin dari. Wasu hanyoyin canza hali yanzu suna wanzuwa don inganta wanke hannu da sabulu a lokuta masu mahimmanci.
Shirin Kula da Lafiya mai mahimmanci da Ma'aikatar Ilimi ta Philippines ta aiwatar da shi misali ne na manyan ayyuka don inganta lafiyar yara da ilimi.
Yin wanka sau biyu a shekara, tare da wanke hannuwanmu da sabulu a kullum, da kuma goge hakora a kullum da ruwan 'ya'yan itace ainihin shirin na kasa.
An yi nasara a Indonesia.
Ana iya ƙara cire ƙwayoyin cuta daga fata ta ƙara sabulu ko kuma wankewa a cikin ruwa.
Babban aikin sabulu da kuma wankewa shine rage hanawar bayani, da kuma kara karamin bayani.
Ruwa kaɗai ba shi da tsabtace fata mai kyau domin kitse da furotin, da suke cikin ƙasa mai ƙanshi, ba su narkewa cikin ruwa.
Amma, samun ruwa mai kyau yana taimakawa wajen tsabtace.
Saboda yadda ake amfani da sabulu mai tsabta, zai iya riƙe ƙwayoyin cuta da aka samu daga amfani da su a dā.
Wasu ƙananan bincike game da canja wurin kwayoyin daga sabulu mai ƙazanta ya gano cewa ba zai yiwu ba domin an kawar da kwayoyin lokacin da aka wanke su da kumfa.
Cibiyar ta CDC ta ce "abin da aka yi da ruwa da aka yi da hannayensu ba shi da kyau".
Sabulu na rigakafi yana da matukar tasiri ga mutanen da ke da muhimmanci ga lafiyarsu.
Babu wata hujja da ta nuna cewa yin amfani da maganin kashe kwayoyin cuta ko kuma maganin kashe kwayoyin cuta yana ba da shawarar zabar kwayoyin da ke da tsayayyar maganin rigakafi.
Duk da haka, sabulu na antibacterial yana dauke da wasu kwayoyin halitta na yau da kullum kamar triclosan, wanda ke da jerin sunayen da suka dace da tsayayya da kwayoyin halitta.
Saboda haka, ko da yake ba a zaɓa wani nau'in maganin rigakafi ba don maganin rigakafi, ba zai yi tasiri sosai kamar yadda ake tallatawa ba.
Baya ga surfactants da kuma magungunan kare fata, wannan ingantaccen tsari na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, benzoic acid mai aiki na antimicrobial da ƙarin maganin fata (aloe vera, bitamin, man shanu, tsire-tsire). Ƙididdigar da aka yi daga Kwalejin Lafiya ta Jama'a a Jami'ar Oregon ta nuna cewa sabulu na yau da kullum yana da tasiri iri ɗaya da sabulu na antibacterial na masu amfani wanda ya ƙunshi triclosan a cikin hana cututtuka da kuma kawar da kwayoyin daga hannayen.
Ruwa ba shi da zafi sosai don wanke hannu, amma ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin suna yin yawaitawa a jiki (37 °C).
Amma, ruwan sanyi da sabulu ya fi kyau wajen kawar da man fetur da ke da ƙasa da kuma ƙwayoyin cuta.
Ba kamar yadda mutane da yawa suke tunani ba, binciken kimiyya ya nuna cewa yin amfani da ruwan zãfi ba ya rage yawan ƙwayoyin cuta a hannayenmu.
Mai tsabtace hannu ko maganin hana hana shan kwayar hannu shine wakili mai tsabtace hannu wanda ba ya dogara da ruwa.
A cikin ƙarshen 1990s da farkon karni na 21, giya mai tsabtace hannu mai tsabtace hannu mai tsabta (wanda aka fi sani da giya mai tsabtace hannu, maganin hana sinadarai, ko kuma tsabtace hannu) ya zama sananne.
Yawancin su ne isopropyl alcohol ko ethanol da aka tsara tare da wakilai masu ƙoshin lafiya kamar Carbomer (acrylic acid polymer) a cikin gel, ko humctane kamar glycerine zuwa ruwa, ko kumfa don sauƙaƙe amfani da kuma rage tasirin bushewar giya.
Ƙara hydrogen peroxide da aka narkar zai ƙara ƙwayoyin cuta.
Shan barasa yana kashe kwayoyin cuta, kwayoyin da ke hana magunguna (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza da hepatitis) da kuma fungi.
Abincin shan giya mai dauke da kashi 70% na giya ya kashe kashi 99.97% (ƙanƙan 3.5 log, daidai da ƙanƙan 35 decibels) na kwayoyin cuta a hannayen 30 seconds bayan amfani da kuma kashi 99.99% (ƙanƙan 4 zuwa 5 log) na kwayoyin cuta a hannayen minti 1 bayan amfani.
Kayan wanke hannu na barasa kusan gaba ɗaya ba shi da tasiri a kan ƙwayoyin cuta na norovirus (ko Norwalk), wanda shine mafi yawan cututtukan gastroenteritis. Dole ne a yi amfani da maganin hana shan magani na hannu ko kuma maganin shan giya don daidaita ko kare hannayen biyu yadda ya kamata.
A gaban da baya na hannayenka da kuma tsakanin yatsunsu duka, ka shafa su na tsawon dakika 30 har sai ruwa, kumfa ko gel sun bushe.
Ƙananan yatsunsu kuma dole ne a wanke su sosai, ta hanyar shafa su a hannayen hannu biyu. Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka sun ba da shawarar wanke hannu maimakon wanke hannu, musamman idan hannu ya zama datti.
Ana amfani da wannan magani sosai saboda sauƙin amfani da shi da kuma saurin kashe kwayoyin halitta. Duk da haka, ba zai iya maye gurbin wanke hannu ba sai dai idan babu sabulu da ruwa.
Yin amfani da kayan wanke hannu na barasa a kai a kai zai iya sa fata ta bushe sai dai idan an ƙara emollients da/ko moisturizers ga kayan aiki.
Ana iya rage ko kawar da tasirin shan giya ta wajen ƙara glycerin da/ko wasu emollients zuwa ga kayan abinci.
A cikin gwaji na asibiti, wanke hannu mai ƙanshi wanda ya ƙunshi emollients ya haifar da raguwa mai yawa na irritation da bushewa a fata idan aka kwatanta da sabulu ko kayan wankewa na antimicrobial.
Allergic contact dermatitis, contact urticaria syndrome ko kuma rashin jin daɗi ga shan giya ko wani abu a cikin shan giya ba shi da yawa.
Ƙa'idar rage yawan cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da ke tattare da cututtukan da suka shafi cututtukan da suka shafi cututtukan da kuma wankewar hannu.
Ba ruwan da ke aiki ba, amma yana da tasiri sosai, ba ya wanke hannayenmu daga kwayoyin halitta.
Wannan shi ne dalilin da ya sa tsabtace hannu ba ta da tasiri sosai idan aka kwatanta da sabulu da ruwa don hana yaduwar kwayoyin cutar, saboda har yanzu akwai kwayoyin cutar a hannayen.
Ingancin tsabtace hannu na giya ya dogara da ƙanshi da kuma maganganunsa, kuma ya kasance da tasiri sosai fiye da giya da giya.
A kwanan nan, an tabbatar da cewa magungunan da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimicrobial kuma suna da yawa bayan amfani, ba kamar giya da aka tabbatar da rage tasiri ba bayan amfani da yawa, mai yiwuwa saboda rashin dacewar halayen fata a hankali.
Yawancin mutanen da suke samun kuɗi kaɗan ba za su iya samun sabulu ba, maimakon haka, suna amfani da toka ko ƙasa.
Ƙura ko ƙasa za su iya yin aiki sosai fiye da ruwa kawai amma ba za su iya yin aiki sosai fiye da sabulu ba.
Akwai damuwa idan ƙasa ko toka ta lalace da ƙwayoyin cuta waɗanda za su iya ƙarawa maimakon rage yaduwar cutar.
Ash yana da ƙwayoyin cuta kamar sabulu saboda yana haifar da maganin alkalin idan ya zo cikin ruwa.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu idan sabulu ba a samu.
Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar yin amfani da wanke hannu don hana yaduwar cututtuka.
Hannunsu suna da ruwa mai dumi ko sanyi.
Ana ba da shawarar ruwa mai gudana saboda ƙarfe mai tsayawa na iya gurɓata, a lokaci guda kuma zafin ruwan ba ya shafar.
Ka wanke hannunka kuma ka shafa shi da sabulu mai yawa, har da baya, tsakanin yatsunsu, da kuma ƙarƙashin kusoshi.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannu sosai sa'ad da suke amfani da sabulu fiye da yin amfani da ruwa kawai.
Aƙalla minti 20.
Yin shinge yana haifar da juyawa, wanda ke taimakawa wajen kawar da kwayoyin daga fata, kuma shinge yana daukan tsawon lokaci don kawar da ƙarin kwayoyin.
Ka yi kyau ka yi amfani da ruwa mai gudana.
Yin wanka a cikin baƙin ƙarfe zai iya sa hannu ya sake gurɓata.
Ka wanke shi da tawul mai tsabta ko kuma ka bar iska ta bushe shi.
Hannun da ke da ruwa da kuma rigar hannu suna da sauƙin sake yin datti.
Ana iya ajiye kwayoyin a cikin ƙusa da ƙusa masu ƙusa da kuma zane-zane.
Ana ba da shawarar yin amfani da kayan shafawa don hana hannayen hannu su bushe; fata mai bushewa na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa cutar.
Akwai zaɓuɓɓukan da ba su da tsada don sauƙaƙe wanke hannu idan babu ruwa mai tsabta da/ko sabulu, misali, zuba ruwa daga kwanon rufi ko kabeji tare da rami mai dacewa da/ko amfani da toka idan ya cancanta a cikin ƙasashe masu tasowa. Idan an iyakance samar da ruwa (kamar a makarantu ko yankunan karkara a cikin ƙasashe masu tasowa), akwai hanyoyin da ke adana ruwa kamar "tube mai laushi" da sauran zaɓuɓɓuka masu rahusa.
Fitaccen bututu fasaha ce mai sauki ta amfani da igiya da aka rataye ta igiya, da kuma hanzari da aka sarrafa ta ƙafa don zuba ruwa kadan a hannayensu da kuma sabulu.
Wani muhimmin ɓangare na aikin tsabtace hannu shine bushewar hannu mai tasiri, amma akwai muhawara game da irin bushewar da ta fi tasiri a cikin ɗakunan wanka na jama'a.
Ƙari da ƙari, bincike ya nuna cewa tawul ɗin takarda sun fi tsabta fiye da na'urorin bushewa na lantarki da ake samu a yawancin ɗakunan wanka.
A shekara ta 2008, wani bincike da Jami'ar Westminster, London ta gudanar, wanda masana'antar takarda ta tallafawa, wato, Tissue European Symposium, ya kwatanta matakan tsabtace jiki a lokacin amfani da takarda, bushewar hannayen iska mai dumi da kuma bushewar hannayen iska na zamani.
Bayan wanke da kuma bushe hannuwanku da na'urar bushewa da iska mai dumi, adadin ƙwayoyin cuta a ƙananan yatsunsu ya karu da kashi 194% a kan matsakaici da kuma kashi 254% a hannu.
Drying tare da jet air dryer ya haifar da karuwar adadin kwayoyin a ƙananan yatsunsu na yatsunsu da matsakaita 42% da kuma a hannun hannu da 15%.
Bayan wankewa da kuma bushewa da hannu tare da tawul na takarda, adadin kwayoyin a ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Jirgin iska mai bushewa, wanda ke fitar da iska daga cikin na'ura a saurin gudu na 180 m/s (650 km/h; 400 bsj), yana iya fitar da ƙwayoyin cuta daga hannayensu da na'urar kuma yana iya gurɓata sauran masu amfani da ruwa da kuma yanayin da ke cikin dakin ruwa har zuwa mita 2.
Yin amfani da bushewar hannu na iska mai zafi yana yada ƙwayoyin cuta har zuwa mita 0.25 daga bushewa.
A shekara ta 2005, wani bincike da TÜV Produkt und Umwelt ya yi ya nuna cewa akwai hanyoyi daban-daban na bushewa.
An gano canje-canje masu zuwa a cikin ƙididdigar ƙwayoyin cuta bayan an bushe hannu:
Akwai masana'antun bushe-bushe da yawa daban-daban, kuma bushe-bushe na hannu suna kwatanta da tawul ɗin takarda don bushewa.
Yin wanka da hannu da kayan wanke hannu ya zama zaɓi na gaba yayin tafiya idan babu sabulu da ruwa.
Dole ne a yi amfani da kayan wanke hannu da giya don a yi amfani da su aƙalla kashi 60 cikin ɗari na giya.
Yin wanka hannu don magani ya daɗe yana da alhakin lokacin da likitan Ignaz Semmelweis na Hungary ya gano (a cikin 1846) yana da tasiri wajen hana cututtuka a cikin asibiti.
Akwai na'urar lantarki da ke gargaɗi ma'aikatan asibiti su wanke hannu idan sun manta.
Wani bincike ya nuna cewa shansa zai iya rage yawan kamuwa da cuta.
Ka wanke hannuwanka a cikin magani na akalla 15 seconds, ta amfani da sabulu da ruwa ko gel don narkewa da kuma shafa kowane ɓangaren hannu.
Dole ne a shafa hannayensu tare da yatsunsu da aka saka a hankali.
Idan akwai ƙazanta a ƙarƙashin ƙusa, za a iya amfani da goga don kawar da shi.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannayenmu, muna bukatar mu wanke su sosai kuma mu shafa su da tawul mai tsabta.
Bayan an bushe hannayensu, ya kamata a yi amfani da tawul ɗin takarda don rufe ruwa (kuma a buɗe ƙofar idan ya cancanta).
Wannan yana hana hannu sake zama datti sa'ad da ta taɓa farfajiya.
Yin wanke hannu a cikin yanayin kula da lafiya yana nufin kawar da kwayoyin cuta ("matsattsi") da kuma hana su yadawa.
New England Journal of Medicine ta ruwaito cewa rashin wanke hannu na dindindin yana da rashin karɓa a yawancin yanayin likitanci, tare da yawancin likitoci da ma'aikatan aikin jinya suna manta da wanke hannu kafin su taɓa marasa lafiya, sannan su yada ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu hanyoyin da suka dace za su iya rage yawan cututtukan jini da ke tattare da kateter da kashi 66 cikin ɗari.
Ana kuma samun rubutun jagorar tsabtace hannu ta ƙungiyar a shafin yanar gizon ta don yin tsokaci ga jama'a.
Wani bincike mai dacewa da Whitby et al.
Na'urorin kasuwanci za su iya auna da kuma tabbatar da tsabtace hannu, idan ana bukatar nuna bin dokoki.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" don wanke hannu:
bayan an sha ruwa a cikin jini
kafin aikin aseptic, kuma
Bayan an yi wa marasa lafiya magani, an ƙara sinadarai masu saurin kashewa a sabulu, wato, sabulu mai magani ko kuma maganin kwayoyin halitta, wanda ke kashe hannuwan masu wanke hannu.
Irin wannan kisan gilla na iya zama da kyau kafin a yi aiki ko kuma a yanayin da kwayoyin cutar ke da tsayayya da kwayoyin cuta. Don 'wanke' hannun mutum don tiyata, ana buƙatar samun bututun da za a iya kunnawa da kashewa ba tare da taɓa hannu ba, wasu wanke chlorhexidine ko iodine, tawul mai hanawa don bushewa da hannu bayan wankewa, da kuma goga mai hanawa don shafawa da sauran kayan aikin hanawa don tsabtace ƙarƙashin kusoshi.
Dole ne a cire kayan ado.
Wannan aikin yana bukatar wanke hannuwanka da hannunka har zuwa wuyanka, yawanci na tsawon minti biyu zuwa shida.
Ba a buƙatar dogon lokaci na gogewa (minti 10) ba.
A lokacin wanka, dole ne a hana ruwa daga hannuwansa.
Bayan an gama wanke hannu, sai a yi wa hannayensu wanka da takalma kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, ya kamata a wanke hannuwanku ko kuma a yi amfani da maganin kashe kwayoyin kafin a yi maganin da kuma bayan an yi wa marasa lafiya magani.
Don hana kamuwa da cutar staphylococcal a asibiti, an gano cewa mafi yawan amfanin wanke hannu ya zo daga wankewar farko na kashi 20 cikin ɗari, kuma kaɗan ne kawai amfanin da aka samu lokacin da yawan wanke hannu ya ƙaru fiye da kashi 35 cikin ɗari.
Yin wanka da sabulu na yau da kullum ya haifar da fiye da sau uku na yawan cututtukan cututtuka masu yaduwa zuwa abinci fiye da wankewa da sabulu mai ƙwayoyin cuta. Idan aka kwatanta wanke hannu da maganin shan giya da wanke hannu da sabulu mai ƙwayoyin cuta na tsawon dakika 30, kowannensu ya nuna cewa wanke hannu da giya ya rage gurɓatar kwayoyin cuta da kashi 26% fiye da sabulu mai ƙwayoyin cuta.
Amma sabulu da ruwa sun fi tasiri fiye da giya-based handwashing don rage cutar mura A H1N1 da kuma ƙwayoyin cuta na Klostridium daga hannayen hannu. Hanyoyin da za a inganta tsabta a cikin yanayin kula da lafiya na iya haɗawa da ilimantarwa ga ma'aikata game da wanke hannu, haɓaka wadatar shan giya-based handwashing, da kuma rubutaccen gargaɗi da gargaɗi ga ma'aikata.
Akwai bukatar bincike mai zurfi game da abin da ya fi tasiri a yanayin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu yana da amfani sosai kuma yana da muhimmanci don samun lafiya da kuma abinci mai gina jiki.
Amma, rashin isashen ruwa da sabulu da kuma wanke hannu a gida, a makaranta da kuma wajen aiki ya sa yin hakan ya zama ƙalubale ga samun halaye na wanke hannu a duniya.
Alal misali, a mafi yawan yankunan karkara na Afirka, yin wanka a kusa da kowane gidan wanka na jama'a da na masu zaman kansu ba shi da yawa, ko da yake akwai zaɓuɓɓukan da ba su da tsada don gina tashoshin wanka.
Amma, rashin wanke hannu zai iya faruwa ne domin rashin sabulu ko ruwa.
Tallafi da kuma tallata wanke hannu da sabulu na iya shafar yanke shawara, yana ƙara wayar da kan jama'a game da fa'idodin wanke hannu kuma yana haifar da canjin halayyar dogon lokaci na yawan jama'a.
Don wannan ya yi aiki yadda ya kamata, dole ne a yi nazari da kuma tantance shi.
Binciken da aka yi a kan bincike 70 ya gano cewa tsarin da aka kafa na al'umma yana da tasiri wajen inganta wanke hannu a LMIC, yayin da yakin neman tallace-tallace na zamantakewa bai da tasiri. Misali na inganta wanke hannu a makarantu shine "Tiga-Star Approach" ta UNICEP wanda ke ƙarfafa makarantu su dauki sauki da kuma sauki matakan tabbatar da cewa dalibai suna wanke hannayensu da sabulu, tsakanin sauran sharudda na tsabta.
Idan aka kai ga mafi ƙarancin ma'auni, makarantar za ta iya motsawa daga taurari daya zuwa uku,
Ƙirƙirar tashoshin wanke hannu na iya zama ɓangare na kamfen na tallata wanke hannu da ake yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya ita ce wani misali na kamfen na wayar da kan jama'a wanda ke ƙoƙarin canza halaye.
Wasu bincike sun yi la'akari da yadda ake amfani da kayan wanke hannu a ƙasashe masu tasowa dangane da DALY.
Amma, wani bincike ya nuna cewa yin amfani da sabulu wajen wanke hannu yana sa mu sami ƙarin kuɗi fiye da yin amfani da ruwa da kuma tsabtace jiki.
Muhimmancin wanke hannu ga lafiyar mutum  musamman ga mutanen da ke cikin yanayin rauni kamar mahaifiyar da ta haifi jariri ko soja da aka ji rauni a asibiti  an fara gane shi a tsakiyar karni na 19 ta biyu masu yin aikin tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria da Forence Nightingale, "kafa aikin jinya na zamani" na Ingila.
A lokacin, mutane da yawa sun gaskata cewa miyagun ƙwayoyi ne suke sa mutane su kamu da cutar.
A cikin shekarun 1980, barkewar cutar abinci da cututtukan da ke tattare da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su fi inganta tsabtace hannu a matsayin babbar hanyar hana yaduwar kamuwa da cuta.
Cutar zazzabin alade a shekarar 2009 da annobar COVID-19 a shekarar 2020 sun haifar da karuwar wayar da kan jama'a a kasashen da dama game da muhimmancin wanke hannu da sabulu don kare kanka daga irin wannan cututtukan.
Alal misali, ana saka wasu banners da ke ɗauke da "hanyar wanke hannu da ta dace" a kusa da wanke hannu a cikin gidajen wanka na jama'a da kuma a cikin gidajen wanke na ofisoshi da na filayen jirgin sama a Jamus.
Kalmar nan "ka wanke hannuwan mutum daga" wani abu tana nufin cewa mutum ya ƙi ɗaukar alhakin abin ko kuma ya ƙi yin wani abu.
Ya fito ne daga ayar Littafi Mai Tsarki a cikin Matta lokacin da Pontius Pilate ya wanke hannunsa daga shawarar gicciye Yesu Kristi, amma ya zama magana da amfani da yawa a wasu al'ummomin Ingila.
A cikin Macbeth ta Shakespreare, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari don wanke ƙazanta da ake tsammani, wanda ke nuna jin ta laifi game da laifukan da ta aikata da kuma abin da ta rinjayi mijinta ya yi.
An gano cewa mutane bayan sun tuna ko sun yi tunani a kan wani abu marar kyau, suna yawan wanke hannuwansu fiye da wasu kuma suna daraja kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba da izinin wanke hannu bayan irin wannan tunani ba su da wataƙila su shiga wasu ayyukan "wanke" na biyan kuɗi, kamar yin aikin sa kai.
Addini ya sanya wanke hannu don dalilai na tsabta da alama. Yin wanke hannu a alamance, ta amfani da ruwa mara sabulu don wanke hannu, wani ɓangare ne na al'adun wanke hannu waɗanda ke cikin addinai da yawa ciki har da imani na Baha'i, Hindu, tevilah da netilat yadayim a cikin Yahudanci, Lavabo a cikin Kiristanci da Wudhu a cikin Musulunci. Addini kuma ya ba da umarnin wanke hannu mai tsabta musamman bayan wasu ayyuka.
Addinai kamar Hindu, Yahudawa da Musulmi sun bukaci a wanke hannuwanmu bayan yin amfani da wanka.
Addinai kamar Hindu, Buddha, Sikh, Yahudawa da Musulmi sun bukaci a wanke hannu kafin da kuma bayan cin abinci.
Gudanar da haɗarin aiki ga COVID-19
Gudanar da haɗarin aiki don COVID-19 aikace-aikace ne na tsarin kiwon lafiya da aminci na aiki don sarrafa haɗari ga rigakafin cutar coronavirus 2019 (COVID-19).
Gudanar da haɗarin da ya dace a wurin aiki ya dogara da wurin aiki da aikin aiki, bisa ga kimantawar haɗarin tushen fallasa, tsanani na cutar a cikin al'umma, da kuma abubuwan haɗarin kowane ma'aikaci wanda zai iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya a Aiki ta Amurka (OSHA), ayyukan da ke da haɗarin rashin haɗari suna da ƙarancin hulɗar aiki tare da jama'a da sauran abokan aiki, wanda matakan rigakafin kamuwa da cuta na asali da aka ba da shawarar sun haɗa da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi, da kuma kula da tsabtace jiki da ƙwayoyin cuta a wurin aiki.
Ayyuka masu haɗarin haɗari na matsakaici sun haɗa da ayyukan da ke buƙatar sau da yawa ko kusanci da mutanen da ba a san su ba ko kuma ake zargin suna da COVID-19, amma suna iya kamuwa da cutar ta hanyar yaduwar al'umma ko tafiya ta duniya.
Wannan ya hada da ma'aikata da ke da hulɗa da jama'a kamar a makaranta, yanayin aiki mai yawan jama'a, da wasu ƙananan wurare masu yawa.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali wanda ya haɗa da iska ta amfani da matattarar iska mai inganci, masu kula da hawan jiki, da kuma samun kayan kariya ta kai tsaye idan sun haɗu da mutanen da ke da cutar COVID-19.
OSHA ta ce ma'aikatan kiwon lafiya da kuma gidajen gawa da ke da sanadin mutanen da aka sani ko ake zargin suna da COVID-19 suna da haɗarin haɗari mai yawa, wanda ke ƙara haɗarin haɗari sosai idan ma'aikata suka yi aikin samar da aerosol a kan, ko tattara ko sarrafa samfurori daga mutanen da aka sani ko ake zargin suna da COVID-19.
Kula da haɗari da ya dace da waɗannan ma'aikata ya haɗa da kula da injiniya kamar ɗakunan iska masu ƙarancin matsa lamba da kayan kariya na kai waɗanda suka dace da aikin.
Cutar COVID-19 na iya haifar da sakamako mai yawa a wurin aiki.
Ma'aikata suna iya yin rashin aiki don suna rashin lafiya ko kuma suna bukatar su kula da wasu ko kuma suna tsoron yin hakan.
Hanyoyin kasuwanci na iya canzawa, ko dai dangane da abin da ake nema, da kuma yadda ake samun waɗannan abubuwa (kamar sayayya a waje da lokacin da aka fi so ko ta hanyar sabis na jigilar kaya ko jagora).
A ƙarshe, jigilar kaya daga yankunan da COVID-19 ke shafar su na iya zama abin takaici. Ana iya amfani da shirye-shiryen shirye-shiryen da ke tattare da cutar don jagorantar matakan kariya.
Shirin yana magance matakan haɗari da suka shafi wuraren aiki da ayyuka daban-daban na aiki ciki har da tushen fallasawa, abubuwan haɗari da ke fitowa daga gida da yanayin al'umma, da abubuwan haɗari na kowane ma'aikaci kamar tsufa ko yanayin rashin lafiya na yau da kullun.
Ya kuma nuna yadda ake gudanar da ayyukan da ake bukata don magance wannan hadarin, da kuma yadda za a magance matsalolin da za su iya tasowa sakamakon annobar.
Shirye-shiryen shiri da kuma amsa cutar ta kamuwa da cuta na iya kasancewa a ƙarƙashin tsarin shirin na kasa ko na ƙasa.
Manufofin amsawa ga annobar sun haɗa da rage yaduwar cikin ma'aikata, kare mutanen da ke da haɗarin kamuwa da mawuyacin cuta, kiyaye ayyukan kasuwanci, da rage mummunan tasiri ga sauran ƙungiyoyi a cikin sarkar samar da su.
Wannan rashin lafiyar da ke cikin al'umma da kasuwancin ke ciki ya shafi yadda ake amsawa.
Tsarin kula da haɗari shine tsarin da aka yi amfani dashi a cikin aminci da lafiyar aiki don rarraba kula da haɗari bisa ga inganci.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, mafi ingancin sarrafawa shine sarrafa injiniya, sannan kuma sarrafawa, kuma na ƙarshe shine kayan kariya.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba, kuma yana iya zama mafi kyawun maganin da za a yi amfani da shi.
Gudanar da gudanarwa shine canji a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki na ma'aikaci ko mai aiki.
Ana ganin cewa kayan kariya ta mutum (PPE) ba su da tasiri sosai idan aka kwatanta da aikin injiniya da kuma gudanarwa amma suna iya taimakawa wajen hana wasu bayyanar.
Dole ne a zabi duk nau'ikan PPE bisa ga haɗarin da ke tattare da ma'aikata, a sanya su daidai gwargwadon dacewa (cth respirator), a yi amfani da su daidai a kai a kai, a duba su koyaushe, a kiyaye su kuma a maye gurbin su, idan ya cancanta, kuma a cire su daidai, a tsabtace su kuma a ajiye su ko a zubar da su don kauce wa gurɓatawa.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA), ƙananan ayyukan da ke da haɗarin haɗari suna da ƙananan hulɗar aiki tare da jama'a da sauran abokan aiki.
Abubuwan da ake ba da shawarar don hana kamuwa da cuta ga duk wuraren aiki sun haɗa da wanke hannuwanmu akai-akai da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, halayyar numfashi ta haɗa da rufewa yayin tari da kumburi, shirya kayan ɗamara da kwandon shara, shirya don teleworking ko aikin aiki idan ya cancanta, ba ƙarfafa ma'aikata su yi amfani da kayan aikin wasu ba, da kuma kiyaye tsabtace da kuma lalata ƙwayoyin cuta a wurin aiki.
Ganowa da kuma warewar mutane da ke da cutar a cikin sauri yana da mahimmanci a cikin kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun numfashi na gaggawa su zauna a gida har sai sun kasance ba tare da zazzabi ba, alamun zazzabi ko wasu alamun aƙalla awanni 24 ba tare da amfani da maganin rage zazzabi ko magani don canza wasu alamun ba, da kuma tsarin izinin rashin lafiya mai sassauƙa, yana ba ma'aikata damar zama a gida don kula da danginsu masu rashin lafiya, kuma ma'aikata suna sane da wannan manufar.
A cewar OSHA, aikin da ke da haɗarin haɗari na matsakaici ya ƙunshi aiki wanda ke buƙatar sau da yawa ko kusanci a cikin ƙafa shida (1.8 m) na mutanen da ba a san su ba ko kuma waɗanda ake zargin suna da cutar COVID-19, amma suna iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma da ke faruwa a kusa da wurin kasuwanci, ko kuma saboda mutumin ya yi tafiya ta duniya zuwa wurin da yaduwar COVID-19.
Wannan ya hada da ma'aikata da ke da hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a da wasu yanayin kasuwanci masu yawa. Kula da aikin injiniya ga waɗannan kungiyoyin da ke da haɗari da yawa ya haɗa da sanya matattarar iska mai inganci, haɓaka yawan iska, shigar da shinge na jiki kamar su masu kare iska na filastik da kuma shigar da windows na wucewa don sabis na abokin ciniki. Kula da gudanarwa ga waɗannan kungiyoyin da kungiyoyin haɗari da yawa ya haɗa da ƙarfafa ma'aikatan marasa lafiya su zauna a gida, maye gurbin allon aiki na fuska da sadarwa ta hanyar sadarwar kai tsaye, ƙirƙirar sauyawa na kayan aiki, dakatar da ba dole ba ne ba don tafiya zuwa wurin da cutar COVID-19 ta faru, haɓaka sadarwar gaggawa ciki har da amsa gabatarwa ga taron tattaunawa, samar da ma'aikata tare da horo da sababbin ayyuka game da abubuwan haɗari na COVID-19 da ayyukan horo, horar da ma'aikata game da amfani da tufafi da kariya da hanyoyin da ake buƙata da samar da yanayi mai ƙarfafawa don amfani da hannayensu da hannu da hannu da kuma na'urar kariya ta sirri, ko kuma sanya takaddamar da ido a kan COVID-19 ko kuma yiwuwar ma'aunin da ke tattare da ma'aunin jama'auka.
Ma'aikata da ke cikin wannan rukunin haɗari ba sa bukatar yin amfani da na'urar numfashi.
Idan wani ya yi rashin lafiya a cikin jirgin sama, kulawa mai kyau don kare ma'aikatan da sauran fasinjoji ya haɗa da ware mai cutar daga wasu da ƙafa 6, sanya ma'aikatan kula da mai cutar, da ba da abin rufe fuska ga mai cutar ko kuma tambayar mai cutar ya rufe bakinsa da hancinsa da takarda lokacin da yake tari ko yin kumburi.
Ma'aikatan jirgin suna bukatar su saka safofin hannu na likita na yau da kullum yayin kula da mai tafiya mai rashin lafiya ko taɓa ruwa ko farfajiyar da za ta iya zama mai guba, kuma wataƙila su saka ƙarin kayan kariya idan mai tafiya mai rashin lafiya yana fama da zazzabi, tari ko wahalar numfashi.
Dole ne a cire safofin hannu da sauran kayan da za a iya amfani da su a cikin jaka mai haɗari, kuma dole ne a tsabtace da kuma cire allurar da aka lalata bayan haka. Don jigilar kaya ciki har da jiragen ruwa da sauran jiragen ruwa, haɗarin haɗari ya haɗa da jinkirta tafiya idan suna rashin lafiya, warewa da kuma sanar da cibiyar likitanci a kan jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamun cutar yayin da yake kan jirgin.
Mafi kyau, ana buƙatar yin aikin biye da likita a cikin ɗakin ɗakin ɗaliban. Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsabtace ko kawar da ƙwayoyin cuta idan mutumin da ya kamu ya kasance a cikin ginin makaranta ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙananan zuwa matsakaiciyar yaduwar al'umma, ana iya aiwatar da dabarun nesa da zamantakewa kamar soke ziyara ta filin, tarurruka da sauran manyan taro kamar ilimin jiki da aji na mawaƙa ko cin abinci a cikin kantin, ƙara sarari tsakanin tebur, lokaci zuwa da dawowa a cikin matakai, iyakance baƙi marasa mahimmanci, da amfani da wuraren ofishin kiwon lafiya daban don yara masu alamun kamar mura.
Idan akwai kamuwa da cutar a cikin al'umma, ban da dabarun nesa da zamantakewa, ana iya la'akari da tsawaita dakatar da makaranta. CDC ta yi la'akari da haɗarin rashin lafiyar gida ga membobin hukumar da ke yin ayyukan yau da kullun.
Jami'an tsaron doka da dole ne su tuntubi mutum wanda aka tabbatar ko ake zargin yana da COVID-19 an ba da shawarar su bi ka'idodin da suka dace kamar yadda masu aikin likitancin gaggawa suka yi tare da kayan kariya ta kai tsaye.
Idan akwai kusanci a lokacin kamawa, ma'aikata suna bukatar su tsabtace da kuma cire belunsu da kayan aikin su kafin su sake amfani da su tare da fesawa ko kuma tsabtace gida, kuma su bi hanyoyin aiki na yau da kullum don rufewa da kuma kawar da PPE da aka yi amfani da shi da kuma don ajiyewa da wanke tufafi.
OSHA ta ce ma'aikatan kiwon lafiya da kuma gidajen gawa suna cikin babban ko kuma babban matakin haɗarin haɗari.
Ayyukan da ke da haɗari mai yawa sun haɗa da isar da kulawar lafiya, tallafi, dakunan gwaje-gwaje da ma'aikatan sufuri na likita ga waɗanda suka san ko kuma ake zargi da cutar COVID-19.
Yana da matukar haɗarin ganowa idan ma'aikaci ya yi aikin samar da aerosol a kan, ko ya tattara ko ya sarrafa samfurin daga sanannun ko kuma masu zargin COVID-19 marasa lafiya.
Ayyukan samar da aerosol sun hada da intubation, tsarin shigar da tari, bronchoscopy, wasu hanyoyin da kuma duba hakora, ko tattara samfurin kai hari.
Ayyukan gida na gawawwakin haɗarin haɗari sun haɗa da ma'aikatan da ke aiki don shirya gawawwakin mutanen da aka sani ko ake zargi da cutar COVID-19 a lokacin mutuwarsu; yana da matukar haɗarin ganowa idan sun yi autopsy. Ƙarin kulawar injiniya ga wannan rukunin haɗari ya haɗa da ɗakin keɓewa don sanannun ko ake zargi da COVID-19 marasa lafiya, gami da lokacin da ake aiwatar da aikin samar da aerosol.
Ana iya yin iska mai ƙarancin ƙarfi a wasu wuraren kula da lafiya da kuma gidajen gawa.
Dole ne a kula da samfurin a hankali, matakin 3 na Biosafety.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya zuwa wuraren jiran daban-daban dangane da ko suna da zargin COVID-19 ko a'a. Baya ga PPE, OSHA ta ba da shawarar masu numfashi ga waɗanda ke aiki a cikin nisan ƙafa 6 daga marasa lafiya da aka sani, ko ake zargi, da cutar SARS-CoV-2, da waɗanda ke yin aikin samar da aerosol.
A Amurka, N95 mai tace fuska mai tsabta wanda aka amince da shi ko mafi kyau dole ne a yi amfani da shi a cikin tsarin tsarin rigakafin numfashi mai zurfi da rubuce ciki har da gwajin dacewa, horo da jarrabawar likita.
Sauran nau'ikan masu numfashi na iya ba da ƙarin kariya da haɓaka kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar yin sutura ba saboda COVID-19 cuta ce ta numfashi da ba ta yaduwa ta hanyar ruwan jiki.
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata kawai ga ma'aikatan duba wuraren shiga.
Ga wadanda ke tattara samfurori na numfashi daga, kula da, ko jigilar marasa lafiya na COVID-19 ba tare da tsarin samar da aerosol ba, WHO ta ba da shawarar yin amfani da masks na tiyata, na ido, ko na fuska, rigar kariya da safar hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin masks na tiyata da N95 ko FFP2 respirator.
Ganin cewa wadatar PPE ta duniya ba ta isa ba, WHO ta ba da shawarar rage bukatar PPE ta hanyar telemedicine, shingen jiki kamar windows a fili, ta hanyar ba da damar waɗanda ke cikin kulawa ta kai tsaye kawai su shiga dakin marasa lafiya na COVID-19, ta amfani da PPE kawai da ake buƙata don takamaiman aiki, ci gaba da amfani da numfashi iri ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da PPE, kuma ba ta ƙarfafa amfani da masks ga marasa lafiya marasa lafiya.
Gidan: Katherine Maher, Shugaba na Gidauniyar Wikimedia
KARANTA: Dukan ma'aikatan Wikimedia Foundation
TAMBAYA: [Covid-19] Saukakawa da kuma shirya domin nan gaba
RATARTA/LATARTA: 14 ga Maris, 2020, 00:24 UTC
Bayani: CC0: Babu haƙƙin adanawa
Mun sami kanmu cikin yanayi mai ban mamaki a wannan watan.
Cutar COVID-19 ta sa dangantakarmu da duniya ta zama mafi haske da kuma alhakin da muke da shi ga juna.
Ba mu taɓa fuskantar irin wannan kalubale ba, amma mun san cewa amsarmu mafi kyau ta dogara ne akan irin tausayi, haɗin kai da kuma gina al'umma da ke tsakiyar ƙungiyar.
Abokanmu da kuma kulawar da muka gani a tsakanin abokan aikinmu ta hanyar imel da waya da kuma tattaunawa, tabbaci ne mai ban mamaki ga mutane masu ban mamaki da muke da sa'a sosai mu yi aiki tare.
Ina matukar godiya da kuma alfahari da zama abokin aikinku.
A makon da ya gabata, wasu mutane sun ba ni kyauta don aikin da muka yi.
Wannan ya tunatar da ni yadda duniya take a yanzu idan aka yi amfani da Wikipedia, da kuma yadda ta zama alama mai karfi saboda wannan muhimmin tushe ya kasance a kan layi kuma yana samuwa ga kowa.
Aikinku ya sa duk wannan ya yiwu, ko kuna sa shafin yanar gizonku ya ci gaba da aiki ko kuma abokan aikinku suna samun kuɗi ko kuma al'ummarmu ta kasance lafiya.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, musamman a wannan lokacin.
Wannan lokaci ne da ba kawai abin da muke yi ba ne, amma yadda muke yi, zai yi tasiri mai mahimmanci ga duniya.
Saboda muhimmancin wannan manufa da kuma rawar da kuke takawa a ciki, za mu yi wasu canje-canje masu muhimmanci ga yadda muke aiki tare, daga mako mai zuwa.
Yin aiki da kuma daidaita jadawalinmu
Kamar yadda Robyn ta ambata a baya, ƙungiyar C ta taru a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi tunanin abin da muke tunani zai zama amsa daidai da abin da muke fuskanta da kuma hanya mafi kyau don tabbatar da cewa kungiyar ta ci gaba a wannan lokacin.
Tare, muna son kawar da damuwa da kuma tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka rage gudu kadan, ba kome.
Ga dukan ma'aikatan, masu kwangila da ma'aikatan kwangila:
Muna sa ran yin aiki na tsawon sa'o'i hudu a rana ko 20 a mako har sai an sanar da mu.
Ba mu sanar da izinin hutu ba - idan za ka iya aiki a lokacin da aka saba, aikin zai iya amfani da kai.
Duk da haka, ba za a iya sanin yadda duniya za ta kasance ba, ko kana bukatar ka kula da ƙaunatattunka, ko ka sayi kayan dafa abinci, ko ka je wurin likita, lafiyarka ita ce abin da muke fifitawa.
Ba za mu rubuta lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Bai kamata a gaya masa ba, amma mun gaya masa.
Babu bukatar ranar rashin lafiya ko PTO - kawai ka gaya wa manajanka kuma ka taimaka wa tawagarka ta sake duba kalandar da jadawalin don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan an gano cewa ka kamu da COVID-19, ka sanar da Bryan a T&C Ops don T&C ta taimaka wajen tallafa maka da kuma tabbatar da cewa kana samun kulawa mai kyau daga gudanarwa.)
Waɗanda aka biya su bisa sa'a za a biya su a cikakke.
Mun sanar da kuma tabbatar da cewa muna da tabbacin girmama alkawuran da 'yan kwangila da abokan aikinmu suka yi.
Kowane mutum zai sami albashinsa bisa ga sa'o'in aikinsa na yau da kullum.
Wannan ya hada da idan kana rashin lafiya kuma ba za ka iya aiki ba.
Idan kana son aiki, muna goyon bayan ku.
Mutane da yawa suna amfani da aikin su wajen ba da gudummawar kansu ga duniya.
Abin da muke yi zai iya sa mu farin ciki sosai, musamman ma a irin wannan lokacin.
Bugu da ƙari, yana da game da kula da kanka.
Muna rokon ka ka yi magana da manajanka don mu san abin da za mu yi tsammani kuma mu daidaita shi yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole ne mu ci gaba da tafiya.
Ƙungiyoyin SRE, HR Ops, Trust & Safety, da kuma Fundraising (duka) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin taimako.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu kuma mu mayar da hankalinmu ga tallafawa abin da ke da muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za mu yi domin dukanmu, za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan ka jinkirta yanzu ba za ka yi wa wani lahani ba.
Ba mu da shirin yin "biyu" don bin abin da ya rage a lokacin da annoba ta wuce.
Ba a sa ran ka yi aiki na dogon lokaci don ka cika wannan kwanan wata da ba ta dace ba.
Mun amince cewa yanayin ya canja, kuma za mu yi ƙoƙari mu kafa sababbin manufofi da kuma jadawalin lokacin da ya dace.
Menene ya faru da APP?
Don daidaitawa da ainihin gaskiyarmu da kuma tsammanin lokutan aiki na yau da kullum, muna son daidaita jadawalin lokacin gabatar da Shirin Shekararmu na 2020-2021.
Muna son mu ba da shawarar ci gaba da shirin 2019-2020 wanda zai ba da ƙarin lokaci ga kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga aiki mai mahimmanci, kula da kansu da kula da ƙaunatattun su yayin da suke taimaka wa waɗanda suke buƙatar ko so su yi aiki tare da rage yawan aiki na makonni masu zuwa.
Ƙaddamar da jadawalin lokaci yana rage yawan aiki da kuma matsa lamba a kan tsarin da ke gudana a cikin dukan ƙungiyoyi.
Za mu gabatar da shawarwarinmu ga hukumar mako mai zuwa kuma za mu sanar da wakilan da kuma tawagar game da matakan da za su biyo baya da zarar mun samu tabbaci.
Na gode wa tawagar APP don jagorancinku a wannan batun.
Matsayin ofishin, fallasawa da tsabtace
A makon da ya gabata, an sanar da mu cewa wani abokin aikinmu na SF na iya kamuwa da cutar COVID-19.
Amma, a matsayin wani mataki na taka tsantsan, mun dauki wani jami'in tsabtace rigakafi don ya kwantar da hankali a fadin ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafi na asibiti don yin amfani da su a kan kowane farfajiyar da kuma ɗakin kwana da kuma tsarin lif da suka kai mu.
Wannan ginin yana amfani da takaddun shaida na aikin kulawa na musamman wajen amfani da kayayyakin da ke tallafawa lafiyar mazauna.
Mun ji dadi cewa ofishin zai zama samuwa da kyau a lokacin da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork, wanda ke raba yarjejeniyar COVID-19 tare da mu da kuma duk ma'aikatanmu na DC.
Har zuwa makon da ya gabata, ofishinmu na DC ya koma kan tsarin nesa gaba daya daidai da jagorar da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu suka sani, muna magana ne game da yin hayar wani wuri a Brooklyn.
Wannan tattaunawar tana ci gaba amma za a iya jinkirta ta.
Wasu abokan aikinmu sun yi aiki a nesa a karon farko.
Abokan aiki na nesa mun san cewa zai iya zama daidaitawa kuma muna so mu ba ku wasu shawarwari:
Ka rage tsawon taron na sa'a ɗaya ko biyu.
Idan ana bukatar ƙarin lokaci, ka yi la'akari da yadda za ka raba shi zuwa kwanaki da yawa.
Ka sa taron ya kasance a bayyane, ka shirya abin da za a yi a kai a kai kuma ka aika da littattafan da za a karanta.
Yi bidiyo ta tsohuwa, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Yana da shugaban da zai gudanar da kowane taro, wani ya lura da masu magana don tambayoyi da kuma sa ido kan jerin masu magana, kuma wani ya taimaka wajen yin rubutu (ko yin rubutu tare).
Aika imel zuwa goyon bayan fasaha idan kana bukatar wani m headphone.
Yi amfani da kuɗin kuɗin ku don abincin dare.
Ka shiga tashar #remoties a Slack don ka yi magana da abokan aikinka game da aikin da aka ba ka
Ƙungiyar HR Operations tana duban jagorar yanar gizo na ergonomic don tallafawa haɓaka a cikin ayyukan da aka rarraba a duk faɗin Foundation.
A cikin 'yan makonnin nan mun nemi duk masu karbar tallafin al'umma su soke ayyukan jama'a da Wikimedia ke tallafawa, kamar editaton har sai WHO ta sanar da kawo karshen annobar.
Mun gaya musu cewa mun fahimci cewa bukatarmu ta sokewa da kuma wasu takunkumi na iya zama da wuya a kammala ayyukan tallafi da suka amince da su kuma babu wanda za a yi masa hukunci saboda jinkiri ko sauya manufofin.
A mako mai zuwa za mu yi wani shiri na gaba da ƙarin bayani game da Wikimania da kuma sauran taron yanki da kuma al'amurran da suka shafi.
Jin daɗin da ke tsakanin al'ummomin duniya duka ya nuna cewa suna baƙin ciki game da rikice-rikice amma suna jin daɗin bayyanar da kuma ikon mayar da hankali ga al'ummomin kansu, Wikimedia da kuma akasin haka.
A gaba, CRT na kokarin samar da wani shafi game da Meta-Wiki domin samar da sarari ga al'umma don lura da tasirin da kuma bin hanyoyinmu na sadarwa da su.
Kasancewa tare kan batutuwan da suka shafi COVID-19
Za mu aika da gayyata zuwa kalandarku na gaba Alhamis, a 14:00 UTC/07:00 PT ga wani taro na musamman na ma'aikata.
Za mu yi amfani da wannan lokaci don raba ƙarin sabuntawa, amsa tambayoyinku kuma mu ɗauki ɗan lokaci don mu haɗa kai.
Muna aiki tare a wannan batun kuma muna nan don taimakawa gwargwadon iyawarmu.
A yanzu haka, za ku iya ci gaba da neman bayanai daga wannan imel ɗin, da kuma duk sauran bayanai masu muhimmanci game da COVID-19 a kan Office Wiki.
CRT za ta tabbatar da cewa duk waɗannan shafuka suna da sabuntawa kuma duk bayanan suna cikin wuri ɗaya.
Muna kuma kokarin tabbatar da sadarwa ta yau da kullum da ma'aikatan da ke cikin kasashen da suka fi fama da cutar a yanzu.
Idan kana da wata tambaya game da tafiya, wani abu, wata babbar hanyar aiki, ko kuma kalubale na ɗaukar hoto, ko duk wani taimako da kake bukata, kada ka yi jinkirin sanar da shi kuma ka yi aiki tare da CRT.
Muna nan don taimaka wajen samar da tallafi da kuma kasancewa a cikin hanyar sadarwa idan an buƙata.
Idan kana da wani abu mai ban mamaki ko kuma mai mahimmanci, ka aika wa Bryan Judan, Darakta na Ayyukan HR na Duniya.
Babu wani canji da ya kamata a ɗauka a matsayin watsi da aikinmu da kuma hakki.
Duk da haka, duk wannan sanarwa ce a yanzu, aikinmu da kuma alhakinmu na iya zama dole a daidaita su a hanyoyi da ba a taɓa yin su ba.
Waɗannan su ne matakan da muka yi imani da cewa wajibi ne mu goyi bayan juna domin mu ci gaba da aiki, mu samar da motsinmu da goyon bayan da suke bukata, da kuma hidimar duniya da za su iya sa ran.
Ayyukanmu na yau da kullum za su kasance a wurin don su jira mu a lokacin da ya dace.
A yanzu haka, wannan alama ce ta tallafa wa juna da kuma samar da sarari ga muhimman ayyuka da za su zo a cikin makonni da watannin da za su zo.
Muna bukatar ku yi hakan, kuma muna bukatar ku kula da kanku da iyalanku don ku kasance a shirye a lokacin da hakan zai faru.
Yanzu, don Allah - wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M da Tony S) da sauransu a cikin tawagar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Angiotensin-converting enzyme 2 (ACE2) wani enzyme ne wanda ke haɗe a farfajiyar (membrane) sel a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana fuskantar aikin angiotensin-transforming enzyme (ACE) wanda ke da alaƙa da rage yawan angiotensin-II da haɓaka Ang(1-7) yana mai da shi magani mai yiwuwa don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin cibiyar shiga cikin kwayoyin halitta don wasu coronavirus.
An kira juyin mutum na enzymes hACE2 sau da yawa.
Anjin mai canza angiotensin 2 shine zinc wanda ke dauke da metaloenzyme wanda yake a saman endothelium da sauran sel.
Protein ACE2 yana dauke da yankin M2 na N-terminal peptidase da kuma yankin mai dauke da renal amino acid na C-terminal colectin.
ACE2 wani furotin ne mai nau'i na membrane mai hanya guda 1, tare da yankin enzymes da ke aiki a kan farfajiyar sel a cikin huhu da sauran kayan.
Ƙarƙashin ƙwayoyin ACE2 suna haɗe daga yankin transmembrane ta wani enzyme da ake kira sheddase, kuma an saki furotin mai narkewa cikin jini kuma a ƙarshe an tattara shi zuwa fitsari.
ACE2 yana cikin yawancin gabobin: ACE2 yana bin membrane na yawancin ƙwayoyin alveolus na huhu na II, ƙwayoyin gut, arteries da endothelial venous cells da kuma ƙwayoyin jijiyoyin jini a cikin yawancin gabobin.
Hakanan ana samun bayyanar mRNA ACE2 a cikin ƙwaƙwalwar ƙwaƙwalwa, striatum, hypothalamus da kuma kwakwalwa.
Babban aikin ACE2 shine ya zama mai daidaitawa ga ACE.
ACE ta haɗa hormone na angiotensin I zuwa cikin narkewar angiotensin II.
ACE2 a madadin haka yana ɗaure phenylalanine amino acid carboxylic-terminal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyzing shi zuwa vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya haɗa wasu wasu peptide ciki har da [des-Arg9]- bradykinin, apelin, neurotensin, dinorphine A da ghrelin.
ACE2 kuma yana sarrafa rarraba membrane na amino acid SLC6A19 wanda ba shi da amfani kuma an nuna shi a cikin cutar Hartnup.
A matsayin furotin mai transmembrane, ACE2 yana aiki a matsayin babban cibiyar shiga cikin kwayoyin halitta don wasu coronavirus ciki har da HCoV-NL63; SARS-CoV (virus mai haifar da SARS); da SARS-CoV-2 (virus mai haifar da COVID-19).
Musamman, haɗi zuwa furotin S1 na SARS-CoV da SARS-CoV2 a cikin yankin enzymatic na ACE2 a saman sel surface yana haifar da endosytosis da kuma translocation na ƙwayoyin cuta da enzymes zuwa endosomes located tsakanin sel.
Tsarin shigarwa kuma yana buƙatar haɓakar furotin S ta hanyar kwayar cutar TMPRSS2 mai kwakwalwa, mai haɓaka a cikin binciken da ake yi a yanzu a matsayin mai yiwuwa magani. Wannan ya sa wasu suka yi tunanin cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen magance kamuwa da cuta.
Duk da haka, kungiyoyi da hukumomi da dama sun bada shawarar ci gaba da ingantaccen ACE da kuma maganin ARB.
A tsarin nazari da kuma meta-analysis da aka buga a ranar 11 ga Yuli, 2012 ya gano cewa "amfani da ACE inhibitors an danganta shi da raguwa mai girma 34% a cikin hadarin cutar pneumonia idan aka kwatanta da na iko".
Bugu da ƙari, "hadarin kamuwa da cutar ta huhu ya ragu ga marasa lafiya da ake bi da su da ACE mai tsawo waɗanda ke da haɗarin kamuwa da cutar ta huhu, musamman waɗanda ke fama da bugun jini da kuma rashin karfin zuciya.
Amfani da ACE spraying ya kuma yi alaƙa da rage yawan mutuwar da ke tattare da cutar huhu, ko da yake sakamakon ya kasance ba shi da ƙarfi a kan haɗarin cutar huhu gaba ɗaya".
Ana ganin sake haɗuwa da ACE2 (rhACE2) a cikin mutane shine sabon magani don rauni na huhu, kuma yana da alama yana haɓaka haemodynamics na huhu da kuma iskar oxygen a cikin alade tare da cutar lipopolysaccharide ta cutarwa ta cutarwa.
Rayuwar rabi na rhACE2 a cikin mutane ita ce sa'o'i 10 kuma farkon aikin shine minti 30 a cikin kari ga aikin sakamako (lokaci) na awanni 24.
Wasu binciken sun nuna cewa rhACE2 na iya zama magani mai yiwuwa ga waɗanda ke da rashin haƙuri a cikin tsarin angiotensin renin classic (RAS) ko a cikin cututtuka da ke kewaye da angiotensin II da aka inganta. An yi nazarin rhACE2 infusion a cikin nazarin asibiti don maganin cutar ta fama da cutar ta respiratory stress syndrome.
Aikace-aikacen b'COVID-19 aikace-aikace ne na wayar hannu wanda aka tsara don taimakawa bin diddigin hulɗa a cikin martani ga annobar coronavirus 2019-20, wanda shine tsarin gano mutanen da suke da alaƙa ("taɓawa") waɗanda zasu iya kasancewa tare da mutanen da suka kamu.
Ana samar da aikace-aikace da yawa ko kuma ana ba da shawarar su tare da goyon bayan jami'an gwamnati a wasu yankuna da yankuna.
An riga an gina wasu tsarin da za su iya yin amfani da su wajen bin diddigin hanyoyin sadarwa.
An yi ta daɗaɗɗen damuwa game da sirrin sirri, musamman game da tsarin da ke bin diddigin yanayin yanayin aikace-aikacen mai amfani.
Sauran hanyoyin da ba su da matsala sun haɗa da amfani da siginar Bluetooth don yin rikodin bayanan kusanci na mai amfani akan sauran wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan don tallafawa aikace-aikacen Bluetooth kai tsaye zuwa tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da Alipay, ta kaddamar da wani aikace-aikace wanda ke ba 'yan kasar damar duba ko sun taba yin hulɗa da wadanda suka kamu da COVID-19.
Ana amfani da shi a birane sama da 200 a kasar Sin. A Singapore, ana amfani da wani app da ake kira TraceTogether.
Kungiyar IT ta kasar ta Arewa ta yi amfani da aikace-aikacen da ake kira "StopKorona!", wanda ke da amfani da Bluetooth don gano yadda za a iya yin amfani da su ga mutanen da ke da cutar.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Kiwon Lafiya ne suka samar da wannan aikace-aikacen.
Har zuwa 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin haɗi yana cikin ci gaba da ci gaba, kuma zai kasance a cikin 'yan makonni don ƙaddamarwa.
Australia da New Zealand suna la'akari da aikace-aikacen bisa ga aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na son gabatar da aikace-aikacen geobates ga marasa lafiya da aka gano suna da COVID-19 da ke zaune a Moscow, an tsara su don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa a jami'ar Cambridge, ya lissafa wasu matsaloli masu amfani da tsarin da aka yi amfani da su, ciki har da kuskuren kuskuren da yiwuwar rashin tasiri idan aikace-aikacen aikace-aikacen ya iyakance ga ƙananan ƙananan al'umma.
Don magance damuwar game da yaduwar "sawu" ko kuma cutarwa, Apple ya sanya iyaka ga nau'ikan kungiyoyi da zasu iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, yana iyakance su ga "masu iko" kawai ko kuma manyan kungiyoyi.
Google da Amazon sun sanya wannan takunkumin.
Masu fafutukar tsare sirri sun bayyana damuwarsu game da tasirin saka idanu na jama'a ta amfani da aikace-aikacen coronavirus, musamman game da ko an kirkiro kayan aikin saka idanu don magance cutar coronavirus za a dakatar da su da zarar barazanar ta wuce.
Amnesty International da fiye da kungiyoyi 100 sun fitar da sanarwa suna neman a takaita irin wannan sa ido.
Ƙungiyoyi sun bayyana abubuwa takwas da za su shafi ayyukan gwamnati:
Dole ne a yi "doka, idan ya cancanta kuma a hankali";
Ƙarin kulawa da kulawa dole ne ya ƙunshi sharuɗɗa masu zurfi;
amfani da bayanai ya kamata a iyakance ga manufar COVID-19;
Ana buƙatar tabbatar da tsaro da kuma tabbatar da tsaro na bayanai.
Ana kuma bukatar a yi amfani da wannan hanyar wajen tabbatar da cewa an yi amfani da wannan hanyar wajen yin amfani da bayanan sirri.
duk wani raba bayanai tare da wasu kamfanoni dole ne a bayyana shi a cikin doka;
ya kamata a kare shi daga cin zarafi da kuma hakkin 'yan kasa na amsawa ga cin zarafi;
Ya kamata a bukaci a yi amfani da dukkanin "kasashen da suka dace" don yin aiki, ciki har da masu kula da lafiyar jama'a da kuma kungiyoyin da ba su da ilimi.
Shawarwarin shirin Google/Apple na nufin magance matsalolin ci gaba da saka idanu ta hanyar cire hanyoyin bin diddigin daga tsarin aiki na na'urorin su da zarar ba su da mahimmanci.
Wasu ƙasashe suna amfani da bin diddigin wuri bisa hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatun saukar da aikace-aikace da ikon guje wa bin diddigin.
A Isra'ila, an amince da bin diddigin da aka yi amfani da su.
Maganin da ke kan hanyar sadarwa wanda ke da damar yin amfani da bayanan wuri na asali yana da babbar matsalar sirri.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwar ba ne ya kamata su sami damar yin amfani da bayanan wuri na sirri; an riga an kirkiro wasu tsarin kiyaye sirrin da ke amfani da cibiyar sadarwar kawai don sadarwa tare da juna (duba sashe na ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da aka yi amfani da shi wajen bin diddigin sadarwa.
Maimakon amfani da aikace-aikacen da aka tsara, tsarin yana tattara bayanan bin diddigin daga tushe daban-daban ciki har da bayanan bin diddigin wayar hannu da bayanan ma'amala na katin, kuma haɗuwa da duk wannan yana samar da sanarwa ta hanyar saƙon rubutu ga mutanen da ke da damar kamuwa da cutar.
Baya ga amfani da wannan bayanin don yin gargadi ga masu iya tuntuɓar, gwamnati ta kuma ba da bayanan wurin ga jama'a, wani abu da aka ba da izini saboda canje-canje masu yawa a cikin dokokin sirrin bayanai bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin a cikin aikace-aikace da kuma shafukan yanar gizo. Kasashe ciki har da Jamus suna la'akari da amfani da tsarin ci gaba da tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a sanar da cikakken bayani ba.
Tallafawa da alaƙa da kiyaye sirrin wani ra'ayi ne da aka tsara tare da mahimman littattafan binciken jiki tun daga 2013. Har zuwa 7 ga Afrilu, 2020, fiye da dozin ƙungiyoyin masana suna aiki don magance matsalar sirrin sirri kamar amfani da Bluetooth Low Energy (BLE) don logs na kusanci na mai amfani akan wasu wayoyin salula.
Duk da haka, PEPP-PT wani shiri ne na daidaitawa wanda ya ƙunshi cibiyar da keɓaɓɓen tsarin, ba yarjejeniya guda ɗaya ba.
A cikin wannan yarjejeniya, bayanan sirri da aka gano ba su taɓa barin na'urar ba, kuma duk bayanan suna faruwa akan na'urar.
Kungiyar Tsare Sirri ta MIT Media Lab tana ci gaba da inganta SafePaths, dandamali don amfani da fasahar tsare sirrin lokacin tattarawa da amfani da wurare ko bayanan juna don bin diddigin yaduwar COVID-19.
Wannan ya dogara ne akan binciken da aka samu daga takardar farin "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic" da aka buga a watan Maris 2020.
SafeTrace yana amfani da fasahar tsaro ta kayan aiki don ba masu amfani damar raba wurare masu mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi, ba tare da yin tasiri ga sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, TCN Coalition ta duniya ta kafa ta ne ta hanyar wasu kungiyoyi da suka hada kai kan irin wannan muhimmin tsari da kuma manyan yarjejeniyar da aka matsa, tare da manufar rage rarrabuwa, da kuma ba da damar yin aiki a duniya ta hanyar aikace-aikacen bin diddigin da kuma gargadi, muhimman fannoni don cimma amfani da yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta riga ta sanya bude tushen yarjejeniyar BlueTrace da aikace-aikacen gwamnati na yau da kullun ke amfani da ita.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke kula da dandamali na Android da iOS, sun sanar da wani shiri don bin diddigin alaƙar da suka yi zargin za su kiyaye sirrin, bisa ga haɗuwa da fasahar Bluetooth Low Power da kuma sirrin kiyaye sirrin.
Sun kuma buga takamaiman fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin yana nufin a kaddamar da shi a matakai uku:
kaddamar da kayan aiki don ba da damar gwamnati ta ƙirƙiri aikace-aikacen bin diddigin coronavirus don kiyaye sirrin
Wannan aiki yana haɗuwa kai tsaye cikin iOS da Android shirin Google da Apple don magance matsalolin aiwatarwa da ci gaba da saka idanu ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, sannan fitar da shi ta hanyar da ta dace da barazanar ta wuce.
Sake sanya magani (wanda aka fi sani da canza manufar magani, sake tsarawa, sake sanyawa ko musayar magani) shine canza manufar magani wanda aka amince dashi don magance wata cuta daban-daban ko yanayin kiwon lafiya daga dalilin da yasa aka fara shi.
Wannan wani bincike ne na kimiyya da ake gudanarwa don bunkasa ingantacciyar magani ga COVID-19.
Sauran manufofin bincike sun hada da ci gaban allurar COVID-19 da kuma canja wurin plasma na farfadowa. SARS-CoV-2 yana da kimanin sunadarai 66 masu magani, kowannensu yana da wuraren da ke ɗaure da ligand.
Binciken shafin ya samar da wani shiri mai ma'ana don bunkasa maganin rigakafi mai tasiri akan furotin COVID-19.
Daga cikin yawancin sunadarai masu mahimmanci na SARS-CoV-2 sune proteases kamar papain, RNA dependent polymerase, helikase, S protein da ribophosphatease ADP.
Hussein A, et al sun yi nazarin wasu kwayoyin da aka yi amfani da su a baya kuma suka yi nazari akan su don su kasance da daidaituwa da kwayoyin da aka amince da su a matsayin mafi girma don hanzarta ci gaban magungunan anti-SARS-CoV-2 masu ƙarfi a cikin binciken su na preclinical don a ba da shawarar a cikin tsarin binciken asibiti.
Chloroquine magani ne na antimalaria wanda ake amfani dashi wajen yaki da wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine masu alaƙa za su kasance daga cikin magunguna huɗu da ake nazari a matsayin wani ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da hydroxychloroquine sulfate da chloroquine phosphate a karkashin Dokar Amfani da gaggawa (EUA).
Magunguna ba su da amincewa ta hanyar gwajin gwaji na FDA kuma an yarda da su a ƙarƙashin EUA kawai a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya da aka kwantar da su asibiti amma ba za su iya karɓar magani a cikin gwajin gwaji ba.
CDC ta ce "amfani, sashi, ko tsawon hydroxychloroquine don rigakafi ko maganin kamuwa da SARS-CoV-2" bai zo ba tukuna.
Likitoci sun ce suna amfani da maganin ne a lokacin da "ba su da wani zaɓi".
Wani rukuni na masu bincike na Turkiyya a Istanbul na gudanar da wani karamin bincike kan amfani da chloroquine tare da hadewar zinc, bitamin A, bitamin C da bitamin D.
Akwai manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Makarantar likitancin NYU Langone tana gudanar da gwaji kan amincin da ingancin maganin hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun ce favipiravir "yana da tasiri sosai".
A Shenzhen, mutane 35 sun kamu da cutar a matsakaici na kwanaki hudu, yayin da marasa lafiya 45 da ba su kamu da cutar ba sun kamu da cutar a kwanaki 11.
A wani bincike da aka gudanar a Wuhan a kan mutane 240 da ke fama da cutar huhu, an ba rabin su favipiravir kuma an ba rabin su umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa akwai karancin shaidu a yanzu da kuma farkon shaidar da ke tallafawa maganin.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magungunan daga Japan don adanawa kuma ta yi amfani da sojoji don aika magungunan zuwa asibitocin jami'a, wanda zai yi amfani da su wajen kula da marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya sauya ra'ayin gwamnatin Trump game da sayen magunguna. Magungunan na iya zama marasa tasiri a cikin mummunan cututtuka lokacin da cutar ta ninka.
Wataƙila ba shi da lafiya ga mata masu ciki ko waɗanda suke ƙoƙarin yin ciki.
Wani bincike na lopinavir/ritonavir (Kaletra), wani hadewar maganin maganin maganin maganin maganin lopinavir da ritonavir, ya ce "ba a lura da wani abu mai kyau ba".
An tsara miyagun ƙwayoyi don nuna cutar HIV maimakon yin kama da shi ta hanyar ɗaure shi zuwa protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado na kokarin canza magungunan don gano wani fili wanda zai yi aiki tare da protease na SARS-CoV-2. Akwai zargi a cikin al'ummar kimiyya game da hana albarkatu don canza manufar magungunan da aka haɓaka musamman don HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ta ci gaba da gano cewa Remdesivir yana da aikin riga-kafi na in vitro a kan kwayoyin cutar filo-, pneumo-, paramyxo- da corona-virus.
Wata matsala da maganin rigakafi yake da ita ita ce nuna juriya ta hanyar maye gurbin da zai iya haifar da cutar da kuma mummunan ƙwayar cuta.
Wasu binciken da aka yi kafin a fara gwajin sun nuna cewa remdesivir na iya samun babban hanawar kwayoyin halitta ga juriya. Akwai wasu gwaji na asibiti a yanzu ciki har da biyu da Cleveland University Hospital ke gudanarwa; daya ga mutanen da ke da cututtuka masu matsakaici da kuma wani ga waɗanda ke da cututtuka masu tsanani.
Akwai gwaji uku na asibiti da ake gudanarwa na bitamin C na intravenous ga wadanda aka kwantar da su asibiti kuma suna da matukar rashin lafiya da COVID-19, placebo biyu na sarrafawa (China, Kanada) da kuma daya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) na shirin yin gwaji na asibiti don Teijin's Alvesco (ciclesonide), wani corticosteroid mai tsotsa don asma, don magance marasa lafiya masu cutar da cutar coronavirus.
Wani nau'i na angiotensin-transforming enzyme 2, wani gwaji na Phase II da ake gudanarwa a kan marasa lafiya 200 da aka zaɓa daga asibitoci masu tsanani a Denmark, Jamus da Austria don sanin tasirin magani.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada suna nazarin rawar da colchicine ke takawa wajen rage cututtukan kumburi da kumburi a cikin marasa lafiya da ke fama da bayyanar cututtukan COVID-19.
A binciken da ake kira COLCORONA, an dauki manya 6000 masu shekaru 40 zuwa sama da suka kamu da COVID-19 kuma suna da alamun rashin lafiya wadanda ba sa bukatar asibiti.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba su da maganin hana haihuwa masu tasiri ba su cancanci yin hakan.
Ana gwada wasu magungunan rigakafi a Italiya.
Ana amfani da ƙananan nauyin heparin a cikin maganin marasa lafiya, wanda ya sa Hukumar Kula da Magunguna ta Italiya ta wallafa jagororin amfani da shi.
An sanar da wani bincike mai zurfi a kan marasa lafiya 300 da ke nazarin amfani da sodium enoxaparin a cikin maganin rigakafi da magani a Italiya a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 kwayar cuta ce, an mayar da hankali sosai ga ilimin kimiyya kan sauya manufofin maganin rigakafi da aka amince da su don dalilai na annobar kamar MERS, SARS da West Nile virus.
Ribavirin: ana ba da shawarar ribavirin don maganin COVID-19 bisa ga jagorar kasar Sin ta 7
Umfenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga jagorar kasar Sin ta 7
An gano wasu kwayoyin cutar a matsayin masu canza manufa na yiwuwar maganin COVID-19:
Tocilizumab (Anti-IL-6 Receptor): An amince da shi a kasar Sin.
Hakanan an gwada a Italiya da China, kuma ga Tocilizumab #COVID-19.
Allurar rigakafin COVID-19 ita ce allurar rigakafin cutar coronavirus 2019 (COVID-2019).
Ko da yake babu wani magani da ya kammala gwajin asibiti, akwai gwaji da yawa a ci gaba don ci gaba da yin maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin allurar rigakafin SARS-CoV-2, cutar da ke haifar da cutar, za ta kasance a cikin ƙasa da watanni 18.
Mutane biyar da suka cancanta su yi allurar rigakafi sun shiga cikin binciken tsaro na Phase 1 a watan Afrilu.
An gano COVID-19 a watan Disambar 2019.
Babban annobar ta duniya a shekarar 2020, ta ba da damar saka hannun jari da ayyukan bincike masu hankali don haɓaka allurar rigakafi.
Yawancin kungiyoyi suna amfani da kwayoyin halitta da aka buga don haɓaka allurar rigakafi da za a iya yi wa SARS-CoV-2.
An bayyana a watan Afrilu, muhimmancin shirin CEPI don hanzarta ci gaban allurar rigakafi, samar da iya aiki, aiwatar da shi a kan sikelin da kuma samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ruwaito cewa dandamali 10 daban-daban na fasaha suna karkashin bincike da ci gaba a farkon shekarar 2020 don ƙirƙirar allurar rigakafin COVID-19.
Babban dandamali da ke niyya don ci gaba da binciken tsaro na Phase I ya hada da:
nucleic acid (DNA da RNA) (Fasa 1 masu tasowa da kuma masu neman allurar rigakafi: Moderna, mRNA-1273)
masu ɗaukar hoto na cutar (Fasa na I na masu haɓakawa da masu neman allurar rigakafi: CanSino Biologics, adenovirus vector nau'i 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, adadin masu neman rigakafin 115 suna cikin matakai na farko na ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da kuma sauran 37 da aka sanar, amma tare da karancin bayanan jama'a da ake samu (da ake zaton suna cikin shiri ko kuma suna cikin zane).
Gwaje-gwaje na I-II sun gudanar da gwajin farko na aminci da rigakafi, yawanci bazuwar, placebo-controlled da multi-site, yayin da suka ƙayyade maganin da ya fi dacewa.
Gwaje-gwaje na III na yawanci sun ƙunshi ƙarin shiga ciki har da ƙungiyar kulawa da tasirin gwajin a kan allurar rigakafi don hana cututtuka, yayin da ake sa ido ga mummunan sakamako a mafi kyawun sashi.
Daga cikin masu neman rigakafin 79 da ke ci gaba da aiki (wanda aka ware a farkon Afrilu 2020), 74 har yanzu ba su cikin kimantawar mutum ba) har yanzu suna cikin binciken "preclinical").
A ranar 24 ga Janairu, 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayoyin da za ta iya canza furotin na kwayar cutar ta hanyar kwayoyin halitta don karfafa aikin rigakafi.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da ci gaba da aikin allurar rigakafi, da nufin fara gwajin mutum a shekara ta 2021.
An sanar da aikin ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cutar China a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanonin Pharmaceutical na Janssen, karkashin Hanneke Schuitemaker, sun sanar da cewa sun fara aikin samar da allurar rigakafi.
Janssen na ci gaba da samar da allurar baki tare da Vaxart, abokin aikinta na fasaha.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa takarda kan ƙirar allurar rigakafi tare da fasahar da ake amfani da ita don maganin allurar neoantigen na cutar kansa.
A ranar 25 ga watan Maris, shugaban cibiyar ta sanar da cewa sun kammala tsarin allurar rigakafi kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani kamfanin mallakar Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin yin allurar rigakafi don ƙirƙirar allurar li-Key peptide na COVID-19.
Suna son samar da allurar rigakafi da za a iya gwadawa a jikin mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da aikinta na bunkasa allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Nazarin Sojojin Amurka da Kayan Aikin Likita a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna aiki kan allurar.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta yi aiki tare da Novavax Inc.
a cikin ci gaba da samar da alluran rigakafi.
Wadannan abokan tarayya sun sanar da shirye-shiryen su na gwaji na farko da Phase I na gwaji na asibiti ta Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki da kwayoyi 11 wadanda duk da cewa a kan hanyar sauri zai dauki aƙalla shekara daya da rabi zuwa shekaru biyu don haɓaka allurar.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere a Quebec City, Quebec, ya ba da rahoton ci gaban kwayoyin halitta kamar coronavirus a karkashin wani ɓangare na asusun Cibiyar Nazarin Lafiya ta Kanada.
Masu neman allurar rigakafi suna cikin binciken dakin gwaje-gwaje, tare da gwajin mutum da aka tsara a watan Yuli ko Agusta 2020.
A farkon makon nan, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac "duka kudade don samun damar yin amfani da allurar Covid-19", kuma gwamnatin Jamus ta yi hamayya da hakan.
A ranar 17 ga Maris, 2020, kamfanin likitancin Amurka Pfizer ya sanar da hadin gwiwa tare da kamfanin BioNTech na Jamus don hada gwiwa wajen bunkasa allurar rigakafin da ke kan mRNA.
Masu neman allurar rigakafi ta mRNA BNT162, a halin yanzu suna cikin gwaji na farko yayin da ake sa ran gwajin gwaji zai fara a watan Afrilu 2020.
A ranar 17 ga Maris, 2020 a Italiya, Takis Biotech, wani kamfanin kimiyyar halittu na Italiya ya sanar da cewa za su sami sakamakon gwajin gwaji a watan Afrilu na 2020 kuma za su iya fara gwajin mutum na karshe na allurar su a cikin kaka.
A ranar 19 ga Maris, 2020 a Faransa, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 ga wata kungiya ta bincike kan allurar COVID-19 da ta hada da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kawo adadin saka hannun jari na CEPI a ci gaban allurar COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na masu neman allurar rigakafi guda shida.
Masu binciken Imperial College London sun sanar a ranar 20 ga Maris, 2020 cewa suna ci gaba da samar da allurar RNA mai karfafa kanta don COVID-19.
An yi amfani da allurar rigakafi a cikin kwanaki 14 bayan karbar takardar shaidar daga kasar Sin.
A karshen watan Maris, gwamnatin Kanada ta sanar da kudade na C$275 miliyan don aikin bincike kan matakan rigakafin likita ga COVID-19, ciki har da masu neman allurar rigakafi da yawa a kamfanoni da jami'o'in Kanada kamar Medicago da kuma yunƙurin Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta sanar da cewa za a ba da dala miliyan 192 don samar da allurar COVID-19, tare da shirin kafa "tashar allurar" ta kasa daga wasu sabbin alluran da za a iya amfani da su idan wani annobar coronavirus ta faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoto game da gwajin PittCoVacc, wani yaduwar COVID-19 a cikin beraye, suna cewa "MNA ta ba da allurar SARS-CoV-2 S1 wanda ke haifar da amsa mai ƙarfi na antigen-specific antibody response [a cikin beraye] wanda aka tabbatar ya fara makonni 2 bayan rigakafi".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da ƙirar takarar allurar rigakafi ta DNA a matsayin yiwuwar maganin hanci.
Ta amfani da kwayoyin cuta, za a tsara DNA don kwaikwayon kwayoyin mutum don samar da ƙwayoyin cuta kamar ƙwayoyin cuta marasa lahani, wanda zai iya ƙarfafa tsarin garkuwar jiki don samar da rigakafi da cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun haɗa albarkatu don samun damar supercomputing daga IBM, tare da albarkatun girgije daga Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako na heterologous, wanda ake kira sakamako na non-specific.
Wannan yana nufin cewa za su iya samun amfanin da ya fi na cututtukan da suke hanawa.
A gwajin da aka yi a Ostiraliya, an yi niyyar yin rajistar ma'aikatan kiwon lafiya 4,170.
Akwai yiwuwar cewa alluran da ake ci gaba da samarwa ba su da lafiya ko tasiri.
Binciken farko don tantance tasirin allurar rigakafi ta amfani da samfurin dabba na COVID-19 na musamman kamar su ACE2 transgenic mice, sauran dabbobi na dakin gwaje-gwaje da kuma primates ba mutane ba, ya nuna buƙatar matakan hana kariya ta 3 don sarrafa kwayar cutar mai rai, da kuma daidaitaccen duniya don tabbatar da daidaitattun hanyoyin tsaro.
An gwada rigakafin SARS da MERS a cikin samfurin dabba ba mutum ba.
A shekarar 2020, babu wani maganin warkarwa ko kariya ga SARS da aka tabbatar da cewa yana da lafiya da tasiri a kan mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sabbin magungunan rigakafi da magunguna don magance SARS shine fifiko ga gwamnatoci da hukumomin kiwon lafiya na jama'a a duniya. Bugu da ƙari, babu wata allurar da aka tabbatar da rigakafin MERS.
Yayin da cutar ta MERS ta bazu, ana ganin cewa binciken SARS da ake yi a yanzu zai iya zama samfurin da zai taimaka wajen samar da allurar rigakafi da kuma maganin kamuwa da cutar MERS-CoV.
A watan Maris na 2020, akwai allurar rigakafin MERS (wanda ke dogara da DNA) wanda ya kammala gwajin gwaji na farko a cikin mutane, kuma wasu uku suna gudana, dukansu alluran rigakafin cutar ne, alluran adenoviral biyu (ChAdOx1-MERS, BVRS-GamVac), da kuma allurar MVA (MVA-MERS-S).
Labaran da aka yi a shafukan sada zumunta na inganta ka'idodin makirci da ke cewa an gano cutar a bayan COVID-19 kuma an riga an samu allurar rigakafi.
Patents da aka nakalto ta hanyar kafofin watsa labarun daban-daban suna nufin takardun da suka wanzu don tsara kwayoyin halitta da kuma alluran rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
Cutar b'Coronavirus 2019 (COVID-19) cuta ce mai kamuwa da cuta ta coronavirus cuta ta 2 ta matsanancin cutar numfashi (SARS-CoV-2).
Alamun bayyanar cututtuka sun haɗa da zazzabi, tari da kuma numfashi.
Sauran alamun za su iya kasancewa gajiya, ciwon tsoka, ciwon ciki, ciwon wuya, rashin jin ƙai da ciwon ciki.
Lokaci daga bayyanar har zuwa bayyanar cututtuka yana da kwanaki biyar amma yana iya farawa daga kwana biyu zuwa goma sha huɗu.
Yayin da yawancin cututtuka ke haifar da bayyanar cututtuka masu sauƙi, wasu sun ci gaba zuwa cutar huhu ta kwayar cuta da kuma rashin aiki na gabobin jiki.
Har zuwa 17 ga Afrilu 2020, an samu karin shari'o'i miliyan 2.24 a fadin kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar sama da 153,000.
Mutane sama da dubu 568 ne suka warke, kuma cutar tana yaduwa tsakanin mutane a lokacin da suke hulɗa da juna, sau da yawa ta hanyar saukad da da ke faruwa ta hanyar tari ko kuma yin magana.
Yayin da ake samar da waɗannan saukad da yayin numfashi, yawanci suna faɗuwa ƙasa ko sama maimakon yin kamuwa da cutar na nesa.
Mutane za su iya kamuwa da cutar ta hanyar taɓa ruɓaɓɓen farfajiyar da suka taɓa idanunsu, hancinsu ko bakinsu.
Kwayar cutar tana iya rayuwa a saman ƙasa har tsawon sa'o'i 72.
Mafi yawan kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan da suka biyo baya na cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suka yi zaton suna dauke da cutar da kuma masu kula da su.
Shawarwari game da amfani da abin rufe fuska ta hanyar jama'a ta yau da kullun sun bambanta, tare da wasu hukumomi suna ba da shawarar kada su yi amfani da shi, wasu suna ba da shawarar yin amfani da shi kuma wasu suna tilasta yin amfani da shi.
A halin yanzu, babu wani maganin rigakafi ko maganin cutar musamman don COVID-19.
An samu karuwar cutar a cikin gida a mafi yawan ƙasashe a duk yankunan WHO guda shida.
Waɗanda suka kamu da cutar za su iya zama marasa alamar cututtuka ko kuma su nuna alamun mura kamar zazzabi, tari, gajiya da kuma numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwo ko ciwon kirji na kullum, rikicewa, wahalar tafiya da fuska ko lebe mai launin shuɗi; ana ba da shawara a ba da shawara ga likita nan da nan idan waɗannan alamun suka bayyana.
Ba a yawan ganin ciwon sama ba kamar kumburi, hanci mai ruwa ko ciwon baya.
Ana lura da cututtukan gastrointestinal kamar naƙuda, kumburi da kuma ciwon ciki a cikin kashi da yawa.
Wasu daga cikin wadanda aka samu a kasar Sin sun fara nuna rashin bayanai da kuma bugun jini.
A wasu, cututtukan za su iya sa mutum ya kamu da cutar huhu, ya yi rashin aiki da gabobin jiki da kuma mutuwa.
Wannan shi ne lokacin da ake kira lokacin incuba.
Lokacin incuba don COVID-19 yawanci kwanaki biyar zuwa shida ne amma zai iya kasancewa daga kwana biyu zuwa 14.
Kashi 97.5 cikin 100 na marasa lafiya da ke nuna alamun cutar za su yi hakan a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda suka kamu da cutar ne ke nuna alamun cutar ba.
Ba a san cikakken matsayin wannan mai ɗaukar hoto a cikin canja wuri ba; duk da haka, shaidar farko ta nuna cewa yana iya taimakawa wajen yaduwar cutar.
Yawan wadanda suka kamu da cutar ba su nuna alamun bayyanar cututtuka ba kuma ana nazarin su, tare da Cibiyoyin Kula da Cututtuka na Koriya (KDCC) sun ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da cutar sun kasance marasa alamun cututtuka yayin da suke cikin asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada da marasa alamar cututtuka a cikin shari'arsu ta yau da kullum a ranar 1 ga Afrilu; daga cikin kamuwa da cutar 166 a ranar, 130 (78%) sun kasance marasa alamar cututtuka a lokacin gwaji.
Ƙura da saliva suna iya ɗaukar nauyin ƙwayoyin cuta.
Magana da ƙarfi tana ba da ƙarin saukad da fiye da magana ta al'ada.
Wani bincike a Singapore ya gano cewa rashin rufe baki zai iya sa mutum ya yi saukowa da ƙafafunsa har zuwa mita 4.5 (ƙafa 15).
Ko da yake ƙwayoyin cuta ba a haife su ba ne, amma National Academy of Sciences ta ba da shawarar cewa yiwuwar canja wurin bioaerosol da kuma samun iska a cikin wuraren da ke cikin hallway a waje da ɗakin jama'a ya nuna samfurin RNA mai kyau ga ƙwayoyin cuta.
Wasu hanyoyin likita kamar su intubation da cardiopulmonary resuscitation (CPR) na iya haifar da numfashi zuwa aerosol kuma daga bisani haifar da yaduwar ciki.
Ko da yake akwai damuwa cewa cutar ta yadu ta hanyar fitsari, an yi imanin cewa wannan hadarin yana da ƙananan. Kwayar cutar tana da matukar yaduwa idan mutum ba shi da alamun bayyanar cututtuka; ko da yake yaduwar na iya faruwa kafin bayyanar cututtuka, haɗarin yana da ƙananan.
Cibiyar Turai don Rigakafin Cututtuka da Kulawa (ECDC) ta ce duk da cewa ba a san yadda cutar ta iya yaduwa ba, mutum ɗaya yana kamuwa da mutane biyu zuwa uku a gaba ɗaya.
Musamman, an gano cewa ana iya gano kwayar cutar a rana ɗaya a kan katako, har zuwa kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), da har zuwa sa'o'i huɗu a kan 99% tagulla.
Amma, wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da kuma wankewa suna da tasiri idan aka yi amfani da su yadda ya kamata; samfurori na sabulu suna raunana ƙwayar ƙwayar cuta, suna shafe su kuma suna cire su daga fata da sauran farfajiyar.
Sauran magunguna kamar benzalkonium chloride da chlorhexidine gluconate (abin da ke hana cututtuka na tiyata) ba su da tasiri. A cikin wani binciken Hong Kong, an dauki samfurin saliva don matsakaici na kwanaki biyu bayan farkon asibiti.
A cikin mutum biyar cikin shida, samfurin farko ya nuna mafi yawan ƙwayar cutar, kuma mutum na shida ya nuna mafi yawan ƙwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus ta cutar ta 2 (SARS-CoV-2) ita ce sabuwar cutar coronavirus ta cutar ta 2 (CRS-2), wanda aka fara ware daga mutane uku da ke fama da cutar pneumonia dangane da cutar ta Wuhan.
Dukkanin fasalulluka na SARS-CoV-2 na cutar coronavirus suna da alaƙa da yanayi.
A waje da jikin mutum, ana kashe kwayar ta ta hanyar sabulu na gida, wanda ke fitar da kumfa mai kare ta. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Fuskokin huhu sune mafi yawan kwayoyin da COVID-19 ya shafa saboda kwayar cutar ta shiga cikin ƙwayoyin hos ta hanyar enzyme mai canza enzyme angiotensin (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolus na nau'in II a cikin huhu.
Kwayar cuta tana amfani da wani glicoprotein mai suna "pepaku" (peplomer) don haɗawa da ACE2 kuma ya shiga cikin sel na mai masaukin baki.
Ana samun cututtukan zuciya a cikin kashi 12 cikin dari na mutanen da suka kamu da cutar da aka kwantar a asibiti a Wuhan, China kuma sun fi yawa a cikin mummunan cututtuka.
Yawan cututtukan zuciya yana da yawa, saboda sakamakon rashin lafiyar tsarin tsarin jiki da kuma rashin lafiyar tsarin jiki yayin da cutar ke ci gaba, amma rauni na myocardial na iya kasancewa yana da alaƙa da masu karɓar ACE2 a cikin zuciya.
Abubuwan karɓar ACE2 suna da yawa a cikin zuciya kuma suna da hannu sosai a aikin zuciya.
An gano manyan lamuran hawan jini (31%) da hawan jini (25%) a cikin marasa lafiya na ICU da ke da kamuwa da COVID-19 kuma suna iya danganta da mummunan hangen nesa.
Duk da cewa SARS-COV-2 yana da tropism ga kwayoyin epithelial na ACE2 a cikin numfashi, marasa lafiya da ke fama da COVID-19 suna da alamun hyperinflammatory systemic.
Musamman, an nuna cewa kwayoyin T-cell na GM-CSF suna da alaƙa da ƙwayar ƙwayar cuta na IL-6 da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma ruwaito cewa an yi wani abu mai kama da na lymphocytic a lokacin da aka yi wa mutum jana'izar.
WHO ta wallafa wasu takardun shaida na gwaji don cutar.
Hanyar gwajin misali ita ce ainihin lokacin juyawar polymerase transcriptional chain reaction (rPT-PCR).
Ana yin gwajin ne a kan samfurin numfashi da aka samu ta hanyar swab na nasopharingeal; duk da haka, ana iya amfani da swab na hanci ko samfurin hanci.
Ana iya yanke shawara a cikin 'yan sa'o'i ko kwana biyu.
Ana iya yin gwajin jini amma yana bukatar a ɗauki jini biyu makonni biyu kuma a yanke shawara ba a yi gaggawa ba.
Masana kimiyya na kasar Sin sun sami damar ware nau'in coronavirus kuma sun wallafa bayanan kwayoyin halitta don haka dakunan gwaje-gwaje na duniya zasu iya ci gaba da gwajin polymerase chain reaction (PCR) don gano kamuwa da cutar.
Kamar yadda aka yi a ranar 4 ga Afrilu 2020, gwajin rigakafi (wanda zai iya gano kamuwa da cutar mai aiki da kuma ko mutum ya taɓa kamuwa da cutar a baya) yana ci gaba amma ba a amfani da shi sosai.
Kwarewar kasar Sin ta nuna cewa an gwada shi ne da kashi 60 zuwa 70 cikin dari.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagorar bincike da asibitin Zhongnan na Jami'ar Wuhan ya wallafa ta ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halaye na asibiti da haɗarin annoba.
Abubuwan da ke faruwa a cikin gilashin da aka lalata na biyu tare da rarraba na gefe, asymmetric da posterior suna da yawa a lokacin farkon kamuwa da cuta.
Dominance na subpleura, yawancin sutura (satsar da septum mai kwakwalwa tare da cika alveolus da yawa) da kuma haɗuwa na iya faruwa lokacin da cutar ta ci gaba.
Akwai wasu bayanai game da cutar ta COVID-19 ta cutar monoscopic da pathophysiology.
Babban binciken da aka samu a lokacin aikin nan da aka yi wa jinin shi ne:
Macroscopy: pleurisy, pericarditis, haɗuwa da huhu da kumburi na huhu
Ana iya lura da nau'i hudu na cutar pneumonia:
ƙananan ciwon huhu: ciwon huhu, ciwon huhu, hyperplasia, babban ciwon huhu, kumburi na sararin samaniya tare da mamayewar lymphocytic da kuma samar da kwayoyin halitta masu yawa
mummunan ciwon huhu: lalacewar alveolus diffus (DAD) tare da exudate alveolus diffus.
DAD shine dalilin cutar ta rikitarwa ta numfashi (ARDS) da kuma matsanancin hypoxia.
dawo da cutar huhu: gyaran exudate a cikin alveolus da kuma pulmonary inter-space fibrosis
Jinin: rarraba intravascular coagulation (DIC), leukoearythroblastic spotting
Matakan rigakafi don rage yiwuwar kamuwa da cuta sun haɗa da zama a gida, guje wa wuraren jama'a, wanke hannuwanku da sabulu da ruwa a kai a kai da kuma aƙalla na tsawon dakika 20, yin tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa wankewa.
CDC ta ba da shawarar rufe baki da hanci da kayan shafawa lokacin da kake tari ko yin tari kuma ta ba da shawarar yin amfani da ɓangaren ciki na kafada idan babu kayan shafawa.
Ana ƙarfafa a tsabtace hannayenmu da kyau bayan wani tari ko kumburi.
CDC ta ba da shawarar yin amfani da suturar fuska a wuraren jama'a, a wani ɓangare don iyakance motsi ta hanyar mutane marasa alamun. Dabarun tsare jama'a suna nufin rage haɗuwa da mutane masu kamuwa da cuta tare da manyan rukuni ta hanyar rufe makarantu da wuraren aiki, iyakance tafiya da soke manyan tarurruka na jama'a.
An kuma haɗa da umurnin tsare mutane aƙalla aƙalla ƙafa 6 (1.8 m) daga gare su.
Babu magungunan da aka gano suna da tasiri wajen hana COVID-19. Tun da ba a tsammanin allurar rigakafi har zuwa farkon 2021, babban abin da za a yi a gudanar da COVID-19 shi ne ƙoƙarin rage ƙarancin annobar, wanda ake kira "ƙaddamar da karkatarwa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa a kai a kai na akalla na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun yi gurɓata, kafin su ci abinci ko bayan sun yi ta numfashi, sun yi tari ko sun yi kumburi.
Ana kuma ba da shawarar yin amfani da tsabtace hannu na tushen barasa tare da aƙalla 60% barasa amma kawai lokacin da sabulu da ruwa ba su da wuri. Don yankunan da ba su da tsabtace hannu na kasuwanci, WHO ta samar da wasu maganganu biyu don samar da gida.
A cikin wannan tsari, antimicrobial aiki ya fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da spores na kwayoyin a cikin barasa; yana da "ba abu ne mai aiki ba don maganin hannayen hannu".
An ƙara glycerol a matsayin mai narkewa.
Ana kula da mutane da kulawa mai taimako, wanda zai iya haɗa da maganin ruwa, goyon bayan oxygen, da kuma tallafawa wasu mahimman gabobin da suka shafi.
Hukumar ta CDC ta bada shawarar cewa duk wanda ya yi zargin cewa yana dauke da cutar ya saka abin rufe fuska mai sauki.
Ana amfani da oxygenation na membrane extracorporeal (ECMO) don magance matsalolin rashin numfashi, amma har yanzu ana la'akari da amfani.
Ana ba da shawarar tsabtace mutum da kuma salon rayuwa mai kyau da kuma cin abinci don inganta rigakafi.
Kulawar tallafi na iya zama da amfani ga waɗanda ke da alamun bayyanar cututtuka a farkon matakin kamuwa da cutar. WHO da Hukumar Lafiya ta China sun ba da shawarwari don kula da waɗanda aka kwantar da su asibiti tare da COVID-19.
Masu kula da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Har zuwa watan Afrilu na shekarar 2020, babu wani magani na musamman ga COVID-19.
Don bayyanar cututtuka, wasu likitoci sun ba da shawarar acetaminophen (paracetamol) a matsayin mai amfani da farko maimakon ibuprofen.
Ya kamata a yi amfani da matakan tsaro don rage haɗarin watsa kwayar cutar, musamman a cikin tsarin kula da lafiya lokacin aiwatar da hanyoyin da za su iya samar da aerosol, kamar intubation ko numfashi na hannu.
Don masu aikin kiwon lafiya da ke kula da waɗanda ke da cutar COVID-19, CDC ta ba da shawarar sanya mutumin a cikin Rukunin Keɓewa na Cutar Cutar (AIIR) a cikin ƙari don amfani da ƙa'idodin tsaro, ƙa'idodin hulɗa da ƙa'idodin kulawa na ciki. CDC ta samar da jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan da aka ba da shawarar sune: rigar PPE, mai numfashi ko abin rufe fuska, mai kare ido da safar hannu na likita. Idan akwai, mai numfashi (a maimakon abin rufe fuska) ya fi dacewa.
An amince da N95 respirator ta hanyar masana'antu amma FDA ta riga ta ba da izinin amfani da abin rufe fuska a ƙarƙashin Dokar Amfani da gaggawa (EUA).
An tsara shi don kare shi daga ƙwayoyin halitta kamar ƙura amma yana da tasiri ga takamaiman kwayoyin halitta ba a ba da tabbacin amfani da su a waje ba.
Idan ba a iya samun abin rufe fuska ba, CDC ta ba da shawarar yin amfani da kariya ta fuska ko a matsayin zaɓi na ƙarshe, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani sosai don haka suna buƙatar iska ta inji ko na madadin, amma wasu kashi suna buƙatar ta.
Ana nazarin nau'ikan tallafin numfashi ga mutane da ke da COVID-19 dangane da gazawar numfashi a cikin asibiti tare da wasu shaidu cewa ana iya kauce wa intubation tare da ƙwayoyin hanci masu ƙarancin ƙarfi ko matsin lamba na iska mai kyau na biyu.
Ko waɗannan biyun suna ba da amfanin iri ɗaya ga mutanen da ke da ciwon cuta ba a sani ba.
Wasu likitoci sun zaɓi su ci gaba da yin amfani da iska mai guba idan ana iya samun su saboda wannan fasaha ta iyakance yaduwar ƙwayoyin aerosol fiye da na hanci mai zurfi.
Yawancin ƙasashe masu tasowa ba su da isasshen asibitocin asibiti a kowace mutum, wanda ke iyakance ƙarfin tsarin kiwon lafiya don sarrafa ƙaruwar ƙaruwar yawan shari'o'in COVID-19 da ke buƙatar shiga asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na mutanen da aka kwantar a cikin gidajen jinya, kashi 2.3 cikin 100 na mutanen da suka yi fama da rashin lafiya suna bukatar taimakon iska kuma kashi 1.4 cikin 100 sun mutu.
A kasar Sin, akalla kashi 30 cikin dari na marasa lafiya da ke asibiti da COVID-19 za a yi musu asibiti a ICU a ƙarshe.
Ana samun rikitarwa ta hanyar iska ta inji saboda ciwon cutar ta shan numfashi mai tsanani (ARDS) da ke tasowa a cikin COVID-19 da kuma samun iskar oxygen yana da wuya.
Ana buƙatar fan don sarrafa matsa lamba da kuma babban PEEP don ƙara yawan isar da iskar oxygen yayin rage haɗarin rauni na huhu da ke tattare da fan da pneumothorax.
Za a iya samun PEEP mai yawa a cikin iska mai iska na dogon lokaci.
Bincike don yiwuwar magani ya fara ne a watan Janairun 2020, kuma wasu magungunan riga-kafi suna cikin gwaji na asibiti.
Remdesivir ya bayyana a matsayin mafi kyawun abin da za a iya tsammani.
Ko da yake sababbin magunguna na iya ɗaukar har zuwa 2021 don ci gaba, wasu magunguna da ake gwadawa sun riga sun sami amincewa don wasu amfani sun riga sun kasance cikin ci gaba da gwaji.
Ana iya gwada maganin rigakafi a kan mutanen da suke da ciwo mai tsanani.
WHO ta ba da shawarar cewa masu aikin sa kai su shiga cikin gwaji na tasiri da aminci na magani. FDA ta ba da izini na wucin gadi ga plasma na farfadowa a matsayin magani na gwaji a cikin lokuta don rayukansu masu tsanani ko masu saukin haɗari.
Har yanzu ba a gwada shi ba, kuma ba a gwada shi ba, don tabbatar da cewa yana da lafiya da kuma tasiri ga cututtuka.
A watan Fabrairun 2020, kasar Sin ta kaddamar da aikace-aikacen hannu don magance annobar.
Ana bukatar masu amfani su saka sunayensu da kuma takardun shaida.
Wannan app na iya gano 'masu kusanci' ta amfani da bayanan kulawa kuma ta haka ne yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya bincika matsayin sauran masu amfani uku.
Idan ana iya gano wata barazana, ba wai kawai aikace-aikacen yana ba da shawarar yin keɓewa ba, amma yana kuma faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da manyan bayanan bayanai akan bayanan wayar hannu, fasahar fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin mutanen da suka kamu da cutar da kuma mutanen da suka tuntube a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba wa hukumomin tsaro damar bin diddigin bayanan wayar salula na wadanda suka kamu da cutar coronavirus.
An dauki matakan da za su tabbatar da killace wadanda ke da alaka da wadanda ke dauke da cutar.
Har ila yau, a watan Maris na 2020, Deutche Telekom ta raba bayanan wurin waya tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar fuska don gano masu yin rigakafi.
Kwamishinan lafiya na lardin Italiya Giulio Gallera ya ce an sanar da shi daga masu amfani da wayoyin hannu cewa "kashi 40 cikin dari na mutane suna ci gaba da motsi zuwa wurare dabam dabam".
Gwamnatin Jamus ta gudanar da hackathon na tsawon sa'o'i 48 a karshen mako tare da fiye da mutane 42,000.
Haka kuma shugaban kasar Estonia, Kersti Kaljulaid ya yi kira ga duniya da ta yi amfani da hanyoyin samar da hanyoyin magance yaduwar cutar coronavirus.
Mutum zai iya fuskantar matsi daga yin rigakafi, ƙuntatawar tafiya, sakamakon magani ko kuma tsoron kamuwa da cutar.
BBC ta ruwaito Rory O'Connor a cewarsa: "Habawar zaman talauci, zaman zaman lafiya, damuwa, damuwa da kuma koma bayan tattalin arziki sune cikakkiyar dubban abubuwan da ke cutar da lafiyar tunanin mutane da kuma jin dadin su".
Cutar za ta haifar da sakamako mai sauƙi tare da ƙananan alamomi ko babu alamomi, kamar na yau da kullum na rashin lafiyar numfashi kamar mura.
Sauƙaƙe cututtuka sukan warke cikin makonni biyu, yayin da waɗanda ke da mummunan ko mawuyacin cuta ke ɗaukar makonni uku ko shida don warkewa.
Mata masu ciki na iya samun haɗarin kamuwa da cutar COVID-19 mai tsanani dangane da bayanan daga wasu ƙwayoyin cuta irin su SARS da MERS, amma bayanan COVID-19 sun kasance kaɗan. A cikin wasu mutane, COVID-19 na iya shafar huhu wanda ke haifar da cutar huhu.
A cikin mafi yawan waɗanda suka sami mummunan rauni, COVID-19 na iya ɓacewa cikin sauri zuwa cututtukan cututtukan numfashi na gaggawa (ARDS) wanda ke haifar da rashin numfashi, damuwa na septic ko rashin aiki na gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gab
Rikicin da ke tattare da COVID-19 ya hada da sepsis, rashin sanyi da kuma lalacewar zuciya, koda da hanta.
Rashin hawan jini, musamman karuwar protrombin lokaci, ya bayyana a cikin kashi 6% na wadanda aka kwantar da su asibiti da COVID-19, yayin da aka lura da rashin aikin koda a cikin kashi 4% na wannan rukuni.
Akalla kashi 20-30% na mutanen da ke da cutar COVID-19 sun nuna karuwar enzymes na hanta (transaminase).
Rahoton ya nuna cewa, a tsakanin bayyanar cututtuka da mutuwa, ana iya ɗaukar kwanaki goma, kuma ana iya ɗaukar kwanaki biyar a asibiti.
Duk da haka, marasa lafiya da aka kwantar a ICU suna da matsakaicin lokaci na kwanaki bakwai tsakanin shiga asibiti da mutuwa.
A cikin binciken farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa shine kwanaki 14, tare da cikakken ɗaukar hoto na kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta gudanar, maza sun samu kashi 2.8 cikin dari na mutuwa yayin da mata suka samu kashi 1.7 cikin dari.
Binciken histopathology a cikin samfurori na huhu na postmortem ya nuna lalacewar alveolus da aka yada tare da fibromisoid cell exudate a cikin huhu biyu.
An lura da canje-canje a cikin cutar cytopathy a cikin ƙwayoyin cuta.
Hotunan huhu sun nuna cewa ana fama da cutar ta numfashi mai tsanani (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya tare da karuwa a matakan troponin ko kuma dakatar da zuciya.
Bisa ga bayanan watan Maris na Amurka, kashi 89% na wadanda aka kwantar da su asibiti tare da yanayin kiwon lafiya na yanzu, wadatar albarkatun kiwon lafiya da tattalin arzikin yankin na iya shafar yawan mutuwar.
Yawan mutuwar da aka samu daga yanayin ya bambanta saboda bambancin yankinsu, amma kuma saboda wahalar da aka samu a cikin hanyoyin.
Ƙananan ƙididdigar ƙananan ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ.
Koyaya, gaskiyar cewa mutuwar ta kasance sakamakon kamuwa da cuta a baya na iya nufin yawan mutuwar yanzu ya wuce kima.
Masu shan sigari suna da damar da ta fi dacewa da bayyanar cututtukan COVID-19 sau 1.4 kuma suna da aƙalla damar 2.4 da za su bukaci kulawa mai kyau ko mutuwa fiye da waɗanda ba sa shan sigari. An nuna damuwa game da ciwon na dogon lokaci.
Hukumar asibitocin Hong Kong ta gano raguwar kashi 20 zuwa 30 cikin 100 na iyawar huhu a cikin wasu marasa lafiya da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar gabobin.
Wannan zai iya haifar da ciwon bayan-kwararrun kulawa da kuma dawo da.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar ta baya ta ba da tasiri mai tsawo da rigakafi a cikin waɗanda suka warke daga cutar ba.
Ana ganin rigakafi a matsayin mai yuwuwa, bisa ga sauran halayen coronavirus, amma a cikin lokuta tare da murmurewa daga COVID-19 an bi shi da gwajin tabbatacce don coronavirus a ranar da aka ruwaito.
Ana ganin cewa duk waɗannan sun fi muni da ciwon da ya daɗe fiye da na sake kamuwa da cutar.
Ana ganin cewa kwayar halitta ce kuma ta fito ne daga dabbobi, ta hanyar kamuwa da cutar.
Ba a san ainihin asalinsa ba amma har zuwa Disamba 2019 kusan dukkanin kamuwa da cutar ta kasance ta hanyar watsawa daga mutum zuwa mutum.
Wani binciken da aka yi na farko da aka tabbatar da mutum 41 da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya bayyana cewa farkon fara bayyanar cututtuka shine a ranar 1 ga Disamba, 2019.
Wata sanarwa ta WHO ta ruwaito farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da wasu matakan da aka saba amfani da su wajen auna yawan mutuwar.
Wadannan lambobi sun bambanta ta yankuna da lokaci kuma suna shafar yawan gwajin, ingancin tsarin kula da lafiya, zaɓin magani, tsawon lokacin da aka fara yaduwar da kuma halaye na yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar ICD-10 ta gaggawa U07.1 don mutuwar daga kwayar cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar daga kwayar cutar SARS-CoV-2 ba tare da tabbatar da gwajin gwaji na COVID-19 da aka gano ba.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar da aka samu a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cutar (IFR) wanda ke nuna yawan mutanen da suka kamu (masu ganowa da marasa ganowa) da suka mutu daga cutar.
Wannan kididdigar ba ta da iyaka a lokaci kuma ta bi wani yanki na al'umma daga kamuwa da cuta zuwa warwarewar hali.
Duk da yake ba kowa ba ne ke samun rigakafi, kasancewa da rigakafi na iya ba da bayani game da yawan mutanen da suka kamu.
A tsakiyar annobar a Italiya, Castiglione d'Adda, ƙauye ƙanana 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar ta yadu ne ta hanyar bikin Carnival, kuma watsawa ga matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ne aka sanya su a hukumance ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai yi nasara ba.
A Netherlands, akalla kashi 3 cikin 100 na iya samun rigakafi kamar yadda aka kimanta daga mai ba da jini.
An tabbatar da mutuwar 69 (0.004% na yawan) daga COVID-19.
Sakamakon annobar da kuma yawan mutuwar ta bambanta ga maza da mata.
Yawan mutuwar da aka samu a maza a cikin binciken da aka gudanar a kasar Sin da Italiya.
Mafi yawan mutanen da ke fuskantar haɗari a cikin maza suna cikin shekaru 50, kuma bambanci tsakanin maza da mata suna yin ciki ne kawai a cikin shekaru 90.
A kasar Sin, yawan mutuwar mata ya kai kashi 2.8 cikin dari na maza da kuma kashi 1.7 cikin dari na mata.
Ba a san ainihin dalilin wannan bambancin jinsi ba amma akwai wasu dalilai na halitta da kuma halaye da za su iya haifar da hakan.
Bambancin rigakafi bisa jinsi, rashin yawan shan sigari a cikin mata da maza yana haifar da yanayin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A Turai, maza ne suka kai kashi 57 cikin 100 na wadanda suka kamu da cutar, kuma maza ne suka kai kashi 72 cikin 100 na wadanda suka mutu sakamakon COVID-19.
Har zuwa watan Afrilu na 2020, gwamnatin Amurka ba ta tattara bayanan jima'i na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan cuta kamar Ebola, HIV, influenza da SARS suna shafar maza da mata daban-daban.
Yawan ma'aikatan kiwon lafiya, musamman ma ma ma'aikatan jinya, mata ne kuma sun fi kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan hukuma na cutar shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa an gano CO ga coronavirus, VI ga virus, D ga cuta da 19 don lokacin annobar a karon farko: 31 ga Disamba, 2019.
An zaɓi sunaye don kauce wa ambaton wani wuri na musamman (cth. China), nau'in dabba ko rukuni na mutane, daidai da ƙa'idodin ƙasashen duniya don ba da sunaye don kauce wa stigma. Kwayar cutar da ke haifar da COVID-19 ana kiran ta coronavirus na cutar ta numfashi mai tsanani 2 (SARS-CoV-2).
Bugu da ƙari, WHO ta yi amfani da "COVID-19 virus" da "virus da ke da alhakin COVID-19") a cikin sadarwa ta jama'a.
Ana kiran cutar da kuma kwayar cutar "coronavirus".
A lokacin farkon yaduwar cutar a Wuhan, China, an yi amfani da ƙwayoyin cuta da cututtuka don kiran "coronavirus" da "coronavirus Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da cututtukan numfashi na 2019-nCoV a matsayin sunayen wucin gadi don ƙwayoyin cuta da cututtuka daidai da jagorar 2015 kan amfani da wuri don ƙwayoyin cuta da sunayen ƙwayoyin cuta.
An sanar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntatawa a cikin ƙarfin samar da kayayyaki na yau da kullun, wasu masana'antun dijital sun fitar da kayan kiwon lafiya kamar swabs na hanci da sassan iska.
A misali, a lokacin da asibitocin Italiya ke bukatar kwandishan nan da nan, kuma mai ba da sabis ba zai iya ba da su a cikin adadin lokacin da ake buƙata ba, wani mai aikin injiniya ya juya gida ya samar da kwandishan 100 da ake buƙata a cikin dare.
Bayan farkon yaduwar COVID-19, ka'idodin makirci, rashin fahimta da rashin fahimta sun bayyana game da asalin, sikelin, rigakafi, magani da sauran fannoni na cutar kuma sun bazu cikin sauri akan layi.
Mutane suna da ikon yada kwayar cutar zuwa wasu dabbobi.
Binciken ya kasa gano wani abu da ya nuna cewa cutar ta kamu da cutar a cikin dabbobi kamar su ƙuda, ducks da kaza.
Babu magani ko allurar rigakafi da aka amince da su don magance cutar.
Binciken duniya kan alluran rigakafi da magungunan COVID-19 na ci gaba da aiki ta hanyar kungiyoyin gwamnati, kungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da "Tunanin SOLIDARITY" don tantance tasirin maganin maganin riga-kafi guda hudu na yanzu tare da ingancin da za a iya tsammani.
Babu allurar rigakafi da za a iya samu amma hukumomi da dama suna aiki sosai wajen samar da allurar rigakafi.
An yi amfani da kokarin da aka yi a baya kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da masu karɓar ACE2 don shiga cikin sel na mutum.
Akwai dabarun rigakafi guda uku da ake bincike a kai.
Na farko, masu bincike suna neman gina maganin cutar gaba daya.
Ana amfani da cutar ta hanyar kashewa ko kashewa, don samun amsawar rigakafi ta gaggawa a jikin mutum ga sabon kamuwa da COVID-19.
Hanyar ta biyu, wato, allurar rigakafi, tana nufin samar da allurar rigakafi mai ƙwarewa da tsarin rigakafi a wasu sassan cutar.
A cikin SARS-CoV-2, binciken ya mayar da hankali ne akan furotin S mai ƙyama wanda ke taimakawa kwayar cutar ta keta kwayar cutar ACE2.
Dabarar ta uku ita ce allurar nucleic acid ( allurar DNA ko RNA, sabuwar fasaha don ƙirƙirar allurar).
A ranar 16 ga Maris, 2020, an fara gwaji na farko na allurar tare da masu aikin sa kai hudu a Seattle.
An yi magana game da karuwar dogaro da rigakafin rigakafi a matsayin ƙalubale ga ci gaban allurar SARS-COV-2, amma wannan abu ne mai ban mamaki.
Akwai fiye da 300 na gwaji na asibiti masu aiki a cikin aiki har zuwa Afrilu 2020.
An amince da gwaje-gwaje bakwai da za a yi nazari a kan maganin zazzabin cizon sauro, ciki har da hudu da aka yi amfani da su wajen magance cutar.
Ana amfani da maganin rigakafi da aka yi amfani da shi a yawancin bincike na kasar Sin, tare da gwaji tara na III akan remdesivir don wasu ƙasashe da za a bayar da rahoto a ƙarshen Afrilu.
Ana ba da damar yin nazarin ci gaban asibiti na allurar COVID-19 da kuma magungunan magani na gaba, har zuwa Afrilu 2020. Wasu magungunan riga-kafi na yanzu ana kimanta su don maganin COVID-19, ciki har da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir suna haɗuwa da interferon beta.
Akwai hujja ta gwaji game da tasirin remdesivir har zuwa watan Maris 2020.
An lura da ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da remdesivir a cikin jinƙai.
An gudanar da gwaji na Phase III a Amurka, China da Italiya. Chloroquine, wanda aka yi amfani da shi wajen magance zazzabin cizon sauro a China a watan Fabrairun 2020, ya ba da sakamako na farko.
Duk da haka, akwai bukatar sake dubawa a matsayin bincike.
Hukumomin Koriya da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayar cutar Wuhan, yayin da ta ba da shawarar kashi ɗaya na kowace rana, ta yarda cewa sau biyu yana da haɗari sosai kuma yana iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chloroquine a kan shawarar likitanci na likitanci don kula da waɗanda ke da cutar COVID-19.
Bayanai na farko sun nuna cewa ribavirin mai yawa yana da mahimmanci don gano SARS-CoV-2 a cikin in vitro.
An ba da shawarar Nitazoxanide don ƙarin nazarin in vivo bayan nuna ƙananan ƙarancin ƙwayar cuta a cikin SARS-CoV-2. Nazarin ya nuna cewa ƙaddamar da furotin na farko na haɓakawa ta hanyar serina protease transmembrane 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa da masu karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan ƙuntatawa waɗanda ke hana ƙungiyar likitanci yin amfani da wannan maganin ba tare da ƙarin bincike ba. Oseltamivir bai gano SARS-CoV-2 a cikin in vitro ba kuma babu wani aikin da aka sani a cikin maganin COVID-19.
Cytokine hadari na iya zama rikitarwa a mataki na gaba ga COVID-19 mai tsanani.
Akwai hujja cewa hydroxychloroquine yana da tasirin antistatic. Tocilizumab an sanya shi cikin jagororin magani ta Hukumar Lafiya ta Kasa ta kasar Sin bayan an kammala karamin bincike.
Yana cikin gwajin gwaji na kasa na biyu a Italiya bayan ya nuna kyakkyawan sakamako na rashin lafiya mai tsanani.
A hade da gwajin jini na serum ferritin don gano hadarin cytokine, ana nufin a magance wannan ci gaban, wanda ake ganin shi ne sanadin mutuwar wasu mutane da suka kamu da cutar.
FDA ta amince da interleukin-6 receptor antagonist bisa ga nazarin binciken da aka yi a baya don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Har zuwa yanzu, babu wata hujja ta bazuwar da ta nuna cewa tocilizumab magani ne mai tasiri ga CRS.
Ana gudanar da bincike kan yadda za a yi amfani da maganin rigakafi da kuma maganin rigakafi da tsarin garkuwarsu na rigakafi ya samar wa mutanen da ke bukatarsa a matsayin hanyar da ba ta da allurar rigakafi ba.
An gwada wannan dabarar a SARS ba tare da wani sakamako mai kyau ba.
Kashewar cutar shine tsarin aikin da ake tsammani wanda maganin antibody mai aiki zai iya zama matsakaici na karewa akan SARS-CoV-2.
Sauran hanyoyin, duk da haka, kamar su cellular cytotoxicity, suna da ƙarancin antibody dependence da/ko yiwu phagocytosis.
Wani nau'i na maganin rigakafi na jiki, misali, ta amfani da kwayoyin halitta na monoclonal ana ci gaba da ci gaba.
Ana iya ƙara yawan ƙwayar ƙwayar ƙwayar ƙwayar cuta, wanda ya ƙunshi sassan jini na marasa lafiya da suka warke kuma yana dauke da ƙwayoyin antibodies na musamman ga cutar don yin aiki da sauri.
Cutar coronavirus, wata cuta ce da ke da nasaba da juna.
Li Wenliang, wani likita a asibitin Wuhan na tsakiya, ya kamu da cutar kuma ya mutu saboda COVID-19 bayan ya haifar da wayar da kan jama'a game da yaduwar cutar.
